type,id,title,category,content
category,1000,GENERAL PATIENT MANAGEMENT,blue,
category,2000,CARDIAC PROTOCOL,red,
category,3000,TRAUMA PROTOCOL,gray,
category,4000,MEDICAL PROTOCOL,indigo,
category,5000,PEDIATRIC CONSIDERATIONS,pink,
category,6000,SPECIAL OPERATIONS,yellow,
category,7000,ADMINISTRATION,green,
,,,,
protocol,1001,Introduction to Treatment Protocols,1000,"<ul>
        <li>Each protocol has been approved by the Greater Miami Valley EMS Council and the Regional Physician Advisory Board for Region 3 (as defined by the State Board of Emergency Medical, Fire and Transportation Services [EMFTS]).</li>
        <li>Each tab bears an effective date and a last modified date marking it as the latest version.</li>
        <li>A new addition to protocol would reflect a duplicate ""Effective"" and ""Last Modified"" date.</li>
        <li>When changes or revisions are made to a tab, only the ""Last Modified"" date will be changed.</li>
        <li>Each time changes or additions are made; they can be referred to by their specific line in the protocol. i.e. A change was made to ""1001.1.e"".</li>
        <li>Each year, changes or additions will be listed in an addendum in the appendix.</li>
    </ul>

    <h3>1001.2 Printing, Retention, and Display</h3>
    <ul>
        <li>All GMVEMSC Treatment Protocols are intended for color printing, and hard copy retention.</li>
        <li>These protocols are also intended for electronic display in Adobe Portable Document Format (PDF).
            <ul class=""list-disc pl-6"">
                <li>The PDF version includes links to the different tabs throughout the document.</li>
                <li>The GMVEMSC logo on most pages is a hyperlink back to the table of contents.</li>
            </ul>
        </li>
        <li>Distribution is provided by means of the GMVEMSC official website.</li>
    </ul>

    <h3>1001.3 Application</h3>
    <ul>
        <li>This protocol is for use by those individuals operating in and under the authority of the Greater Miami Valley EMS Council (GMVEMSC) Drug Bag Exchange Program and certified by the State of Ohio as an EMS provider.</li>
        <li>The provider must pass both the skills check-off and Computer Based Testing (CBT) for the current year.</li>
        <li>The GMVEMSC Treatment Protocols apply to the following certification levels:
            <ul class=""list-disc pl-6"">
                <li>Emergency Medical Responder (EMR)</li>
                <li>Emergency Medical Technician (EMT)</li>
                <li>Advanced Emergency Medical Technician (AEMT)</li>
                <li>Paramedic (PM)</li>
            </ul>
        </li>
    </ul>

    <h3>1001.4 Stipulations</h3>
    <ul>
        <li>The protocol is to be used in the field only.</li>
        <li>Communicate with the receiving facility as soon as practical:
            <ul class=""list-disc pl-6"">
                <li>When transporting unstable patients</li>
                <li>Transporting to hospitals that request contact for all patients delivered to their facility.</li>
            </ul>
        </li>
        <li>No procedures, techniques, or drugs will be used without the proper equipment or beyond the training or capabilities of the prehospital personnel.</li>
        <li>Nothing in this protocol may be used without specific pre-approval of the Medical Director for the local department or agency.</li>
        <li>The protocol is to be utilized as clinically indicated. Not every standing order in a treatment protocol must be carried out on every patient treated under that treatment protocol.</li>
        <li>Discretionary judgment is required and stepwise adherence to specific protocols may not be in the patient's best interest.</li>
        <li>At no time should treatment options exceed those authorized without direct consultation with the Medical Control Physician (MCP).</li>
    </ul>

    <h3>1001.5 Protocol Design</h3>
    <ul>
        <li>The GMVEMSC protocols are organized around the General Patient Management Protocol which must be followed for all patients. This universally applicable protocol/flowchart allows the providers to integrate additional treatment protocols beyond general patient management as clinically necessary for specific patient care, emergency stabilization, and treatment.
            <ul class=""list-disc pl-6"">
                <li>As an example, while caring for a specific patient with chest pain, shortness of breath, and nausea the provider would:
                    <ol class=""list-decimal pl-6"">
                        <li>Follow the General Patient Management Protocol</li>
                        <li>Integrate and follow the Chest Pain Protocol</li>
                        <li>Integrate and follow the Respiratory Distress Protocol if indicated</li>
                        <li>Integrate and follow the Cardiac Alert Protocol if indicated</li>
                        <li>Integrate and follow the Abdominal Pain Protocol if indicated</li>
                        <li>Refer to protocol for specific medication concentrations, dosages, and volumes.</li>
                        <li>Complete the General Patient Management Protocol</li>
                    </ol>
                </li>
            </ul>
        </li>
        <li>In most cases, a specific guideline will only be mentioned once within the protocol. All other circumstances where that guideline would be applicable will simply refer to the original guideline.</li>
        <li>Where applicable, a guideline mentioned in another section will have a hyperlink provided.</li>
        <li>Formatting
            <ul class=""list-disc pl-6"">
                <li>All attempts will be made to keep the protocol focused and specific.</li>
                <li>Extracurricular and enhancing information will be provided in an official study guide.</li>
                <li>All levels of providers will be addressed within a single protocol.</li>
                <li>Procedures and treatments marked with a diamond (&diams;) always require a physician's order.</li>
                <li>Items enclosed in brackets ({}) are at the option of the agency and their Medical Director.</li>
                <li>Sections that apply only to adults are bulleted with an ""A""</li>
                <li>All pediatric treatments will be in pink and bulleted with a ""P"".</li>
                <li>There are also sections which apply to only Geriatric patients and are bulleted with a ""G.""</li>
            </ul>
        </li>
    </ul>

    <h3>1001.6 Clinical Management Tables</h3>
    <ul>
        <li>In addition to general statements, this protocol will utilize table-based algorithms where applicable.</li>
        <li>The table will demonstrate what care can be given at each provider level.
            <ul class=""list-disc pl-6"">
                <li>The level of certifications will be signified by the colored tabs to the right of each section.</li>
            </ul>
        </li>
        <li>Even with a step-by-step algorithm in place, critical thinking is encouraged.</li>
        <li>While the table is sequential and listed by provider level, many elements in each section can be completed simultaneously.</li>
        <li>The following is an annotated example of a Clinical Management Table:
            <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
                <p><strong>Pediatric Considerations:</strong> This is where pediatric specific info might go. Dosing and treatment will still be listed in the algorithm.</p>
                <p class=""mt-2""><strong>Assessment:</strong> This is where Signs & Symptoms and Differential Diagnosis will go.</p>
                <p class=""mt-2""><strong>Treatment Algorithm:</strong> This will be where guidelines for all certification levels will go (EMR, EMT, AEMT, Paramedic).</p>
                <p class=""mt-2""><strong>Consult:</strong> If requirements exist for any level to call for orders, that will be listed here. This section will also list guidelines for alerts, requests for MCP advice, or requests to call the receiving facility.</p>
                <p class=""mt-2""><strong>Clinical Pearls:</strong> Any important guidelines or clinical information will be added here. This will not be a study guide nor a skill sheet.</p>
            </div>
        </li>
    </ul>"
protocol,1002,Communication with Hospital or Medical Control ,1000,"<div>
    <h3>1002.1 Reasons to Contact the Hospital</h3>
    <p>To notify the hospital when time is needed to prepare for patient arrival. Examples include:</p>
    <ul>
        <li>Cardiac arrest</li>
        <li>Any of the defined alerts such as Cardiac Alert, Stroke Alert, Trauma Alert</li>
        <li>Pre-Arrival notification of behavioral patients (e.g. Dr. White, ACE, etc.)</li>
        <li>Indications of sepsis</li>
        <li>Significant communicable disease</li>
        <li>Other serious patients that may require acute care</li>
        <li>Hazardous material exposures (mandatory)</li>
        <li>Bedbugs</li>
    </ul>

    <h3>1002.2 Reasons to Contact Medical Control</h3>
    <ul>
        <li>To obtain orders for procedures or medications as indicated within the protocol.</li>
        <li>For field termination or DNR clarification.</li>
        <li>To obtain advice in a difficult situation or circumstance. Examples include:
            <ul class=""list-roman pl-6 mt-2"">
                <li>Before a medication is given, even though protocol allows it to be used without permission.</li>
                <li>A situation where the patient has an unfamiliar condition.</li>
                <li>To discuss a destination decision.</li>
            </ul>
        </li>
    </ul>

    <h3>1002.3 Call-in Procedures</h3>
    <ul>
        <li>When contacting a hospital, make sure a clear picture is painted.</li>
        <li>When calling about a trauma patient, include:
            <ul class=""list-roman pl-6 mt-2"">
                <li>MIVT-Mechanism, Injuries, Vital Signs and Time</li>
                <li>Estimated time of arrival (ETA)</li>
                <li>The components of the Glasgow Coma Score (GCS)</li>
                <li>Patient assessment findings which are relevant to the decision to transport to a Trauma Center.</li>
            </ul>
        </li>
        <li>If consultation with a physician is desired, specifically request the Medical Control Physician.</li>
        <li>When calling with an Alert (Cardiac, Stroke, Trauma, etc.):
            <ul class=""list-roman pl-6 mt-2"">
                <li>Request to speak directly to the Medical Control Physician at the beginning of the call.</li>
                <li>Verbalize, ""We recommend a _______ Alert.""</li>
                <li>The MCP has the discretion to withhold the Alert and may decide not to activate it.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,1003,Non-initiation of Care ,1000,"<div>
    <h3>1003.1 General Guidelines</h3>
    <ul>
        <li>This protocol may be applied by EMT, AEMT and Paramedic providers only. The EMR cannot determine that a patient is deceased.</li>
        <li>All patients (Adult, Pediatric, and Geriatric) may meet criteria for non-initiation of care.</li>
        <li>If care had begun and is readily apparent to the provider that the patient meets non-initiation of care criteria, <span class=""important-note"">RESUSCITATION EFFORTS MAY CEASE.</span></li>
    </ul>

    <h3>1003.2 Criteria for Non-Initiation of Care</h3>
    <p>Resuscitation will not be initiated in the following circumstances:</p>
    <ul>
        <li>Deep, penetrating, cranial injuries</li>
        <li>Massive truncal wounds</li>
        <li>DNR Order-present and valid (see 1004 Do Not Resuscitate)</li>
        <li>Frozen body</li>
        <li>Rigor mortis, tissue decomposition, or severe dependent lividity</li>
        <li>Triage demands</li>
        <li>For patients in arrest resulting from <span class=""font-bold"">BLUNT OR PENETRATING TRAUMA</span> consider not initiating care for injuries obviously incompatible with life.
            <ol class=""list-decimal pl-6 mt-2"">
                <li>Prolonged arrest (greater than 10 minutes)</li>
                <li>Consider possibility of MIXED MECHANISMS</li>
            </ol>
        </li>
    </ul>

    <h3>1003.3 Exclusionary Conditions</h3>
    <p>The following conditions will not meet non-initiation of care criteria:</p>
    <ul>
        <li>Traumatic arrest in female patient with either:
            <ol class=""list-decimal pl-6 mt-2"">
                <li>Known pregnancy greater than 24 weeks or</li>
                <li>Uterine fundus palpable at or above the umbilicus</li>
            </ol>
        </li>
        <li>Possible medical etiology for traumatic cardiac arrest</li>
        <li>Arrest witnessed by EMS providers</li>
        <li>Lightning strike</li>
        <li>Signs or symptoms of a hypothermic patient</li>
        <li>Focused blunt trauma to the chest, (commotio cordis)</li>
    </ul>
    
    <h3 class=""mt-6"">1003.4 Organ Donation</h3>
    <p>For an inquiry about organ donation, direct the call to Life Connection of Ohio at 1-800-535-9206.</p>
</div>"
protocol,1004,Do Not Resuscitate ,1000,"<div>
    <h3>1004.1 General Guidelines</h3>
    <ul>
        <li>Per ORC 2133.01-2133.26, providers will consider and honor all valid Ohio Do Not Resuscitate orders.</li>
        <li>The two valid DNR orders are DNR: Comfort Care and DNR: Comfort Care Arrest.</li>
    </ul>

    <h3>1004.2 Do-Not-Resuscitate Orders Defined</h3>
    <ul>
        <li><strong>Do-Not-Resuscitate: Comfort Care Arrest (DNR-CCA)</strong>
            <ul class=""list-roman pl-6 mt-2"">
                <li>Permits any GMVEMSC Protocol treatment until the patient goes into cardiac or respiratory arrest.</li>
                <li>Once the patient meets the above criteria, then only permitted DNR treatment is performed.</li>
            </ul>
        </li>
        <li class=""mt-2""><strong>Do-Not-Resuscitate: Comfort Care (DNR-CC)</strong>
            <ul class=""list-roman pl-6 mt-2"">
                <li>Permits any medical treatment to diminish pain or discomfort</li>
                <li>No treatment should be used to postpone the patient's death.</li>
                <li>The order is initiated at the moment it is signed by the patient's physician.</li>
            </ul>
        </li>
    </ul>

    <h3>1004.3 Permissible and Impermissible Treatments Once the DNR is Initiated</h3>
    <h4>The following treatments are permitted:</h4>
    <ul>
        <li>Conduct an initial assessment</li>
        <li>Perform basic medical care</li>
        <li>Clear airway of obstruction or suctioning</li>
        <li>If necessary, for comfort or to relieve distress, may administer oxygen, CPAP or BiPAP</li>
        <li>If necessary, may obtain IV access for hydration or pain medication to relieve discomfort, but not to postpone death</li>
        <li>If possible, may contact other appropriate health care providers</li>
    </ul>
    <h4 class=""mt-4"">The following treatments are <span class=""font-bold"">not</span> permitted once an order is valid and effective:</h4>
    <ul>
        <li>Perform CPR</li>
        <li>Administer resuscitation medications with the intent of restarting the heart or breathing</li>
        <li>Insert an airway adjunct</li>
        <li>Defibrillation, cardioversion or initiate pacing</li>
        <li>Initiate continuous cardiac monitoring</li>
    </ul>

    <h3>1004.4 Stipulations</h3>
    <ul>
        <li>If more than one living will declaration or DNR exists, the most recent supersedes the previous.</li>
        <li>The authority of a DPOA-HC supersedes the DNR if the DPOA-HC previously consented to the DNR.</li>
        <li>The GMVEMSC protocol will recognize the following special situations as valid. If these scenarios present, then contact MCP and request to honor the DNR with physician permission.
            <ul class=""list-roman pl-6 mt-2"">
                <li>Out-of-State DNR orders</li>
                <li>Pediatric DNR orders</li>
            </ul>
        </li>
        <li>Blood glucose checks and treatment of 4008 Diabetic Emergencies - Hypoglycemia/Hyperglycemia, is acceptable even with a valid DNR.</li>
        <li>While 1005 General Patient Management requires continuous cardiac monitoring when administering pain medications, this focused protocol supersedes that requirement in valid DNR patients.</li>
        <li>In situations where there are questions about the documents, try to keep the patient's intent in mind.</li>
        <li>If there is any confusion on scene, Call MCP for clarification.</li>
    </ul>
</div>"
protocol,1005,General Patient Management ,1000,"<div>
    <h3>1005.1 Guideline</h3>
    <ul>
        <li>The General Patient Management protocol is to be applied to all patients.</li>
        <li>Once a primary impression and differential diagnosis is made, then the provider should look to specific treatment algorithms within these standing orders.</li>
        <li>Unless explicitly addressed, the GMVEMSC Protocol will not specify or endorse any type or brand of medical equipment. It is the responsibility of agency leadership and their medical direction to determine the appropriate equipment needed for medical care and insure that personnel are trained on its use.</li>
    </ul>

    <h3>1005.2 Basic Patient Care</h3>
    <ul>
        <li>The emphasis in patient care should ensure airway protection, oxygenation, and adequate ventilation without causing harm.</li>
        <li>Injury reduction strategies may include noninvasive ventilation when appropriate, titration of oxygen in certain settings, and being cautious not to over ventilate.</li>
        <li>Tailor treatment to the overall clinical picture.</li>
        <li>With the exception of suspected acute cerebral herniation, the rate and depth of ventilation in the prehospital setting should not be guided by the EtCO2 reading alone.</li>
        <li>For the patient with cerebral herniation, ventilate the patient at approximately 20 times per minute to obtain an EtCO2 of 30 mmHg.</li>
        <li>""Permissive hypercapnia"" in most cases is appropriate, particularly in those with chronic lung disease who may chronically retain CO2.</li>
        <li>It is recommended to listen to the chest to ensure that adequate exhalation is occurring during manual ventilation.</li>
    </ul>

    <h3>1005.3 EMT Assisting the Advanced Provider</h3>
    <ul>
        <li>Per Ohio Revised Code, the EMT is permitted to assist the advanced provider with skills that are outside of the EMT's scope of practice.</li>
        <li>The EMT is only allowed to prepare ALS equipment under the direct supervision of the AEMT or Paramedic.</li>
        <li>The skills that an EMT may set up for and assist with are:
            <ul class=""list-roman pl-6 mt-2"">
                <li>Endotracheal intubation</li>
                <li>Intravenous access</li>
                <li>IV fluid administration</li>
                <li>Saline locks</li>
                <li>Placement of 4 and/or {12 Lead EKG} for cardiac monitoring</li>
            </ul>
        </li>
        <li>Accessing the GMVEMSC Drug Bag to locate drugs and/or to assemble pre-jects.</li>
    </ul>

    <h3 class=""mt-6"">1005.4 General Patient Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">Pediatric patients are defined as patients less than 16 years old. A Pediatric reference guide or length-based resuscitation tape may be used to reference pediatric equipment recommendations. Pedi-Wheel may be used as a reference for pediatric vital signs. Unless otherwise specified, the maximum dose for pediatric medication administration is the adult dose.</p>
        
        <div class=""mt-4"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Scene/Crew Safety/PPE; with appropriate equipment/medications to patient side.</li>
                        <li>Initial Assessment/Physical Exam</li>
                        <li>Follow basic life support and airway algorithms as indicated based on current AHA guidelines.</li>
                        <li>An unresponsive patient with gasping breaths and poor color should get supplemental oxygen via BVM.</li>
                        <li>Obtain chief complaint, OPQRST, SAMPLE history, and other pertinent information.</li>
                        <li><strong>Vital Signs:</strong>
                            <ul class=""list-disc pl-5"">
                                <li>Blood Pressure (EMR are limited to obtaining manual blood pressures)</li>
                                <li>Pulse, rate and quality</li>
                                <li>Respirations; Rate, quality, and work-of-breathing</li>
                                <li>Assess every 5 to 15 minutes per patient condition</li>
                                <li>Temperature as needed</li>
                            </ul>
                        </li>
                         <li>Utilize monitoring devices, pulse oximeter, CO-oximetry, capnography, etc. as appropriate and approved by medical direction.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Perform blood glucose check.</li>
                        <li>Where indicated, the EMT may obtain a {12 Lead EKG} for the purpose of transmission.</li>
                        <li>The EMT may assist the advanced provider with:
                            <ul class=""list-disc pl-5"">
                                <li>{12 Lead EKG} application assisting a Paramedic who is present</li>
                                <li>Set up an IV administration kit in the presence of an AEMT or Paramedic</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                 <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                        <li>Utilize cardiac monitor as appropriate.</li>
                        <li>Where indicated, the AEMT may obtain a {12 Lead EKG} for the purpose of transmission.</li>
                        <li>The AEMT may apply a {12 Lead EKG} when assisting a Paramedic who is present.</li>
                        <li>Start IV crystalloid solutions or saline lock as appropriate.</li>
                        <li><strong>IV Therapy:</strong> Follow 4016 Shock Protocol.
                            <ul class=""list-disc pl-5"">
                                <li>For medical emergencies, head trauma, cardiac issues with stable BP, etc.: Use TKO rate.</li>
                                <li>Shock (not related to penetrating trauma): Run IV fluid wide-open, use macro-drip or blood tubing. Decrease fluid rate if SBP greater than 100.</li>
                                <li>P IV fluid 20 ml/kg using macro-drip tubing. Titrate to maintain adequate perfusion.</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>Use of IO devices for both adults and pediatrics is limited to patients who are unresponsive or hemodynamically unstable, and only when less invasive means are not available or are ineffective (e.g. Narcan IN and Versed IN).</li>
                        <li>Provide continuous cardiac monitoring, EtCO2 and pulse oximetry (if available) for all patients with fentanyl, ketamine, morphine or midazolam if not already doing so.</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> If a patient with an existing IV pump experiences an allergic reaction, consider discontinuing the pump.</li>
                        <li>Use of an {IV pump} is optional for any agency with approval from their Medical Director.</li>
                        <li>Existing central venous catheters, dialysis catheters, fistulas, or grafts may be utilized for infusion of IV fluids and medication if the patient is hemodynamically unstable. These may also be used when the patient is deteriorating rapidly.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
             <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">Do not stop the flow of medication in an established medication pump except under direct orders from Medical Control. If a patient with an existing IV pump experiences an allergic reaction, call the MCP for an order to discontinue the pump.</p>
            </div>
             <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                 <ul>
                    <li>If a patient was discharged from a hospital in the last 24 hours, it is recommended to return to the same facility or at the very least, the same network of hospitals.</li>
                    <li>If the patient is experiencing complications from a recent surgery, if possible, transport the patient back to the facility where the surgery was performed. If that is not practical, then try to transport to the same network.</li>
                    <li>If possible, bring medications or a list of the medications to the hospital; include the dose and frequency of administration.</li>
                    <li>Crystalloid fluids include Normosol, Plasmalyte, Lactated Ringers or Normal Saline in that order. Their pH is closer to neutral.</li>
                    <li>Medical emergencies, head trauma, cardiac problems with stable BP: Use TKO rate.</li>
                    <li>IV medication administration: Slow IV = over 2 minutes, unless otherwise specified.</li>
                    <li>Any medication given intravenous can also be administered intraosseous.</li>
                    <li>Maintain normothermia.</li>
                </ul>
            </div>
        </div>
    </div>
</div>
"
protocol,1006,Patient Abuse and Neglect ,1000,"<div>
    <h3>1006.1 Guideline</h3>
    <ul>
        <li>EMS providers MUST, by law, report all alleged or suspected pediatric and adult abuse/neglect.</li>
        <li>Ohio Revised Code requires providers to report incidents of pediatric and adult abuse/neglect to:
            <ul class=""list-disc pl-6 mt-2"">
                <li><span class=""font-bold"">A</span> Their county's adult protective services agency (for patients over 60 years old)</li>
                <li><span class=""font-bold text-pink-600"">P</span> Their county's public children services agency</li>
                <li>Or for both adults and pediatrics; Law enforcement</li>
                <li>For adult patients see ORC 5101.63 and for pediatric patients see ORC 2151.421</li>
            </ul>
        </li>
        <li>Simply notifying hospital personnel does not meet mandated EMS reporting responsibilities.</li>
        <li>Hospitals have copies of the EMS Social Services Referral Form, supplied by GDAHA, for documenting cases of abuse/neglect.</li>
        <li>Use of this form can help providers in providing information needed to their reporting agency, as well as provide for a continuum of care with hospital social services departments.</li>
        <li>Document on the Patient Care Report, all efforts that EMS made to report the suspected abuse; include name of agency notified, method used, and name of person contacted.</li>
    </ul>

    <h3 class=""mt-6"">1006.2 Pediatric Abuse and Neglect</h3>
    <p class=""font-bold text-pink-600"">P Report all alleged or suspected child abuse or neglect to the appropriate agency.</p>
    <div class=""overflow-x-auto mt-2"">
        <table class=""w-full text-sm text-left text-gray-500"">
            <thead class=""text-xs text-gray-700 uppercase bg-gray-100"">
                <tr><th colspan=""4"" class=""px-6 py-3 text-center"">Pediatric Public Social Services Agencies</th></tr>
                <tr><th class=""px-6 py-3"">County</th><th class=""px-6 py-3"">Phone</th><th class=""px-6 py-3"">After Hours Phone</th><th class=""px-6 py-3"">Fax</th></tr>
            </thead>
            <tbody>
                <tr class=""bg-white border-b""><td>Butler</td><td>513-887-4055</td><td>513-868-0888</td><td>513-887-4260</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Champaign</td><td>937-484-1500</td><td>Contact County SO: 937-484-6092</td><td>937-484-1506</td></tr>
                <tr class=""bg-white border-b""><td>Clark</td><td>937-327-1700</td><td>937-324-8687</td><td>937-327-1910</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Darke</td><td>937-548-7129</td><td>937-548-2020</td><td>937-548-8723</td></tr>
                <tr class=""bg-white border-b""><td>Greene</td><td>937-562-6600</td><td>937-372-4357</td><td>937-562-6650</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Miami</td><td>937-335-4103</td><td>Contact County SO: 937-440-3965</td><td>937-339-7533</td></tr>
                <tr class=""bg-white border-b""><td>Montgomery</td><td>937-224-5437</td><td>937-224-5437 (same as daytime)</td><td>937-276-6597</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Preble</td><td>937-456-1135</td><td>937-456-1135 (same as daytime)</td><td>937-456-6086</td></tr>
                <tr class=""bg-white border-b""><td>Shelby</td><td>937-498-4981</td><td>Contact County SO: 937-498-1111</td><td>937-498-1492</td></tr>
                <tr class=""bg-gray-50""><td>Warren</td><td>513-695-1558</td><td>513-695-1600</td><td>513-695-1800</td></tr>
            </tbody>
        </table>
    </div>

    <h3 class=""mt-6"">1006.3 Adult Abuse or Neglect</h3>
    <p class=""font-bold"">A Report all alleged or suspected abuse or neglect to the appropriate agency.</p>
    <div class=""overflow-x-auto mt-2"">
        <table class=""w-full text-sm text-left text-gray-500"">
            <thead class=""text-xs text-gray-700 uppercase bg-gray-100"">
                <tr><th colspan=""4"" class=""px-6 py-3 text-center"">Adult Public Social Services Agencies</th></tr>
                <tr><th class=""px-6 py-3"">County</th><th class=""px-6 py-3"">Phone</th><th class=""px-6 py-3"">After Hours Phone</th><th class=""px-6 py-3"">Fax</th></tr>
            </thead>
            <tbody>
                <tr class=""bg-white border-b""><td>Butler</td><td>513-887-4081</td><td>Contact County SO: 513-785-1000</td><td>513-785-5969</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Champaign</td><td>937-484-1500</td><td>Contact County SO: 937-484-6092</td><td>937-484-1506</td></tr>
                <tr class=""bg-white border-b""><td>Clark</td><td>937-327-1700</td><td>937-324-8687</td><td>937-327-1910</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Darke</td><td>937-548-7129</td><td>937-548-2020</td><td>937-548-4928</td></tr>
                <tr class=""bg-white border-b""><td>Greene</td><td>937-562-6315</td><td>Contact County SO: 937-562-4800</td><td>937-562-6177</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Miami</td><td>937-440-3471</td><td>Contact County SO: 937-440-3965</td><td>937-335-2225</td></tr>
                <tr class=""bg-white border-b""><td>Montgomery</td><td>937-225-4906</td><td>Contact County SO: 937-225-4357</td><td>937-496-7464</td></tr>
                <tr class=""bg-gray-50 border-b""><td>Preble</td><td>937-456-1135</td><td>937-456-1135 (same as daytime)</td><td>937-456-6086</td></tr>
                <tr class=""bg-white border-b""><td>Shelby</td><td>937-498-4981</td><td>Contact County SO: 937-498-1111</td><td>937-498-1492</td></tr>
                <tr class=""bg-gray-50""><td>Warren</td><td>513-695-1420</td><td>513-425-1423</td><td>513-695-2940</td></tr>
            </tbody>
        </table>
    </div>
</div>"
protocol,1007,Basic Airway Maintenance ,1000,"<div>
    <h3>1007.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
            <div>
                <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
                <p class=""text-sm italic"">Repeated and prolonged suctioning could cause hypoxia and bradycardia.</p>
                <div class=""overflow-x-auto mt-2"">
                    <table class=""w-full text-sm"">
                        <thead><tr class=""bg-gray-100""><th colspan=""4"" class=""py-1"">Respirations by Age</th></tr></thead>
                        <tbody>
                            <tr><td>Up to 1 year</td><td class=""font-mono"">30-60</td><td>7-9 years</td><td class=""font-mono"">16-24</td></tr>
                            <tr class=""bg-gray-100""><td>2-3 years</td><td class=""font-mono"">20-40</td><td>10-14 years</td><td class=""font-mono"">16-20</td></tr>
                            <tr><td>4-6 years</td><td class=""font-mono"">20-30</td><td>15+ years</td><td class=""font-mono"">12-20</td></tr>
                        </tbody>
                    </table>
                </div>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Respiratory difficulty or distress</li>
                    <li>Poor SpO2 or EtCO2</li>
                    <li>Mechanism of Injury or Nature of Illness that would require O2 therapy</li>
                    <li>Impending airway issues</li>
                    <li>Adventitious respiratory sounds</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>EtCO2 monitors can be used on all patients with or without adequate perfusion, and with or without artificial airways.</li>
                        <li>Administer Oxygen as needed. Use the following rates as guidelines:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">G</span> 2 LPM by nasal cannula (NC) for patient with COPD, or as prescribed.</li>
                                <li>4-6 LPM by nasal cannula (NC) for other patients.</li>
                                <li>12-15 LPM by non-rebreather mask (NRM) for any patients with increased respiratory rates or effort (including COPD).</li>
                            </ul>
                        </li>
                        <li>Ventilate patients who are symptomatic with an insufficient respiratory rate, depth or effort.</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Patient less than 2 years old showing respiratory distress with nasal congestion, cough, rales, rhonchi or wheezing-without previous history of wheezing, reactive airway disease, breathing treatments:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">P</span> Nasopharyngeal suctioning in both nares (3-5 seconds) with an appropriate device</li>
                                <li><span class=""font-bold"">P</span> If distress continues, repeat nasopharyngeal suctioning for 3-5 seconds</li>
                            </ul>
                        </li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> For patients less than 6 years old showing respiratory distress with agitation, upper airway noise, stridor, and/or ""barky cough"":
                             <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">P</span> Lower temperature of ambulance as much as possible.</li>
                                <li><span class=""font-bold"">P</span> Deliver oxygen as the patient tolerates.</li>
                                <li><span class=""font-bold"">P</span> Often these symptoms resolve with less intervention.</li>
                                <li><span class=""font-bold"">P</span> Consider keeping distance from the patient.</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Consider patient airway anatomy for the appropriate selection of the airway adjunct.</li>
                        <li><span class=""font-bold"">G</span> If indicated, suction the tracheostomy.</li>
                        <li>If patient has history of reactive airway disease with prescribed breathing treatments then treat with 4003 Asthma protocol.</li>
                        <li>Consider the need for a supraglottic or dual lumen rescue airway. The EMT may only place a rescue airway in a pulseless, apneic patient.</li>
                        <li>For guidelines to placement of rescue airways, see 1008 Advanced Airway Management</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                     <ul>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Oxygen flow rate for nebulized medications should be 8-10 LPM.</li>
                        <li>Nebulized medication may be administered while ventilating with a BVM. Preferably use two oxygen sources.</li>
                        <li>Consider the need for intubation. The AEMT may only intubate if patient is apneic.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>If routine ventilation procedures are unsuccessful, try to visualize obstruction with laryngoscope.</li>
                        <li>If a foreign body is seen, attempt to remove it using suction or Magill forceps.</li>
                        <li>When deciding whether to intubate, consider the following:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li>Insufficient respiratory rates, less than 10 or greater than 29, that are not rapidly controlled by other measures</li>
                                <li>Irregular respiratory rhythm</li>
                                <li>Abnormal breath sounds</li>
                                <li>Inadequate chest expansion and respiratory depth</li>
                                <li>Excessive effort to breathe</li>
                                <li>Use of accessory muscles</li>
                                <li>Nasal flaring</li>
                                <li>Pallor or cyanosis</li>
                                <li>Cardiac dysrhythmias</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
             <div><h4 class=""text-base font-bold"">Consult</h4><p class=""text-sm"">The EMT needs MCP ordered to administer nebulized medications.</p></div>
             <div><h4 class=""text-base font-bold"">Clinical Pearls</h4><p class=""text-sm"">COPD patients in severe respiratory distress or with chest pain need the same O2 devices and flow rates as any other patient in such condition.</p></div>
        </div>
    </div>
</div>"
protocol,1008,Advanced Airway Management ,1000,"<div>
    <h3>1008.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
        <ul class=""list-disc pl-5 text-sm"">
            <li>Patient unable to manage their own airway</li>
            <li>Patient in cardiac arrest</li>
            <li>Patient in respiratory arrest (AEMT & Paramedic)</li>
            <li>Rapidly collapsing airway</li>
        </ul>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>The EMT may only place a rescue airway in a pulseless, apneic patient.</li>
                        <li>If approved, ""rescue airways"" such as the Supraglottic Airways or Dual Lumen Airways are appropriate airway devices for both adult and pediatric patients.</li>
                        <li>Confirm correct placement of advanced airways by at least 5 methods, see protocol 1009 Advanced Airway Confirmation Devices.</li>
                        <li>Reassess advanced airway placement every time the patient is moved.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                     <ul>
                        <li>An AEMT may only intubate if patient is apneic.</li>
                        <li>Consider patient airway anatomy and condition for proper advanced airway device selection.</li>
                        <li>If a total of two attempts with an ET tube are not successful, move to a rescue airway.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Supraglottic airway is recommended as the primary airway except in extreme cases such as airway edema.</li>
                        <li>Always secure the ET tube in place, preferably with a commercial tube-securing device.</li>
                        <li>A cervical collar is effective in maintaining patient's head in a neutral position during the intubation process.</li>
                        <li>If there are indications of tension pneumothorax and the patient is hemodynamically unstable:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li>Decompress the chest with a 14-gauge or larger, 3½"" angiocath</li>
                                <li>Location options include:
                                    <ul class=""list-disc pl-5 mt-1"">
                                        <li>Fourth or fifth intercostal space in the mid-axillary line</li>
                                        <li>Second or third intercostal space in the mid-clavicular line</li>
                                    </ul>
                                </li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> less than 8 years old, site choice will only be the second or third intercostal space at the mid-clavicular line</li>
                            </ul>
                        </li>
                        <li>Approved advanced airways satisfy the ""rescue airway"" component for 1010 {Sedate-to-Intubate or RSI}.</li>
                        <li>If a conscious patient requires intubation, consider the following:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">A</span> Apply Lidocaine Jelly to the ET tube.</li>
                                <li><span class=""font-bold"">A</span> Lidocaine 100 mg IN (half dose per nostril) or nebulized with 8-10 LPM O2.</li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> Lidocaine 1.5 mg/kg nebulized with 8-10 LPM O₂ or IN. Maximum dose is 100 mg.</li>
                            </ul>
                        </li>
                         <li>If the patient resists the tube after confirmed intubation:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">A</span> SBP is greater than 100, consider Midazolam 2.5 mg slow IV.</li>
                                <li><span class=""font-bold"">A</span> SBP less than 100, consider Ketamine 100 mg slow IV.</li>
                                <li><span class=""font-bold"">G</span> For patients greater than 69 y/o reduce dosing for sedatives and analgesics to one half (½) of the adult doses.</li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> SBP is age/weight appropriate consider Midazolam 0.1 mg/kg (max dose 2.5 mg), slow IV.</li>
                            </ul>
                        </li>
                        <li><span class=""font-bold"">A</span> As an alternative to advanced oral airway procedures, consider nasal intubation.</li>
                        <li><span class=""font-bold"">A</span> {If a patient needs intubation but is combative, agitated, or has jaws clenched, use 1010 {Sedate to Intubate or RSI} procedures if approved to do so by Medical Direction.}</li>
                        <li>Whenever all reasonable attempts to provide an adequate airway by less invasive means have failed due to a total airway occlusion and you are unable to ventilate:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">A</span> Perform a needle cricothyrotomy or surgical airway utilizing an approved method.</li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> Patient must be 8 years old or greater for a surgical airway.</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
             <h4 class=""text-base font-bold"">Clinical Pearls</h4>
             <ul>
                 <li>For the EMT, AEMT and Paramedic, Dual Lumen Airways, King Airway or Laryngeal Mask Airways (LMA), are acceptable airway devices.</li>
                 <li>For the AEMT and Paramedic, {Lighted Stylet Intubation} or {Camera Assisted Intubation} may be utilized.</li>
                 <li>For the Paramedic, Nebulized Lidocaine can be administered simultaneously with Albuterol and Ipratropium.</li>
                 <li>If feasible, wait one to two minutes before intubation.</li>
             </ul>
        </div>
    </div>
</div>"
protocol,1009,Advanced Airway Confirmation Devices ,1000,"<div>
    <h3>1009.1 General Guidelines</h3>
    <ul>
        <li>Confirm correct placement of advanced airways with waveform capnography and at least 4 other methods as listed below.</li>
        <li>Reassess advanced airway placement every time the patient is moved.</li>
    </ul>

    <h3>1009.2 Confirmation Methods</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800 col-span-full md:col-span-1"">EMT / AEMT / Paramedic</div>
            <div class=""md:col-start-2"">
                <p class=""font-bold"">Advance airway device confirmations (Utilize at least 5 methods after airway insertion):</p>
                <ol class=""list-decimal pl-6 mt-2"">
                    <li>Continuous EtCO₂ detection is mandatory for advanced airway confirmation.</li>
                    <li>Auscultate the epigastrium, the lungs at the anterior chest, the lungs at the mid-axillary areas, and then the epigastrium again for ventilation sounds.</li>
                    <li>Observe rise and fall of the chest with each breath.</li>
                    <li>Look for condensation in the tube of the advanced airway.</li>
                    <li>Look at patient's appearance.</li>
                </ol>
                <p class=""mt-2 font-bold"">For ETT depth placement and measurement:</p>
                <ul class=""list-disc pl-6 mt-1"">
                    <li>If signs of cerebral herniation are present, hyperventilate at 20 ventilations per minute to an EtCO₂ value of 30 mmHg.</li>
                    <li><span class=""font-bold"">A</span> Keeping an oral endotracheal tube at the 21-23 cm mark at the teeth is recommended in most cases.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Proper endotracheal tube placement in the pediatric patient can be calculated by: Depth of insertion (length of tube at teeth or gum line) = Tube size x 3.</li>
                    <li>Avoid placing the ETT too deeply and the possibility of a right main stem bronchus intubation. Do not confuse right main stem intubation for a pneumothorax.</li>
                    <li><span class=""font-bold"">A</span> A nasotracheal tube that is 22 cm at the nose is unlikely to reach the glottis in most cases. Nasotracheal tubes need to be deeper.</li>
                    <li><span class=""font-bold"">A</span> Avoid nasal intubation after trauma, if there is central facial movement or cerebrospinal fluid present.</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
             <h4 class=""text-base font-bold"">Clinical Pearls</h4>
             <ul class=""list-disc pl-5 text-sm"">
                <li>Intravenous sodium bicarbonate will produce more carbon dioxide and affect EtCO₂ values.</li>
                <li>End tidal capnography should be maintained through transfer to the hospital.</li>
             </ul>
        </div>
    </div>
    
    <h3 class=""mt-6"">1009.3 Confirmation Devices</h3>
    <ul>
        <li>These devices can help recognize esophageal intubation, but cannot identify bronchial placement.</li>
        <li>Maintain EtCO₂ devices until patient care is transferred to the receiving ED staff.</li>
        <li><strong>Electronic End Tidal CO₂ (EtCO₂) Monitors (Capnography)</strong>
            <ul class=""list-roman pl-6 mt-2"">
                <li>Continuous waveform capnography is a required confirmation device.</li>
                <li>EtCO₂ should be used on EVERY advanced airway.</li>
            </ul>
        </li>
        <li class=""mt-2""><strong>End Tidal CO₂ Detector (EtCO₂) - Colorimetric</strong>
             <ul class=""list-roman pl-6 mt-2"">
                <li>In cardiac arrest, if there is no color change, use other confirmation methods.</li>
                <li>Secretions, emesis, etc. can ruin the device.</li>
                <li>Large amounts of carbonated beverage in the stomach can give a false positive.</li>
                <li>The device can be used for no more than two hours.</li>
                <li>Follow manufacturer's recommendations for weight restrictions.</li>
            </ul>
        </li>
        <li class=""mt-2"">Beck Airway Airflow Monitor (BAAM) is authorized for use by the Paramedic during nasal intubation.</li>
    </ul>
</div>"
protocol,1010,Sedate to Intubate and Rapid Sequence Intubation ,1000,"<div>
    <h3>1010.1 General Guidelines</h3>
    <ul>
        <li>Sedate to Intubate and Rapid Sequence Intubation are optional skills in the GMVEMSC protocol.</li>
        <li>These skills are to be performed by the Paramedic only.</li>
        <li>This standing order applies to agencies whose personnel have received the appropriate training and Medical Director's approval only.</li>
        <li>Under no circumstances is RSI to be used as ""behavioral control"" or restraint in patients with otherwise intact airways.</li>
        <li>Some Medical Directors may recommend RSI as a primary airway control procedure.</li>
        <li>While this protocol recommends Succinylcholine as a short-term paralytic, a Medical Director may choose to use a different medication. Should a different paralytic be used, the Medical Director will be responsible to establish dosing and training.</li>
        <li>Inclusion criteria:
            <ul class=""list-roman pl-6 mt-2"">
                <li>The patient must be an adult (16 years old or older)</li>
                <li>The patient cannot have suffered a paralyzing injury more than one week and less than 6 months ago (this guideline is specific to Succinylcholine)</li>
            </ul>
        </li>
    </ul>

    <h3 class=""mt-6"">1010.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
             <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Decreased LOC</li>
                    <li>Ineffective or absent breathing</li>
                    <li>Patient unable to maintain their own airway</li>
                    <li>Respiratory failure or inevitable loss of airway</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                 <ul class=""list-disc pl-5 text-sm"">
                    <li>Cardiac arrest</li>
                    <li>Anaphylaxis</li>
                    <li>Esophageal obstruction</li>
                </ul>
            </div>
        </div>
         <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li><strong>{Sedate-to-Intubate}:</strong>
                            <ul class=""list-disc pl-5 mt-1"">
                                <li>{Pre-oxygenate the patient with O₂ via BVM at 15 lpm}</li>
                                <li>{Complete an airway assessment. Remove dentures or dental appliances.}</li>
                                <li>{If the paramedics doubt that they will be able to successfully intubate, the procedure should be avoided}</li>
                                <li>{Must have cardiac monitor, IV and pulse oximetry in place}</li>
                                <li><strong>{Sedate the patient}:</strong>
                                    <ul class=""list-disc pl-5 mt-1"">
                                        <li>{Administer Etomidate 0.3 mg/kg IV (maximum dose 40 mg)} OR</li>
                                        <li>{Ketamine 100 mg IV, may repeat 100 mg IV if patient not sufficiently sedated by first dose} (Recommended in hemodynamically unstable patients) OR</li>
                                        <li>{Midazolam 5 mg slow IV (in patients who are normotensive), may repeat up to 10 mg if patient not sufficiently sedated by first dose}</li>
                                    </ul>
                                </li>
                                <li><span class=""font-bold"">G</span> DO NOT reduce Ketamine or Midazolam doses by half for patients greater than 69 y/o. Instead, give full doses to all patients to achieve sedation.</li>
                            </ul>
                        </li>
                        <li class=""mt-2"">If stopping at {Sedate-to-Intubate}, then intubate the patient.</li>
                        <li class=""mt-2""><strong>{Rapid Sequence Intubation}:</strong>
                             <ul class=""list-disc pl-5 mt-1"">
                                <li>{Sedate the patient as outlined above}</li>
                                <li>{Paralyze the patient with Succinylcholine 200 mg IV}</li>
                                <li>{Once paralyzed, intubate the patient, and maintain continuous waveform capnography}</li>
                                <li><strong>{Maintain sedation}:</strong>
                                    <ul class=""list-disc pl-5 mt-1"">
                                        <li>{Midazolam 5-10 mg IV}</li>
                                        <li>{If hypotensive, then Ketamine 100-200 mg IV}</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li class=""mt-2"">Maintain continuous waveform capnography after intubation.</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
             <div><h4 class=""text-base font-bold"">Consult</h4><p class=""text-sm"">Paramedics may seek guidance or approval from medical control prior to initiating the protocol; however, this is not required.</p></div>
             <div><h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Paralytics or sedation do not change poor airway anatomy.</li>
                    <li>The most important decision may be when NOT to paralyze the patient or intubate them.</li>
                    <li>Succinylcholine paralyzes the muscles but does not affect LOC. ALWAYS SEDATE THE PATIENT.</li>
                    <li>Tachycardia may be a sign that the patient is paralyzed but not adequately sedated.</li>
                    <li>No more than 2 intubation attempts.</li>
                    <li>If you can still ventilate the patient with a BLS airway, a cricothyroidotomy is not necessary.</li>
                </ul>
            </div>
        </div>
    </div>
    
    <h3 class=""mt-6"">1010.3 RSI Educational Recommendations</h3>
    <ul>
        <li>Rapid Sequence Intubation should not be available to all paramedics in the system.</li>
        <li>Only those paramedics willing to undergo additional initial training and continuing training should be allowed to perform it.</li>
        <li>In initial training, the paramedic should demonstrate proficiency during the following practical evaluations:
            <ul class=""list-roman pl-6 mt-2"">
                <li>2 endotracheal intubations on airway simulators</li>
                <li>3 endotracheal intubations on airway simulator with C-spine immobilization</li>
                <li>5 surgical cricothyrotomies on simulators using surgical technique or an approved device</li>
                <li>4 intubations using the eschmann stylet (gum bougie) on airway simulators (optional)</li>
                <li>5 insertions of a rescue airway on airway simulators</li>
            </ul>
        </li>
        <li class=""mt-2"">Once a quarter, the paramedic should demonstrate proficiency during the following practical evaluations:
             <ul class=""list-roman pl-6 mt-2"">
                <li>1 endotracheal intubation on airway simulators</li>
                <li>2 endotracheal intubations on airway simulator with C-spine immobilization</li>
                <li>1 surgical cricothyrotomy on airway simulator</li>
                <li>1 intubation using the eschmann stylet (gum bougie) on airway simulators (optional)</li>
                <li>1 insertion of rescue airway on airway simulators</li>
            </ul>
        </li>
        <li class=""mt-2"">Any of the above evaluations could be credited if the procedure is performed under direct supervision by the Medical Director, Supervisor or Training Officer the field or a clinical setting.</li>
    </ul>
</div>
"
protocol,1011,Tracheostomy and Laryngectomy Care ,1000,"<div>
    <h3>1011.1 General Guidelines</h3>
    <ul>
        <li>Consult the patient's caregiver for assistance. They are typically trained to manage these airways.</li>
        <li>Find out why they have an artificial airway (cancer, stroke, ventilator dependent, etc.)</li>
        <li>Ask if there have been any prior difficulties (reinserting, plugging, etc).</li>
        <li>Find out when the airway was first placed (newer airways may be more difficult to replace).</li>
        <li>For assessing failed tracheostomies and laryngectomies, consider:
            <ul class=""list-disc pl-6 mt-2 font-mono"">
                <li><span class=""font-bold"">D</span> - displaced, dislodged or damaged</li>
                <li><span class=""font-bold"">O</span> - obstructed (mucus, food, blood, secretions)</li>
                <li><span class=""font-bold"">P</span> - pulmonary problems</li>
                <li><span class=""font-bold"">E</span> - equipment failure (bent tubing, ventilator malfunction, depleted oxygen supply)</li>
            </ul>
        </li>
        <li>Look for subcutaneous air in the neck as it might indicate a false passage of tube.</li>
    </ul>

    <h3 class=""mt-6"">1011.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
            <div>
                <h4 class=""text-base font-bold"">Assessment</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Place the patient on high-flow O₂</li>
                    <li>Assess pulse oximetry</li>
                    <li>Assess EtCO₂ if available</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <p class=""text-sm"">Patient with tracheostomy or laryngectomy tube with signs of respiratory distress or failure.</p>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Assess and frequently reassess the artificial airway for easily reversible causes of distress (D.O.P.E.).</li>
                        <li>Administer high-flow oxygen over the stoma or tube.</li>
                        <li>Consider assisting ventilations using a bag-valve-mask attached to the device end. BVM typically will only attach over the inner cannula.</li>
                        <li>If there is no inner cannula, an endotracheal tube adapter (BVM end of ETT) a half size larger than the trach tube may be inserted into the outer cannula.</li>
                        <li>Consider infant BVM to stoma ventilation if the tracheostomy or laryngectomy tube has been removed.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Pre-oxygenate when possible for 30-60 seconds prior to suctioning.</li>
                        <li>Suction the tracheostomy tube if:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li>Unable to ventilate with BVM.</li>
                                <li>Coarse upper airway sounds are heard.</li>
                                <li>If respiratory distress continues despite BVM ventilation.</li>
                            </ul>
                        </li>
                        <li>If the airway tube has an inner cannula, remove it prior to suctioning.</li>
                        <li>Use the patient's suctioning supplies or a catheter that is no more than ½ the tube diameter (typical size is 10 fr).</li>
                        <li>DO NOT force the suction catheter into the tracheostomy tube.</li>
                        <li>Determine the proper suction catheter depth by measuring the length of the obturator or inner cannula and advancing slightly beyond this measure.</li>
                        <li>If no obturator is available:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">A</span> Insert the suction catheter 2-3 inches into the tube.</li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> Use the patient's pinky finger as an approximate length to insert the suction tubing.</li>
                            </ul>
                        </li>
                        <li>Consider inserting 2-3 mL of saline or nebulized saline to help loosen thick or hard secretions.</li>
                        <li>Suction on the way out, for no more than 10 seconds, rotating the catheter as you go.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                     <ul>
                        <li>If respiratory distress continues, consider likely cause and reference appropriate protocol.</li>
                        <li>Place patient on cardiac monitor.</li>
                        <li>If measures have not succeeded in improving respiratory status, consider replacing the airway tube as defined in 1011.3.</li>
                     </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>If no replacement tube is available, insert an ETT as a replacement.</li>
                        <li>If all other means fail, including tube replacement, consider attempting oral tracheal intubation.</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Clinical Pearls</h4>
            <ul class=""list-disc pl-5 text-sm"">
                <li>Patients with laryngectomy airways have the larynx removed, completely separating oral- and nasal- pharynx from the trachea and lungs. These patients are sometimes referred to as neck breathers.</li>
                <li>Established stomas are less likely to close off.</li>
                <li><span class=""font-bold"">G</span> Closed off stomas require surgical techniques to replace the tube and replacement should be avoided in the field.</li>
                <li>Often the cuff is deflated allowing the patient to have more air movement past the vocal cords thus enabling speech.</li>
                <li>There may also be speaking valve (a one-way valve allowing air in not out) attached to the outside end of the tracheal tube.</li>
                <li>Tube replacement is a clean procedure (mask, splash protection, and clean gloves). Keep the patient's airway as clean as possible.</li>
            </ul>
        </div>
    </div>

    <h3 class=""mt-6"">1011.3 Artificial Airway Tube Replacement (AEMT & Paramedic)</h3>
    <p class=""font-bold"">a. Necessary Equipment:</p>
    <ul class=""list-disc pl-5"">
        <li>Replacement tracheostomy tube or laryngectomy tube (from the patient or care giver).
            <ul class=""list-disc pl-6 mt-1 text-pink-600"">
                <li><span class=""font-bold"">P</span> If patient is pediatric, there is a one size smaller tracheostomy tube in the GoBag that should always be with the patient.</li>
            </ul>
        </li>
        <li>If no replacement tracheostomy tube is available, use an ETT of similar internal diameter.</li>
        <li>If possible, water-based lubricant jelly.</li>
    </ul>
    <p class=""font-bold mt-2"">b. Procedure:</p>
    <ol class=""list-decimal pl-5"">
        <li>Apply high-flow O₂, pulse oximetry, EtCO₂, and cardiac monitor.</li>
        <li>Place patient semi-recumbent with slight neck extension (consider a roll under the neck).</li>
        <li>Keep the head midline (may need additional personnel to maintain head position).</li>
        <li>For adults, consider use of a bougie when removing the old tube. (this is not a pediatric practice)</li>
        <li>Lubricate the new tracheostomy tube or replacement ETT.</li>
        <li>Deflate the old tracheostomy tube's balloon and remove during exhalation by gently pulling and rotating towards the patient's feet.</li>
        <li>Remove the stoma dressing, then wipe area clean with only saline or medically packaged water.</li>
        <li>Using the replacement tracheostomy tube's obturator or (in adults only) the bougie, gently advance the replacement tracheostomy tube in a fluid fashion, using the natural curvature of the tube until the flange is flush against the neck.</li>
        <li>If present, remove the obturator and insert the hollow internal cannula.
             <ul class=""list-disc pl-6 mt-1"">
                <li>Internal cannulas are not part of the most commonly used tracheostomy tubes for pediatric patients.</li>
                <li>If possible, use a non-fenestrated (no window) inner cannula. Note: A fenestrated inner cannula will allow air leak through the glottis; potentially allowing air to enter the stomach and not allowing PEEP (positive end-expiratory pressure) to be achieved.</li>
             </ul>
        </li>
        <li>If using an ETT as a replacement:
             <ol class=""list-decimal pl-6 mt-1"">
                <li>Insert a bougie (adults only) into the stoma directed downward.</li>
                <li>Slowly advance the lubricated ETT into the stoma.</li>
                <li>Only advance the ETT a few centimeters into the stoma (as deep as the trach tube).</li>
                <li>Consider shortening the ETT by cutting the tube AFTER the takeoff for the pilot balloon.</li>
            </ol>
        </li>
        <li>Inflate the cuff of the replacement tracheostomy tube or ETT with the minimum amount of air to stop any audible leak at the stoma.</li>
        <li>Place clean gauze around the stoma to absorb mucous. Never cut this gauze. Fold it to size, to avoid creating small particulates of lint that could enter the airway.</li>
        <li>Secure the device to the patient's neck.</li>
    </ol>
     <p class=""font-bold mt-2"">c. Emergency Procedures:</p>
     <ul class=""list-disc pl-5"">
        <li>If the airway has been surgically altered and the glottis is hard to recognize, consider pushing on the chest to force air into the pharynx.</li>
        <li>Where air bubbles are seen, insert bougie (in adults) and/or insert the ETT into the opening.</li>
     </ul>
    <div class=""mt-4"">
        <p class=""text-center font-bold text-sm"">Tracheostomy Tube Parts</p>
            </div>
</div>
<div class=""flex flex-col items-center text-center"">
        <img src=""./images/1011-1.png"" alt=""img1"" class=""w-full"">
        <img src=""./images/1011-2.png"" alt=""img1"" class=""w-full"">
      </div>"
protocol,1012,Intraossesous Infusion ,1000,"<div>
    <h3>1012.1 General Guidelines</h3>
    <ul>
        <li>Use of IO devices is limited to patients who are unresponsive or hemodynamically unstable; and then, only when less invasive means are ineffective or not available.</li>
        <li>In patients with acceptable perfusion, and all other routes of access have failed, then consider an intraosseous access in the following acceptable locations, in no particular order:
            <ul class=""list-roman pl-6 mt-2"">
                <li>The proximal humeral head (must be greater than 12 years old)</li>
                <li>The distal femur</li>
                <li>The proximal tibia</li>
            </ul>
        </li>
        <li>For an adult in cardiac arrest, the preferable order of vascular access is:
            <ul class=""list-roman pl-6 mt-2"">
                <li>External jugular (EJ) vein IV</li>
                <li>Antecubital (AC) vein IV</li>
                <li>Proximal humeral head IO (the proximal tibia or distal femur is not to be used in cardiac arrest)</li>
            </ul>
        </li>
        <li>For equipment sizing, follow manufacturer's recommendations.</li>
    </ul>

    <h3 class=""mt-6"">1012.2 Intraosseous Equipment Sizing</h3>
    <ul>
        <li>The longer yellow (55 or 45 mm) needle should be used for proximal humeral IOs in adults.</li>
        <li>For the distal femur or proximal tibia in adults, use the properly sized needle.</li>
        <li class=""text-pink-600""><span class=""font-bold"">P</span> For pediatrics, access the distal femur or proximal tibia:
            <ul class=""list-disc pl-6 mt-1"">
                <li><span class=""font-bold"">P</span> Use the (25 mm or blue) IO needle for 3-45 kg.</li>
                <li><span class=""font-bold"">P</span> Use the (15 mm or pink) IO needle for 0-3 kg.</li>
            </ul>
        </li>
    </ul>

    <h3 class=""mt-6"">1012.3 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
         <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
            <div>
                <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
                <p class=""text-sm italic"">Consider weight for IO selection.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <p class=""text-sm"">Hemodynamically unstable patient needing vascular access with no IV.</p>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT+</div>
                <div>
                     <ul>
                        <li>After IO confirmation, IV pressure bags may facilitate infusion.</li>
                        <li>For the pain associated with infusion:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li><span class=""font-bold"">A</span> Lidocaine 2% 1.5 mg/kg via IO up to 100 mg.</li>
                                <li class=""text-pink-600""><span class=""font-bold"">P</span> Lidocaine 2% 0.5 mg/kg via IO (max 100 mg).</li>
                            </ul>
                        </li>
                     </ul>
                </div>
            </div>
        </div>
    </div>
</div>"
protocol,1013, Alternate Vascular Access ,1000,"<div>
    <h3>1013.1 General Guidelines</h3>
    <p>This guideline is not for EMR, EMT or AEMT. Only Paramedics may utilize alternative vascular routes.</p>

    <h3 class=""mt-6"">1013.2 Central Vascular Access Devices (CVAD)</h3>
    <ul>
        <li>Patients who require long-term intravascular therapy may have Central Vascular Access Devices (CVAD).</li>
        <li>CVADs may be used for IV access if the patient is hemodynamically unstable or in arrest.
            <ul class=""list-disc pl-6 mt-2"">
                <li><strong>Central catheter:</strong> Catheter placed through chest wall into the internal jugular or subclavian vein.
                    <ol class=""list-decimal pl-6 mt-1"">
                        <li>Central catheters can be single or multilumen.</li>
                        <li>Distal portion of catheter has two access ports, either of which may be used for access.</li>
                    </ol>
                </li>
                <li class=""mt-2""><strong>PICC Line:</strong> Catheter placed in arm.
                    <ol class=""list-decimal pl-6 mt-1"">
                        <li>Distal portion of catheter is external with access port.</li>
                        <li>Do not force fluids or drugs through the device or failure could result in an embolism.</li>
                        <li>PICC line diameter creates significant resistance to fluid flow making it difficult to infuse large quantities of fluids.</li>
                        <li>Dextrose 10% (D10) by PICC is preferable to IM Glucagon.</li>
                    </ol>
                </li>
                <li class=""mt-2""><strong>Subcutaneously Implanted Port:</strong> Device surgically placed under the skin on the chest.
                    <ol class=""list-decimal pl-6 mt-1"">
                        <li>No external access. <span class=""important-note"">PARAMEDICS ARE NOT PERMITTED TO ACCESS THIS DEVICE.</span></li>
                    </ol>
                </li>
            </ul>
        </li>
        <li class=""mt-4""><strong>Complications of CVADs</strong>
            <ul class=""list-disc pl-6 mt-2"">
                <li><strong>Infection:</strong> Thorough cleaning of the port must be done three times during the procedure: before attaching each syringe and before attaching the IV tubing.</li>
                <li><strong>Air Embolism:</strong> The catheter must be clamped before attaching or removing the syringes.</li>
                <li><strong>Heparin Bolus:</strong> These catheters remain in place without fluids continually flowing through them. To prevent blood clot formation, a bolus of Heparin or other anticlotting agents will be in the catheter. Remove 5 ml of blood to ensure that the Heparin is not systemically administered to the patient.</li>
                <li><strong>Catheter Damage:</strong>
                     <ol class=""list-decimal pl-6 mt-1"">
                        <li>Use a 10 ml syringe or larger when drawing off the blood. Smaller syringes create too much pressure.</li>
                        <li>After verifying blood return, flush catheter with 10 ml of NS with a 10 ml or larger syringe utilizing a pulsating technique.</li>
                        <li>Administer medications slowly to avoid creating too much pressure. Do not use catheter if unable to get blood return.</li>
                    </ol>
                </li>
                <li class=""important-note"">DO NOT USE A PRESSURE INFUSION DEVICE ON CVADs.</li>
            </ul>
        </li>
    </ul>

    <h3 class=""mt-6"">1013.3 Internal Dialysis Fistula</h3>
    <ul>
        <li>An artificial passage between an artery and a vein used to gain access for hemodialysis.</li>
        <li>Usually located in the inner aspect of the patient's forearm or bicep.</li>
        <li>A bulge under the skin that should be visible or easily palpated.</li>
        <li>In cardiac arrest or with a profoundly unstable patient, a dialysis fistula may be used to administer IV fluids or medication.
            <ul class=""list-roman pl-6 mt-2"">
                <li>Use aseptic technique.</li>
                <li>Be careful not to puncture back wall of vessel.</li>
                <li>Use IV pressure bag.</li>
                <li>Blood may still back-up into tubing.</li>
                <li>Control bleeding with direct pressure.</li>
                <li>Dialysis patients are usually on anticoagulants.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,1014,Pain Management ,1000,"<div>
    <h3>1014.1 General Guidelines</h3>
    <ul>
        <li>This protocol is for management of acute moderate to severe pain, including pain from suspected cardiac events, trauma (including thermal and chemical burns), crush syndrome, frostbite, fractures, dislocations, sprains, and abdominal pain (including unilateral flank pain).</li>
        <li>It is not for the treatment of exacerbations of chronic pain.</li>
        <li>Prehospital pain management reduces time to pain relief, avoids exacerbation of pain during movement, is compassionate, and is good medical care.</li>
        <li>Ketamine is not to be administered to patients with suspected cardiac chest pain.</li>
    </ul>

    <h3 class=""mt-6"">1014.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
             <div>
                <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
                <ul class=""list-disc pl-5 text-sm text-pink-600"">
                    <li><span class=""font-bold"">P</span> Fentanyl is not to be administered to anyone less than 2 years old.</li>
                    <li><span class=""font-bold"">P</span> If unable to obtain a blood pressure, look for evidence of adequate perfusion (skin color, capillary refill, and mental status) prior to Fentanyl administration.</li>
                    <li><span class=""font-bold"">P</span> To account for medication remaining in the needle and syringe, add an additional 0.1 ml Fentanyl for pediatric intranasal doses.</li>
                    <li><span class=""font-bold"">P</span> Ketamine is not to be administered for pain to anyone less than 16 years old.</li>
                    <li><span class=""font-bold"">P</span> Fentanyl IN is the first choice for pediatrics.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Severity of pain (pain scale)</li>
                    <li>Quality (sharp, dull, etc.)</li>
                    <li>Radiation of pain</li>
                    <li>Pain upon movement</li>
                    <li>Increased pain upon palpation</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Use ice packs, position of comfort, and splinting to reduce pain.</li>
                        <li>Provide oxygen as indicated.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                     <ul>
                        <li>For an alert patient with moderate to severe pain, give Fentanyl for relief.</li>
                        <li>Ketamine should be considered a second line medication for the management of pain.</li>
                        <li>If Fentanyl dosing does not relieve pain or if the patient refuses Fentanyl, then administer Ketamine.</li>
                     </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>Call for orders if you feel narcotics are needed for pain from a chronic condition.</li>
                        <li><span class=""font-bold"">G</span> For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half (½) of the adult doses.</li>
                        <li><span class=""font-bold"">A</span> If SBP is greater than 100, then Fentanyl 50-100 mcg IV. May repeat Fentanyl 50-100 mcg IV after 5 minutes.</li>
                        <li><span class=""font-bold"">A</span> If no IV, Fentanyl 50-100 mcg IN, SQ, or IM. May repeat Fentanyl 50-100 mcg IN, SQ or IM after 10 minutes.</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> If SBP is normal for patient's age (80 + 2 times age) or evidence of adequate perfusion then Fentanyl 1 mcg/kg IN, max 100 mcg. May repeat after 10 minutes.</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> If unable to administer IN, Fentanyl 1 mcg/kg IV, max 100 mcg. May repeat after 5 minutes.</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> As a last resort, Fentanyl 1 mcg/kg SQ or IM, max 100 mcg. May repeat after 10 minutes.</li>
                        <li><span class=""font-bold"">A</span> Ketamine 25 mg IV. May repeat after 5 minutes.</li>
                        <li><span class=""font-bold"">A</span> If no IV, Ketamine 25 mg IN or 50 mg IM. May repeat after 10 minutes.</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
             <div><h4 class=""text-base font-bold"">Consult</h4><p class=""text-sm text-pink-600""><span class=""font-bold"">P</span> MCP contact required before administration of Fentanyl for pediatric patients with abdominal pain.</p></div>
             <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Always consider the weight of your patient when dosing pain meds, especially for the elderly.</li>
                    <li>Document patient's reported pain during initial patient contact, during treatment, and after any intervention.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,2001,Resuscitation Guidelines ,2000,"<div>
    <h3>2001.1 General Guidelines</h3>
    <ul>
        <li>A patient's BEST CHANCE for resuscitation is at the scene with high quality CPR and code management.</li>
        <li>Paramedics are expected to provide ALS resuscitative care at the scene.</li>
    </ul>

    <h3 class=""mt-6"">2001.2 Resuscitation and Field Termination</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
             <div>
                <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
                <p class=""text-sm italic text-pink-600"">FIELD TERMINATION DOES NOT APPLY TO PEDIATRIC PATIENTS.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Pulseless and apneic</li>
                    <li>Does not meet Non-initiation of Care Guideline</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div><p>The EMR will continue resuscitation until the patient is handed off to a higher-level provider.</p></div>
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div><p>The EMT will continue resuscitation until the patient is handed off to a higher-level provider. If no higher-level provider is available, then transport.</p></div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                        <li>Patient with return of spontaneous circulation (ROSC) should be transported to an interventional facility if transport time is less than 30 minutes.</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> If no ALS equipment is available at the scene, and transport time to a medical facility will exceed 20 minutes, field termination may be considered.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>Patients will require prolonged resuscitation efforts if:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li>They have PEA with a rate greater than 40 per minute</li>
                                <li>They have an upward trending or persistent EtCO₂ greater than or equal to 20 mmHg, refractory to VF or VT.</li>
                            </ul>
                        </li>
                        <li>If arrest due to profound hypothermia, then rapidly transport to a Trauma Center.</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Following all appropriate efforts, field termination requires MCP approval, and may only be considered when the following criteria are met:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li>18 years or older</li>
                                <li>In asystole or PEA, with rates less than 40</li>
                                <li>Not be in arrest due to hypothermia</li>
                                <li>Have an advanced airway in place</li>
                                <li>Have vascular access in place</li>
                                <li>There are no signs of neurological function such as reactive pupils, response to pain or spontaneous movement</li>
                            </ul>
                        </li>
                        <li>The following should be transported to a cardiac interventional facility if transport time is less than 30 minutes:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li>A documented STEMI and a witnessed cardiac arrest</li>
                                <li>A return of spontaneous circulation (ROSC)</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
             <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm""><span class=""font-bold"">A</span> When the AEMT or Paramedic contacts MCP directly to receive consent for field termination, they must provide the following information:</p>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>The duration of the resuscitation</li>
                    <li>How long the patient may have been in arrest prior to EMS arrival</li>
                    <li>Whether it was a witnessed or unwitnessed event</li>
                    <li>The current EtCO₂</li>
                    <li>The presenting rhythm</li>
                </ul>
            </div>
             <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>There are situations where resuscitation may take 30 minutes or more.</li>
                    <li>Research has shown that CPR quality diminishes while being transported.</li>
                    <li>Consider aeromedical transport for transports greater than 30 minutes if the patient has ROSC.</li>
                    <li>In pseudo PEA, the patient may not be in true cardiac arrest, but simply not have palpable pulses due to profound shock.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,2002,Cardiac Arrest - BLS ,2000,"<h3>2002.1 This protocol has adopted the 2020 American Heart Association CPR Guidelines</h3>
    <div class=""overflow-x-auto"">
        <table class=""w-full text-sm text-left text-gray-500"">
            <thead class=""text-xs text-gray-700 uppercase bg-gray-50"">
                <tr>
                    <th scope=""col"" class=""py-3 px-6""></th>
                    <th scope=""col"" class=""py-3 px-6"">ADULTS</th>
                    <th scope=""col"" class=""py-3 px-6"">CHILDREN & INFANTS</th>
                    <th scope=""col"" class=""py-3 px-6"">NEWBORNS</th>
                </tr>
            </thead>
            <tbody>
                <tr class=""bg-white border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">CPR Order</th>
                    <td colspan=""3"" class=""py-4 px-6 text-center"">CAB: Compression, Airway, Breathing</td>
                </tr>
                <tr class=""bg-gray-50 border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Compression to Breaths Ratio Without Advanced Airway</th>
                    <td class=""py-4 px-6"">1 or 2 Rescuers 30:2</td>
                    <td class=""py-4 px-6"">1 Rescuer - 30:2<br>2+ Rescuers - 15:2</td>
                    <td class=""py-4 px-6"">3:1</td>
                </tr>
                <tr class=""bg-white border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Compression to Breaths Ratio With Advanced Airway</th>
                    <td class=""py-4 px-6"">Continuous compressions at a rate of 100-120/min. Give 1 breath every 6 seconds.</td>
                    <td class=""py-4 px-6"">Continuous compressions at a rate of 100-120/min. Give 1 breath every 2-3 seconds.</td>
                    <td class=""py-4 px-6"">40-60 breaths/min</td>
                </tr>
                <tr class=""bg-gray-50 border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Compression Rate</th>
                    <td colspan=""2"" class=""py-4 px-6 text-center"">100 to 120 per minute</td>
                    <td class=""py-4 px-6"">120 per minute</td>
                </tr>
                <tr class=""bg-white border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Compression Notes</th>
                    <td colspan=""3"" class=""py-4 px-6 text-center"">Minimize interruptions in chest compressions. Limit interruptions to less than 10 seconds</td>
                </tr>
                 <tr class=""bg-gray-50 border-b"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Compression Depth</th>
                    <td class=""py-4 px-6"">At Least 2 Inches</td>
                    <td class=""py-4 px-6"">1/3 Depth of Chest (About 2"""")<br>1/3 Depth of Chest (About 1½"""")</td>
                    <td class=""py-4 px-6"">1/3 Depth of Chest</td>
                </tr>
                <tr class=""bg-white"">
                    <th scope=""row"" class=""py-4 px-6 font-medium text-gray-900 whitespace-nowrap"">Rescue Breathing</th>
                    <td class=""py-4 px-6"">1 breath every 5-6 seconds (10-12 breaths/min)</td>
                    <td class=""py-4 px-6"">1 breath every 2-3 seconds (20-30 breaths/min)</td>
                    <td class=""py-4 px-6"">40-60 breaths/min</td>
                </tr>
            </tbody>
        </table>
    </div>

    <h3 class=""mt-6"">2002.2 Basic Life Support</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">If available, use age-appropriate AEDS or pads</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Unresponsive</li>
                    <li>Pulseless and apneic</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Signs of irreversible death</li>
                    <li>Other causes of unresponsiveness</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>If witnessed or unwitnessed arrest, initiate quality CPR for 1-2 minutes</li>
                        <li>If available, initiate mechanical CPR using an approved device</li>
                        <li>Attach and use AED after at least 2 minutes of CPR</li>
                        <li>Utilize AED as it is programmed. (Even if it is not to AHA guidelines)</li>
                        <li>Repeat cycles of defibrillation and CPR for 2 minutes</li>
                        <li>Patient should be transported as appropriate</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Patient with return of spontaneous circulation (ROSC) should be transported to an interventional facility if transport time is less than 30 minutes.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Obtain and transmit 12 Lead EKG if patient has ROSC</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Paramedics are expected to provide resuscitative care at the scene.</li>
                        <li>Cardiac arrests should not be transported unless:
                            <ul class=""list-disc pl-5"">
                                <li>Return of spontaneous circulation (ROSC)</li>
                                <li>The airway cannot be secured</li>
                                <li>Vascular access is not established</li>
                                <li>MCP declines to authorize Field Termination</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">No consult required unless applying Field Termination Guideline</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Use jaw-thrust method to open airway on trauma patients</li>
                    <li>Allow the chest to fully recoil after each compression</li>
                    <li>Change person compressing chest every 2 minutes</li>
                    <li>Resume CPR beginning with compressions after each defibrillation</li>
                    <li>Minimize interruptions to compressions before and after each shock to less than 10 seconds</li>
                    <li>For pregnant patients in cardiac arrest: Consider need for manual uterine displacement</li>
                    <li>In all cardiac arrests, consider the ACLS treatable causes (Hs & Ts) to your level of certification:
                        <ul class=""list-disc pl-5"">
                            <li>Hypoxia</li>
                            <li>Hypovolemia</li>
                            <li>Hydrogen Ion</li>
                            <li>Hypothermia</li>
                            <li>Toxins</li>
                            <li>Tension pneumothorax</li>
                            <li>Tamponade, Cardiac</li>
                            <li>Thrombosis (Coronary, Pulmonary)</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>"
protocol,2003,Cardiac Arrest – Asystole or PEA ,2000,"<h3>2003.1 General Guidelines</h3>
    <ul>
        <li>In all cardiac arrest patients, apply the 2002 Cardiac Arrest: Basic Life Support protocol.</li>
        <li>Apply the appropriate guideline after rhythm interpretation.</li>
        <li>The rhythms may change and will require flexibility to move between the different protocols.</li>
        <li>If ROSC, then follow 2001 Resuscitation Guidelines</li>
    </ul>

    <h3 class=""mt-6"">2003.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">Pediatric dosing should never exceed adult doses</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Unresponsive</li>
                    <li>Pulseless and apneic</li>
                    <li>Either:
                        <ul class=""list-disc pl-5"">
                            <li>No electrical activity on cardiac monitor</li>
                            <li>Electrical activity on monitor with no pulse present</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Ventricular Fibrillation</li>
                    <li>Pulseless Ventricular Tachycardia</li>
                    <li>Other causes of unresponsiveness</li>
                    <li>Device (lead) error</li>
                    <li>Signs of irreversible death</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>If witnessed or unwitnessed arrest, initiate quality CPR for up to 2 minutes.</li>
                        <li>Follow 2002 Cardiac Arrest -BLS protocol</li>
                        <li>Apply the Automatic External Defibrillator (AED) and check for a shockable rhythm.</li>
                        <li>If no defibrillation is indicated, continuous CPR</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Obtain and transmit 12 Lead EKG if patient has ROSC</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Consider possible causes</li>
                       <li>Consider Field Termination as identified in 2001 Resuscitation Guidelines</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>A Epinephrine (1:10,000) 1 mg, IV or IO, repeat every 3-5 minutes.</li>
                        <li>P Epinephrine (1:10,000) 0.01 mg/kg IV or IO, repeat every 3-5 minutes.</li>
                        <li>The Paramedic may consider Field Termination after administering Epinephrine</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>No consult required unless applying Field Termination Guideline.</li>
                    <li>The AEMT or paramedic may consult MCP to field terminate.</li>
                    <li>Contact ED to request a Cardiac Alert if applicable.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Contact receiving hospital prior to arrival with a cardiac arrest patient</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,2004,Cardiac Emergencies – Renal Dialysis ,2000,"<div>
    <h3>2004.1 General Guidelines</h3>
    <ul>
        <li>This protocol is for cardiac patients who receive renal dialysis treatment and is only to be administered by Paramedics.</li>
        <li>Dialysis patients who are bradycardic or experience cardiac arrest should be given both calcium (chloride or gluconate) and sodium bicarbonate.</li>
    </ul>

    <h3 class=""mt-6"">2004.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
         <div class=""grid grid-cols-1 md:grid-cols-2 gap-4"">
             <div>
                <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
                <p class=""text-sm italic text-pink-600"">Pediatric dosing should never exceed adult doses.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>Cardiac arrest</li>
                    <li>Bradycardia</li>
                    <li>Confirmed history of renal dialysis</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <p class=""font-bold"">For renal dialysis patients in arrest:</p>
                    <ul>
                        <li><span class=""font-bold"">A</span> Calcium Chloride 10% 1 g IV</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Calcium Chloride 10%, 20 mg/kg (0.2 ml/kg) IV (max dose 500 mg)</li>
                        <li><span class=""font-bold"">A</span> Sodium Bicarbonate 100 mEq IV</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Sodium Bicarbonate 1 mEq/kg IV</li>
                    </ul>
                    <p class=""font-bold mt-2""><span class=""font-bold text-blue-600"">&diams;</span> For a renal dialysis patient presenting with a wide complex bradycardia:</p>
                     <ul>
                        <li><span class=""font-bold"">A</span> Calcium Chloride 10% 1 g IV.</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Calcium Chloride 10%, 20 mg/kg (0.2 ml/kg) IV (max dose 500 mg)</li>
                        <li><span class=""font-bold"">A</span> Sodium Bicarbonate 100 mEq IV</li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> Sodium Bicarbonate 1 mEq/kg IV</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
            <div><h4 class=""text-base font-bold"">Consult</h4><p class=""text-sm"">In the treatment of hyperkalemia (wide complex bradycardia).</p></div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul class=""list-disc pl-5 text-sm"">
                    <li>It is critical that these drugs not be given together, as they will precipitate.</li>
                    <li>Flush well between these medications.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,2005,Cardiac Arrest – V-Fib or Pulseless V-Tach ,2000,"<h3>2005.1 General Guidelines</h3>
    <ul>
        <li>In all cardiac arrest patients, apply the 2002 Cardiac Arrest: Basic Life Support protocol.</li>
        <li>Apply the appropriate guideline after rhythm interpretation.</li>
        <li>The rhythms may change and will require flexibility to move between the different protocols.</li>
        <li>If ROSC, then follow 2001 Resuscitation Guidelines</li>
    </ul>

    <h3 class=""mt-6"">2005.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">Pediatric dosing should never exceed adult doses</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Unresponsive</li>
                    <li>Pulseless and apneic</li>
                    <li>Ventricular fibrillation or ventricular tachycardia on cardiac monitor or AED</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Asystole</li>
                    <li>Artifact/Device failure</li>
                    <li>Signs of irreversible death</li>
                    <li>Other causes of unresponsiveness</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>If witnessed or unwitnessed arrest, initiate quality CPR for 1-2 minutes and proceed to first defibrillation</li>
                        <li>Follow Basic Life Support protocol</li>
                        <li>Defibrillate as indicated by the Automatic External Defibrillator (AED)</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Obtain and transmit 12 Lead EKG if patient has ROSC</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Consider possible causes</li> 
                       <li>Defibrillate as required based on EKG interpretation</li>
                       <li>A {For refractory V-Fib/PVT after three shocks, consider Vector Change Defibrillation for subsequent shocks}</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Alternate between CPR/Defibrillation/Medication Administration</li>
                        <li>A Epinephrine 1 mg 1:10,000, IV or IO, repeat every 3-5 minutes</li>
                        <li>P Epinephrine (1:10,000) 0.01 mg/kg IV or IO, repeat every 3-5 minutes</li>
                        <li>After third defibrillation:
                            <ul class=""list-disc pl-5"">
                                <li>A Amiodarone 300 mg, IV or IO</li>
                                <li>P Amiodarone 5 mg/kg IV or IO (max first dose 300 mg)</li>
                                <li>If Amiodarone is not available, use Lidocaine
                                    <ul class=""list-disc pl-5"">
                                        <li>A Lidocaine 150 mg, IV or 10</li>
                                        <li>P Lidocaine 1.0 mg/kg IV or IO (max first dose 100 mg)</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li>A With evidence of pulseless polymorphic ventricular tachycardia (torsades de pointes), Magnesium Sulfate 2 gm infused with macro-drip tubing over 10 minutes.</li>
                        <li>A {After three traditional defibrillations and at least one antiarrhythmic medication, consider Double Sequential Defibrillation for subsequent shocks}</li>
                        <li>After sixth defibrillation:
                             <ul class=""list-disc pl-5"">
                                <li>A Amiodarone 150 mg, IV or IO</li>
                                <li>P Amiodarone 5 mg/kg IV or IO (max first dose 150 mg)</li>
                                <li>If Amiodarone is not available, use Lidocaine
                                    <ul class=""list-disc pl-5"">
                                        <li>A Lidocaine 75 mg, IV or IO</li>
                                        <li>P Lidocaine 1.0 mg/kg IV or IO (max first dose 75 mg)</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li>If patient converts with ROSC from a ventricular arrhythmia and no anti-arrhythmic has been given, then:
                            <ul class=""list-disc pl-5"">
                                <li>A Amiodarone 150 mg in 250 ml NS, IV over 10 minutes using 60 drop/ml tubing</li>
                                <li>Do not infuse unless SBP is greater than 100</li>
                                <li>Consider IV fluid 500 ml to increase SBP to 100 or higher prior to infusion</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>No consult required unless applying Field Termination Guideline.</li>
                    <li>The AEMT or paramedic may consult MCP to field terminate.</li>
                    <li>Contact ED to request a Cardiac Alert if applicable.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>For initial and subsequent defibrillations, follow manufacturer recommendation for energy settings</li>
                    <li>Pediatric defibrillation settings will start at 2 J/kg (or biphasic equivalent) and increase by 2 J/kg (or biphasic equivalent) each shock.</li>
                    <li>Maximum pediatric shock will be 10 J/kg (or biphasic equivalent)</li>
                    <li>Resume chest compressions immediately following each defibrillation, without performing pulse check, for 1-2 minutes</li>
                    <li>Contact receiving hospital prior to arrival with a cardiac arrest patient</li>
                </ul>
            </div>
        </div>
    </div>
    
    <h3 class=""mt-6"">2005.3 Alternate Defibrillation Techniques</h3>
    <ul>
        <li>Vector Change and Double Sequential Defibrillation are optional skills in the GMVEMSC Protocol</li>
        <li>Providers SHOULD NOT apply these techniques without the explicit consent of their Medical Director.</li>
        <li>These procedures are approved for adult patients only.</li>
        <li>Vector Change Defibrillation (for Advanced EMTs and Paramedics)
            <ul class=""list-disc pl-5"">
                <li>This technique is for refractory ventricular fibrillation/pulseless ventricular tachycardia.</li>
                <li>Refractory V-Fib/PVT is defined as NOT CONVERTED by three standard defibrillations.</li>
                <li>The AEMT or Paramedic will place a second set of defib pads in an anterior-posterior position.</li>
                <li>There should be minimal interruption in CPR when placing the second set of pads.</li>
                <li>Subsequent defibrillations will be through the anterior-posterior placed pads.</li>
            </ul>
        </li>
        <li>Double Sequential Defibrillation (for Paramedics)
             <ul class=""list-disc pl-5"">
                <li>This technique is for refractory V-Fib/PVT following three standard defibrillations and a least one round of an antiarrhythmic agent (amiodarone or lidocaine).</li>
                <li>This requires the presence of two manual biphasic defibrillators.</li>
                <li>One set of pads will be placed in the anterior-apical (traditional) position and one set will be placed in the anterior-posterior position.</li>
                <li>With both sets of pads in place and both machines charged to maximum energy level, the discharge of the monitors should be as simultaneous as possible.</li>
                <li>Repeat as indicated. All subsequent defibrillations should be double sequential.</li>
                <li>CAUTION: Every agency considering applying this procedure needs to consult with the manufacturer of their cardiac monitor for advice. This technique is considered ""off-label"".</li>
            </ul>
        </li>
        <li>Neither Vector Change nor Double Sequential Defibrillation is indicated in Recurrent V-Fib/PVT, which is defined as V-Fib/PVT that reoccurs episodically after successful conversion with intervening episodes of organized electrical activity.</li>
    </ul>"
protocol,2006,AICD Activations ,2000,"<h3>2006.1 General Guidelines</h3>
    <ul>
        <li>A patient experiencing repeated AICD (Automatic Implantable Cardioverter-Defibrillator) activations should receive sedation or pain management from the AEMT or Paramedic.</li>
    </ul>

    <h3 class=""mt-6"">2006.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>AICD in place and firing</li>
                    <li>Sudden pain</li>
                    <li>Muscle spasms</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Monitor and be prepared to provide BLS care.</li>
                        <li>Be prepared to defibrillate in the event of AICD failure.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Monitor and transport as indicated.</li>
                        <li>Consider calling for ALS care.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Be prepared to defibrillate in the event of AICD failure.</li>
                       <li>Midazolam 2.5 mg slow IV for sedation.</li>
                       <li>Consider 1014 Pain Management Protocol.</li>
                       <li>G For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half ( ) of the adult doses.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Be prepared to manually cardiovert or defibrillate in the event of AICD failure.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <p class=""text-sm"">None</p>
            </div>
        </div>
    </div>"
protocol,2007,Ventricular Assist Device ,2000,"<h3>2007.1 General Guidelines</h3>
    <ul>
        <li>It is important to recognize the patient with a ventricular assist device (VAD).</li>
        <li>Routinely, your agency will be advised when a VAD patient is in your community.</li>
        <li>Otherwise, these patients could be travelling through, or visiting in your jurisdiction.</li>
        <li>The patient or family members are generally knowledgeable about the VAD and how to troubleshoot it.</li>
    </ul>

    <h3 class=""mt-6"">2007.2 Assessing the VAD Patient</h3>
    <ul>
        <li>Skin color and mental status are the best indicators of stability in the VAD patient.</li>
        <li>A pulse is usually not palpable in the VAD patient. Nearly all VADs are continuous flow devices.</li>
        <li>If the device is a pulsatile flow device, a pulse should be palpable.</li>
        <li>Blood pressure may or may not be obtainable and auscultated readings are usually unreliable.
            <ul class=""list-disc pl-5"">
                <li>In a continuous flow device, mean arterial blood pressure (MAP) can be obtained by auscultating with a {Doppler}.</li>
                <li>The first sound heard during auscultation reflects the MAP.</li>
                <li>The MAP displayed by an automated non-invasive measurement may also be used.</li>
                <li>A normal and expected MAP in a patient with a VAD is 65-90 mmHg.</li>
                <li>If the device is a pulsatile flow device, a blood pressure should be measurable.</li>
            </ul>
        </li>
        <li>Pulse oximetry readings seem to be accurate, despite the manufacturer stating otherwise.</li>
        <li>Quantitative waveform capnography should be accurate and can be reflective of cardiac output</li>
        <li>An EtCO2 of less than 30 mmHg can be indicative of low perfusion secondary to poor pump function.</li>
        <li>{ECG 12-lead} as usual, no interference from the VAD is expected</li>
        <li>Temperature should be measured as infection and sepsis are common.</li>
    </ul>

    <h3 class=""mt-6"">2007.3 Transporting the VAD Patient</h3>
    <ul>
        <li>Patients with or without a VAD problem should be transported to the nearest appropriate Hospital ED.</li>
        <li>Do NOT delay ground transportation waiting to speak with the patient’s VAD Coordinator.</li>
        <li>Always bring the patients resource bag with you. It should contain:
            <ul class=""list-disc pl-5"">
                <li>Spare batteries and a battery charging unit</li>
                <li>Spare control unit</li>
                <li>Contact information for the VAD Coordinator.</li>
                <li>Directions for equipment and alarm troubleshooting.</li>
            </ul>
        </li>
        <li>Always bring spare batteries for the VAD with the patient, even if it is not a VAD related problem.</li>
        <li>If the transport is going to be prolonged or it is expected that the patient will be away for a while, try to bring the VAD base power unit with you.
             <ul class=""list-disc pl-5"">
                <li>Alternately, you can ask the patient’s family/caregiver to bring it to the hospital.</li>
            </ul>
        </li>
        <li>There may be a need to bring it with the patient and plug it into an inverter for power.</li>
    </ul>
    
    <h3 class=""mt-6"">2007.4 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>VAD equipment</li>
                    <li>VAD vests or battery packs</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Determine if you have a patient with a VAD problem, or a patient with a VAD that has a medical/trauma problem.</li>
                        <li>If there is no indication of possible VAD malfunction or failure, exit to appropriate protocols.</li>
                        <li>Assess the VAD:
                            <ul class=""list-disc pl-5"">
                                <li>Auscultate over the VAD pump location (Should be just to the left of the epigastrium, immediately below the heart)</li>
                                <li>If the pump is functioning, a low hum should be audible.</li>
                                <li>Do not assume that the pump is functioning just because the control unit does not indicate a problem.</li>
                            </ul>
                        </li>
                         <li>Palpate the control unit.
                            <ul class=""list-disc pl-5"">
                                <li>A hot control unit indicates the pump may be working harder than it should be</li>
                                <li>This often indicates a pump problem such as a thrombosis.</li>
                            </ul>
                        </li>
                        <li>Look at the alarms on the control panel
                            <ul class=""list-disc pl-5"">
                                <li>Trouble with the VAD will usually be identified by an alarm.</li>
                                <li>The patient will usually have a resource guide to direct alarm troubleshooting.</li>
                            </ul>
                        </li>
                        <li>Ask if the device is a continuous or pulsatile flow device.</li>
                        <li>Ask if the patient can receive electrical therapy.</li>
                        <li>Ask if chest compressions can be performed in the event of pump failure.</li>
                        <li>Inquire about DNR status.</li>
                        <li>If there is indication of possible device malfunction or failure:
                             <ul class=""list-disc pl-5"">
                                <li>Attempt to restart VAD if previously off for less than 5 minutes.</li>
                                <li>If VAD off longer than 5 minutes, then:
                                     <ul class=""list-disc pl-5"">
                                        <li>Locate the patients ""Emergency Contact Card""/VAD ID Card</li>
                                        <li>Contact the VAD coordinator.</li>
                                     </ul>
                                </li>
                             </ul>
                        </li>
                        <li>Discuss the plan with caregivers.</li>
                    </ul>
                    <li>If a VAD patient is unresponsive and pulseless with a non-functioning VAD and has previously indicated a desire for resuscitative efforts, begin chest compressions.
                            <ul class=""list-disc pl-5"">
                                <li>Defibrillation pads should be placed anterior/posterior</li>
                                <li>AVOID THE USE OF MECHANICAL CPR DEVICES</li>
                                <li>Ensure that all troubleshooting efforts (reconnecting wires, changing batteries, replacing the control unit) have failed prior to starting chest compressions.</li>
                            </ul>
                        </li>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Follow BLS protocol.</li>
                        <li>Transport urgently.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>No additional directives at this level.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Only symptomatic dysrhythmias not at the patient's baseline should be treated.</li>
                        <li>If indicated, place electrical therapy/defibrillation pads away from VAD site and AICD.</li>
                        <li>VAD patients may receive ACLS interventions.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Utilize the patient and family as a resource.</li>
                    <li>Always contact the VAD Coordinator if there is a VAD related problem or question.</li>
                    <li>Common complications in VAD patients include stroke (incidence up to 25%), bleeding, dysrhythmias, and infection.</li>
                    <li>The most common causes of death in VAD patients are sepsis and stroke. Consider this with a VAD patient showing altered mental status.</li>
                    <li>VAD patients are preload dependent. Consider that a fluid bolus can often reverse hypoperfusion.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,2008,Suspected Cardiac Chest Pain ,2000,"<h3>2008.1 General Guidelines</h3>
    <ul>
        <li>Unstable cardiac patients are hypotensive, or have chest pain with poor skin color or diaphoresis.</li>
    </ul>

    <h3 class=""mt-6"">2008.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">Chest pain in the pediatrics is rarely related to a cardiac event. Assessment for other causes (e.g., muscle pain, respiratory difficulties, injury) should be completed to determine the source of pain. Apply supplemental oxygen and transport. THE REST OF CHEST PAIN ALGORITHM DOES NOT APPLY TO PEDS.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Chest pain</li>
                    <li>Shortness of breath</li>
                    <li>Syncope</li>
                    <li>Pallor, Diaphoresis</li>
                    <li>Radiation of pain</li>
                    <li>Weakness</li>
                    <li>Nausea</li>
                    <li>Vomiting</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Pericarditis</li>
                    <li>Pulmonary embolism</li>
                    <li>Asthma/COPD</li>
                    <li>Pneumothorax</li>
                    <li>Aortic dissection or aneurysm</li>
                    <li>GE reflux or hiatal hernia</li>
                    <li>Chest trauma</li>
                    <li>Esophageal spasm</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Arrange for rapid ALS transport.</li>
                        <li>Apply O2 as appropriate.</li>
                        <li>Oxygen saturations less than 94%, should be given oxygen via NC and titrated to 94%.</li>
                        <li>Oxygen saturations 94% or higher, should not get any oxygen.</li>
                        <li>Do not withhold oxygen from a patient with SOB or respiratory distress.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Give Aspirin (ASA) 324 mg (chewed) to every patient greater than 25y/o with symptoms of Acute Coronary Syndrome (ACS).</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Administer Nitroglycerin 0.4 mg SL, every 5 minutes, for pain, to a total of three pills with vital signs between doses.
                            <ul class=""list-disc pl-5"">
                                <li>SBP must be greater than 100.</li>
                                <li>Patient must be greater than 25 y/o.</li>
                            </ul>
                        </li>
                        <li>Prior to moving patient, acquire a supine {12-lead EKG} on all patients with ACS symptoms.</li>
                        <li>{Transmit 12 Lead EKG} with two identifiers to MCP.</li>
                        <li>The MCP shall be contacted after at least the initial {12-lead EKG} transmission is completed.</li>
                        <li>Consult MCP for appropriate destination.</li>
                        <li>Consider and transmit repeat {12-lead EKGs} during transport.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li><span class=""font-bold text-blue-600"">&diams;</span> Must obtain MCP permission to administer Aspirin (ASA) to patients 25 y/o or younger</li>
                       <li>The AEMT must also transmit the {12-Lead EKGs}</li>
                       <li>Administer Nitroglycerin 0.4 mg SL, every 5 minutes, for pain, to a total of three pills with vital signs between doses.</li>
                       <li>Prior to Nitroglycerin administration, establish vascular access for patients who have not previously had Nitroglycerin.</li>
                       <li>Consider 1014 Pain Management Protocol, provided SBP greater than 100 after first dose of nitroglycerin.</li>
                       <li><strong>DO NOT WAIT UNTIL 3 NITROGLYCERIN TABLETS ARE GIVEN BEFORE CONSIDERING FENTANYL.</strong></li>
                       <li>IV fluid, up to 500 ml, may be administered to a patient with SBP less than 100 without pulmonary edema.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        
                        <li>Treat cardiogenic shock with or without pulmonary edema as identified in 4016 Shock.</li>
                        <li>If evidence of STEMI, transport to an interventional cardiac catherization lab.</li>
                        <li>The Paramedic should only transmit a {12-lead EKG} that meets Cardiac Alert criteria, or that is questionable.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Without consultation, the Suspected Cardiac Chest Pain protocol only applies to patients greater than 25 years old with ACS symptoms.</li>
                    <li>Contact MCP for further advice with pediatric chest pain as needed.</li>
                    <li>For the EMT, the following requires MCP orders:
                        <ul class=""list-disc pl-5"">
                            <li>Aspirin administration</li>
                            <li>Nitroglycerin administration</li>
                            <li>Accessing the GMVEMSC Drug Bag</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>No significant change in patient condition in the field should be expected from the administration of Aspirin.</li>
                    <li>Patient must chew Aspirin.</li>
                    <li>Aspirin is contraindicated in third trimester of pregnancy.</li>
                    <li>Do not administer Nitroglycerin (NTG) if the patient has taken Viagra, Cialis, Levitra, Revatio, or similar medications within the last 24 hours.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,2009,Cardiac Alert Program ,2000,"<h3>2009.1 General Guidelines</h3>
    <ul>
        <li>The intent of the Program is to decrease the ""Door to Balloon"" time for pre-hospital AMI Patients.</li>
        <li>Providers will make early notification to the receiving facility and speak directly with the Physician.</li>
        <li>The Physician may activate a Cardiac Alert, based on provider impression and {12 Lead EKG} interpretations.</li>
    </ul>

    <h3 class=""mt-6"">2009.2 Inclusionary Criteria</h3>
    <ul>
        <li>Patients presenting with anginal-type chest pain or an equivalent anginal event may be candidates.</li>
        <li>Evidence of an AMI (greater than 1mm ST elevation in 2 contiguous leads) on a diagnostic {12-lead EKG}.</li>
    </ul>

    <h3 class=""mt-6"">2009.3 Exclusionary Criteria</h3>
    <ul>
        <li>Patient with a Left Bundle Branch Block (QRS greater than 120 milliseconds).</li>
        <li>Patients with a pacemaker rhythm.</li>
    </ul>

    <h3 class=""mt-6"">2009.4 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">Consider differential diagnosis</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Chest pain</li>
                    <li>Difficulty breathing</li>
                    <li>Syncope</li>
                    <li>Anginal equivalents</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None in the presence of ACS symptoms</li>
                    <li>Chest trauma</li>
                    <li>Pulmonary issues</li>
                    <li>Cardiac Alert imitators on 12 Lead EKG</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>No additional orders at this level.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Acquire and transmit the {12 Lead ECG} in any suspected AMI or in cardiac arrest with ROSC.</li>
                        <li>Contact the receiving hospital for further orders and/or destination directives.</li>
                        <li>Acquire serial {12 Lead ECGs} enroute to the hospital.</li>
                        <li>The recommendation is to repeat {12 Lead ECGs} every 5 minutes or with any change in condition/presentation}</li>
                        <li>Consider applying defibrillation pads to confirmed myocardial infarction patients.</li>
                        <li>Transport patients with ST Elevation MI (STEMI) or ROSC after cardiac arrest to an Interventional facility.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Consider aggressive fluid administration of up to 500 ml to manage cardiogenic shock.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Reassess lungs frequently.</li>
                        <li>In significant AMIs, patients may develop cardiac conduction disorders (PVCs, BBB and 2º or 3º blocks).</li>
                        <li>If patient develops significant bradycardia, then utilize 2010 Bradycardia</li>
                        <li>Monitor blood pressure and administer Nitroglycerin or Fentanyl cautiously.</li>
                        <li>A If patient is still hypotensive after other therapy, begin Norepinephrine by adding 4 mg to 250 ml of IV fluids. Infuse starting at 30 drops per minute (max. 45 drops) with 60 drop tubing and titrate to effect. Increase by 5 drops/minute every 5 minutes.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>The EMT and AEMT should contact the MCP after {12 Lead EKG} transmissions for further orders.</li>
                    <li>The Paramedic is expected to read and interpret the {12-lead EKG}.</li>
                    <li>Do not rely solely on the computer interpretation or expect the physician to interpret the transmitted {12 Lead EKG} for you.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>An interventional facility is a hospital that provides Percutaneous Cardiac Interventions 24 hours a day.</li>
                    <li>To determine the regional interventional facilities, see 7013 Hospital Capabilities Chart.</li>
                    <li>Rerouting at interventional facilities does not apply to Cardiac Alerts.</li>
                    <li>Consider air medical transport if the interventional facility is over 30 minutes away.</li>
                    <li>Exceptions to transporting to an interventional facility include:
                        <ul class=""list-disc pl-5"">
                            <li>It is medically necessary to transport the patient to the closest hospital for stabilization.</li>
                            <li>It is unsafe to transport the patient directly due to adverse weather/ground conditions or excessive transport time.</li>
                            <li>Transporting the patient to would cause a critical shortage of local EMS resources.</li>
                            <li>Patient requests transport to a different facility, despite EMS education of patient.</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>"
protocol,2010,Bradycardia ,2000,"<h3>2010.1 General Guidelines</h3>
    <ul>
        <li>Bradycardia is any rate less than 60 bpm.</li>
        <li>Non-symptomatic bradycardia may be a normal finding in otherwise healthy individuals.</li>
        <li>Assess the patient and determine medical history.</li>
        <li>Treat unexplained or symptomatic bradycardia</li>
    </ul>

    <h3 class=""mt-6"">2010.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">With adequate perfusion, monitor vital signs, and apply oxygen if needed. Hypoxia in pediatric patients will produce bradycardia.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Heart rate less than 60 bpm</li>
                    <li>Syncope</li>
                    <li>Unstable bradycardia
                        <ul class=""list-disc pl-5"">
                            <li>Hypotension</li>
                            <li>Altered mental status</li>
                            <li>Unresolved chest pain</li>
                            <li>Poor skin color</li>
                            <li>Diaphoresis</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Acute myocardial infarction</li>
                    <li>Hypoxia</li>
                    <li>Hypothermia</li>
                    <li>Elevated ICP (Stroke or Trauma)</li>
                    <li>Spinal cord lesion</li>
                    <li>Sick sinus syndrome</li>
                    <li>Athletic patients</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Administer oxygen as indicated.</li>
                        <li>Call for transport immediately.</li>
                        <li>For adequate perfusion, observe and monitor vital signs.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Obtain {12-lead EKG}, transmit and call receiving facility.</li>
                        <li>Transport immediately unless ALS intercept is less than 5 minutes.</li>
                        <li>For Pediatric patients less than 2 years old:
                           <ul class=""list-disc pl-5"">
                               <li>P Look for signs and symptoms of shock or hypoperfusion</li>
                               <li>P Secure the airway and ventilate with BVM at 1 breath every 3-4 seconds</li>
                               <li>P If heart rate and perfusion do not increase within 30 to 60 seconds, then perform CPR.</li>
                           </ul>
                       </li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>No additional orders at this level.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Obtain and interpret {12 Lead EKG}</li>
                        <li>Wide complex bradycardia patients should spark consideration of treatment of hyperkalemia.
                            <ul class=""list-disc pl-5"">
                                <li><span class=""font-bold text-blue-600"">&diams;</span> Administer both Calcium Chloride 10% 1 g (Calcium Chloride or Gluconate) and Sodium Bicarbonate 100 mEq.</li>
                                <li>Flush well between these medications. It is critical that these drugs not be given together, as they will precipitate.</li>
                            </ul>
                        </li>
                        <li>With evidence of poor perfusion in adults and pediatrics:
                            <ul class=""list-disc pl-5"">
                                <li>A Consider Atropine 1 mg IV, up to total of 3 mg.</li>
                                <li>P If AV block:
                                    <ul class=""list-disc pl-5"">
                                        <li>P Consider Atropine 0.02 mg/kg IV (minimum dose 0.1 mg, maximum single dose 0.5 mg)</li>
                                        <li>P May repeat dose every 5 minutes. Max total dose of 1 mg.</li>
                                    </ul>
                                </li>
                                <li>P Epinephrine (1:10,000) 0.01 mg/kg, IV, repeat every 5 minutes.</li>
                            </ul>
                        </li>
                        <li>If treatments are ineffective begin pacing:
                            <ul class=""list-disc pl-5"">
                                <li>A If time permits, Ketamine 25 mg IV (preferred method) or Midazolam 2.5 mg slow IV prior to pacing.</li>
                                <li>A DO NOT reduce Ketamine or Midazolam doses by half for patients greater than 69 y/o</li>
                                <li>A Set at 70 BPM, 20 mA and increase until mechanical capture is obtained.</li>
                                <li>P Consider pacing:
                                    <ul class=""list-disc pl-5"">
                                        <li>P Pediatric electrodes should be used on patients less than 15 kg.</li>
                                        <li>P Consider Midazolam 0.1 mg/kg (max dose 2 mg) slow IV prior to pacing.</li>
                                        <li>P Start with 5 mA increasing as needed to 200 mA at a rate of 80 bpm until capture.</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">The paramedic will consult for administration of Calcium Chloride 10% (or Gluconate) and Sodium Bicarbonate.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <p class=""text-sm"">None</p>
            </div>
        </div>
    </div>"
protocol,2011,Tachycardia ,2000,"<h3>2011.1 General Guidelines</h3>
    <ul>
        <li>Tachycardia is any heart rate greater than 100 bpm.</li>
        <li>Assess the patient and determine medical history.</li>
        <li>Treat unexplained or symptomatic tachycardia</li>
    </ul>

    <h3 class=""mt-6"">2011.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">With adequate perfusion, monitor vital signs, and apply oxygen if needed.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Heart rate greater than 100 bpm</li>
                    <li>Dizziness</li>
                    <li>Chest pain</li>
                    <li>Shortness of breath</li>
                    <li>Unstable tachycardia
                        <ul class=""list-disc pl-5"">
                            <li>Hypotension</li>
                            <li>Altered mental status thought to be due to tachycardic rhythms</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Myocardial infarction</li>
                    <li>Electrolyte imbalance</li>
                    <li>Exertion/pain/emotional stress</li>
                    <li>Fever</li>
                    <li>Hypoxia</li>
                    <li>Hypovolemia or anemia</li>
                    <li>Drug overdose</li>
                    <li>Hyperthyroidism</li>
                    <li>Pulmonary embolus</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Administer oxygen as indicated.</li>
                        <li>Call for transport immediately.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Obtain {12-lead ECG}, transmit and call receiving facility.</li>
                        <li>Transport immediately unless ALS intercept is less than 5 minutes.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>No additional orders at this level.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Obtain and interpret {12 Lead ECG}</li>
                        <li><strong>Stable:</strong>
                           <ul class=""list-disc pl-5"">
                                <li><u>Narrow Complex - Regular</u>
                                    <ul class=""list-disc pl-5"">
                                        <li>A Vagal maneuvers</li>
                                        <li>A Adenosine 6 mg rapid IVP, saline flush</li>
                                        <li>A May repeat Adenosine 12 mg rapid IVP x 2, saline flush</li>
                                    </ul>
                                </li>
                                <li><u>Wide Complex - Regular or Irregular</u>
                                    <ul class=""list-disc pl-5"">
                                        <li>A Amiodarone 150 mg in 250 ml NS, IV over 10 minutes using 60 drop/ml tubing.</li>
                                        <li>A If Amiodarone not available use Lidocaine</li>
                                        <li>A Lidocaine 150 mg IV/IO</li>
                                    </ul>
                                </li>
                           </ul>
                        </li>
                        <li><strong>Unstable:</strong>
                           <ul class=""list-disc pl-5"">
                                <li>A Consider administration of a sedative/analgesic prior to cardioversion</li>
                                <li>A Ketamine 25 mg IV (preferred method) or Midazolam 2.5 mg slow IV</li>
                                <li>A DO NOT reduce Ketamine or Midazolam doses by half for patients greater than 69 y/o</li>
                                <li>A Cardioversion: 100, 200, 300, 360 J for monophasic or biphasic equivalent</li>
                           </ul>
                        </li>
                        <li>With evidence of polymorphic ventricular tachycardia (torsades de pointes):
                            <ul class=""list-disc pl-5"">
                                <li>A If unstable: Unsynchronized Cardioversion: 100, 200, 300, 360 J for monophasic or biphasic equivalent</li>
                                <li>A If stable: Magnesium Sulfate 2 gm infused with macro-drip tubing over 10 minutes</li>
                            </ul>
                        </li>
                        <li><strong>Stable Pediatrics:</strong>
                            <ul class=""list-disc pl-5"">
                                <li>P Vagal maneuvers (blowing through a straw or oxygen tubing, etc.)</li>
                                <li>P Adenosine 0.1 mg/kg rapid IVP (max dose 6 mg), saline flush.</li>
                                <li>P If no response, Adenosine 0.2 mg/kg rapid IVP (max dose 12 mg), saline flush. Repeat x 1.</li>
                            </ul>
                        </li>
                        <li><strong>Unstable Pediatrics:</strong>
                             <ul class=""list-disc pl-5"">
                                <li>P Consider cardioversion.</li>
                                <li>P If time permits, Midazolam 0.1 mg/kg slow IV (max dose 2.5 mg).</li>
                                <li>P Cardioversion 1 J/kg</li>
                                <li>P If no response, repeat cardioversion at 2 J/kg</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Paramedics should not cardiovert:
                        <ul class=""list-disc pl-5"">
                            <li>Patients without hemodynamic changes</li>
                            <li>Patients whose hemodynamic changes have other apparent causes.</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>If patient has history of Paroxysmal Supraventricular Tachycardia (PSVT) and advises it takes 12 mg of Adenosine, then skip the 6 mg dose.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3001,General Trauma Management ,3000,"<h3>3001.1 General Guidelines</h3>
    <ul>
        <li>Minor trauma patients may be transported to non-trauma centers.</li>
        <li>Major trauma patients are to be transported as soon as possible to the nearest appropriate facility.</li>
        <li>Scene size-up, with rapid assessment and recognition of major trauma/multiple system trauma and effective evaluation of the mechanism of injury are essential to the subsequent treatment.</li>
        <li>If patient meets criteria as defined in 3018 Trauma Transport Guidelines, then call ""Trauma Alert"".</li>
        <li>If transporting by helicopter, ensure a copy of the patient care report gets to the receiving facility.</li>
    </ul>

    <h3 class=""mt-6"">3001.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">May not exhibit typically. Injuries may not present the same as in adults. Will present decompensated shock late.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Traumatic injuries</li>
                    <li>DCAP-BTLS</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Medical complaints with S/S that mimic traumatic injuries</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>The only procedures that should take precedence to transport of major trauma patients are:
                            <ul class=""list-disc pl-5"">
                                <li>Airway management</li>
                                <li>Stabilization of neck/back or obvious femur and pelvic fractures on a backboard</li>
                                <li>Exsanguinating hemorrhage control</li>
                                <li>Extrication</li>
                            </ul>
                        </li>
                        <li>Maintain patient's body temperature.</li>
                        <li>Take a manual BP on all trauma patients.</li>
                        <li>Repeat vitals on trauma patients every 5 minutes.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>On-scene time should be limited to 10 minutes or less, except when there are extenuating circumstances.</li>
                        <li>Report Mechanism of Injury, Injuries, Vital signs, Treatment (MIVT), GCS with components, and ETA to the receiving facility.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>IVs should be established en route to the hospital unless the patient is trapped, transport is otherwise delayed, or patient has no life-threatening injuries, and transport prior to analgesia would be extremely painful.</li>
                       <li>A Start the IV with a large bore catheter and macro drip tubing.</li>
                       <li>A Administer up to a 1000 ml IV fluid bolus</li>
                       <li>P Administer 20 ml/kg of IV fluid</li>
                       <li>A IV flow rates are as follows:
                           <ul class=""list-disc pl-5"">
                               <li>Keep open rate for major head trauma with adequate perfusion</li>
                               <li>IV wide open if the patient has inadequate perfusion (including head trauma) utilizing {IV Pressure Infusion Pump or Bag} or similar equipment if available</li>                              
                           </ul>                         
                       </li>
                       <li>Titrate all IV flow rates to maintain SBP ~100</li> 
                       <li>For penetrating trauma to the chest and abdomen:
                            <ul class=""list-disc pl-5"">
                               <li>If a radial pulse is present and the patient is conscious and mentating, load and go.</li>
                               <li>If no radial pulse, infuse IV fluid in 250 ml boluses until radial pulse is present and then stop fluid.</li>
                            </ul>
                       </li>
                       <li>Consider 1014 Pain Management Protocol.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Use of on-line MCP for medical direction in the field for difficult cases is encouraged.</li>
                    <li>Pre-arrival notification of the receiving facility is essential!</li>
                    <li>Keep the receiving hospital informed on the patient's condition, significant changes should be reported.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Hypothermia is a significant and frequent problem in shock for major trauma patients.</li>
                    <li>Surgical emergencies with increased fluid administration cause dilution, lower body temperatures and increase coagulopathies, all of which increase mortality.</li>
                    <li>To address this, allow for ""permissive hypotension,""</li>
                    <li>This means that IV fluids are not administered to these patients unless there is loss of radial pulse.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3002,Major Trauma ,3000,"<div>
    <h3>3002.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
        <ul class=""list-disc pl-5 text-sm"">
            <li>Significant injuries or life threats</li>
        </ul>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Patients meeting criteria for transport to a Trauma Center are considered ""Load and Go.""</li>
                        <li>Consider the trauma care mnemonics M.A.R.C.H. to establish treatment priorities:
                            <ul class=""list-disc pl-5 mt-1 font-mono"">
                                <li><span class=""font-bold"">M</span>assive Hemorrhage: Assess for and address significant bleeding</li>
                                <li><span class=""font-bold"">A</span>irway: Assess for and ensure a patent airway using adjuncts and positioning</li>
                                <li><span class=""font-bold"">R</span>espirations: Assess respiratory rate, quality and effort and oxygenate the patient with 100% O₂</li>
                                <li><span class=""font-bold"">C</span>irculation: Double check all bleeding interventions and perform a head-to-toe sweep for additional bleeding</li>
                                <li><span class=""font-bold"">H</span>ypothermia: Prophylactically treat patient for hypothermia</li>
                            </ul>
                        </li>
                        <li>Other trauma care considerations:
                             <ul class=""list-disc pl-5 mt-1"">
                                <li>Open pneumothorax: cover wound with an occlusive dressing, tape down three sides.</li>
                                <li>Tension pneumothorax: lift one side of any occlusive dressing.</li>
                                <li>Flail chest: stabilize immediately with a gloved hand, then immobilize with a bulky dressing or towels taped to the chest.</li>
                            </ul>
                        </li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <p><strong>Tension pneumothorax:</strong></p>
                    <ul>
                        <li>Use caution not to confuse right main stem intubation for a pneumothorax.</li>
                        <li>Perform needle decompression as indicated.</li>
                        <li>Decompress the chest with a 14-gauge or larger, 3 ½"" angiocath.</li>
                        <li>Location options include:
                            <ul class=""list-disc pl-5 mt-1"">
                                <li>Fourth or fifth intercostal space in the mid-axillary line</li>
                                <li>Second or third intercostal space in the mid-clavicular line (use nipple line as a guide)</li>
                            </ul>
                        </li>
                        <li class=""text-pink-600""><span class=""font-bold"">P</span> In patients less than 8 years old, decompression site choice will only be the second or third intercostal space at the mid-clavicular line.</li>
                    </ul>
                </div>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t space-y-2"">
            <div><h4 class=""text-base font-bold"">Consult</h4><p class=""text-sm"">Contact Medical Control and advise them of patient condition with MIVT, ETA, and GCS components.</p></div>
            <div><h4 class=""text-base font-bold"">Clinical Pearls</h4><p class=""text-sm"">For pregnant patient in arrest consider need for manual uterine displacement.</p></div>
        </div>
    </div>
</div>"
protocol,3003,Glasgow Coma Score ,3000,"<div>
    <h3>3003.1 General Guideline</h3>
    <ul>
        <li>When assessing the level of consciousness, use the appropriate Glasgow Coma Score.</li>
        <li>All patients should have at least one recorded and reported GCS.</li>
    </ul>

    <h3 class=""mt-6"">3003.2 The Glasgow Coma Score</h3>
    <div class=""overflow-x-auto"">
        <table class=""w-full text-sm text-left"">
            <thead class=""text-xs text-gray-700 uppercase bg-gray-100"">
                <tr><th class=""px-2 py-2 text-center"" colspan=""3"">LESS THAN 2 YEARS OLD</th><th class=""px-2 py-2 text-center"" colspan=""3"">ADULT & PEDIATRIC OVER 2 YEARS OLD</th></tr>
            </thead>
            <tbody>
                <tr class=""border-b""><td rowspan=""4"" class=""px-2 py-2 font-semibold align-top"">EYES</td><td>SPONTANEOUSLY</td><td class=""text-center"">4</td><td>SPONTANEOUSLY</td><td class=""text-center"">4</td></tr>
                <tr class=""border-b""><td>TO VOICE</td><td class=""text-center"">3</td><td>TO VOICE</td><td class=""text-center"">3</td></tr>
                <tr class=""border-b""><td>TO PAIN</td><td class=""text-center"">2</td><td>TO PAIN</td><td class=""text-center"">2</td></tr>
                <tr class=""border-b""><td>NO RESPONSE</td><td class=""text-center"">1</td><td>NO RESPONSE</td><td class=""text-center"">1</td></tr>
                
                <tr class=""border-b bg-gray-50""><td rowspan=""5"" class=""px-2 py-2 font-semibold align-top"">VERBAL</td><td>COOS, BABBLES</td><td class=""text-center"">5</td><td>ORIENTED</td><td class=""text-center"">5</td></tr>
                <tr class=""border-b bg-gray-50""><td>IRRITABLE CRY, CONSOLABLE</td><td class=""text-center"">4</td><td>CONFUSED</td><td class=""text-center"">4</td></tr>
                <tr class=""border-b bg-gray-50""><td>CRIES TO PAIN</td><td class=""text-center"">3</td><td>INAPPROPRIATE WORDS</td><td class=""text-center"">3</td></tr>
                <tr class=""border-b bg-gray-50""><td>MOANS TO PAIN</td><td class=""text-center"">2</td><td>GRUNTS, GARBLED SPEECH</td><td class=""text-center"">2</td></tr>
                <tr class=""border-b bg-gray-50""><td>NO RESPONSE</td><td class=""text-center"">1</td><td>NO RESPONSE</td><td class=""text-center"">1</td></tr>

                <tr class=""border-b""><td rowspan=""6"" class=""px-2 py-2 font-semibold align-top"">MOTOR</td><td>NORMAL MOVEMENTS</td><td class=""text-center"">6</td><td>OBEYS COMMANDS</td><td class=""text-center"">6</td></tr>
                <tr class=""border-b""><td>WITHDRAWS TO TOUCH</td><td class=""text-center"">5</td><td>LOCALIZES PAIN</td><td class=""text-center"">5</td></tr>
                <tr class=""border-b""><td>WITHDRAWS TO PAIN</td><td class=""text-center"">4</td><td>WITHDRAWS TO PAIN</td><td class=""text-center"">4</td></tr>
                <tr class=""border-b""><td>FLEXION (DECORTICATE)</td><td class=""text-center"">3</td><td>FLEXION (DECORTICATE)</td><td class=""text-center"">3</td></tr>
                <tr class=""border-b""><td>EXTENSION (DECEREBRATE)</td><td class=""text-center"">2</td><td>EXTENSION (DECEREBRATE)</td><td class=""text-center"">2</td></tr>
                <tr><td>NO RESPONSE</td><td class=""text-center"">1</td><td>NO RESPONSE</td><td class=""text-center"">1</td></tr>
            </tbody>
        </table>
    </div>
</div>"
protocol,3004,Trauma Arrest ,3000,"<h3>3004.1 General Guidelines</h3>
    <ul>
        <li>Traumatic cardiac arrest care will follow the same algorithm as other cardiac arrest scenarios.</li>
        <li>Mechanical CPR devices are contraindicated in traumatic arrest where there is:
            <ul class=""list-disc pl-5"">
                <li>Injury or mechanism of injury to the neck</li>
                <li>Injury or mechanism of injury to the thoracic cavity (anterior or posterior)</li>
                <li>Injury or mechanism of injury to the abdominal cavity</li>
                <li>Minor injuries to these areas or the extremities do not apply.</li>
            </ul>
        </li>
        <li>If appropriate, providers may consider termination of resuscitation.</li>
    </ul>

    <h3 class=""mt-6"">3004.2 Termination of Resuscitation</h3>
    <ul>
        <li>Emergency medical responders (EMRs) may not terminate a trauma cardiac arrest.</li>
        <li>The criteria for termination of resuscitation in arrest from blunt or penetrating trauma is:
            <ul class=""list-disc pl-5"">
                <li>No immediately reversible cause can be determined after rapid primary survey and treatment.</li>
                <li>No signs of life after BLS (e.g. respiratory effort, purposeful movement, reactive pupils, etc.)</li>
                <li>Sustained EtCO2 of below 10 mmHg</li>
                <li>If no ALS equipment is available at the scene and transport will exceed 20 minutes.</li>
            </ul>
        </li>
        <li>Continue care and transport if patient arrests after in the care of EMS.</li>
    </ul>

    <h3 class=""mt-6"">3004.3 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">If the pediatric patient does not meet non-initiation criteria, then begin resuscitation.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Cardiac arrest with traumatic injury or significant mechanism of injury</li>
                    <li>Unresponsive, pulseless, and apneic</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Signs of irreversible death</li>
                    <li>Other causes of unresponsiveness</li>
                    <li>Meets 1003 Non-initiation of Care Protocol</li>
                    <li>Excessive hemorrhage</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Initiate basic life support as defined in 2002 Cardiac Arrest - BLS</li>
                        <li>Internal/External hemorrhage control (e.g., tourniquets, pelvic binders, etc.)</li>
                        
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                       <li>Consider the possibility of both medical and traumatic causes (mixed mechanisms).</li>
                       <li>Initiate a Rapid Primary Survey for reversible causes. TREATMENT OF REVERSIBLE CAUSES SHOULD BE A PRIORITY.</li>
                       <li>Cardiac monitoring/defibrillations via AED.</li>
                       <li>Consider Termination of Resuscitation. (AEMT and Paramedic will continue through the algorithm before termination).</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Continue treating any organized rhythm with rate greater than 40 because of the potential of pseudo-PEA.</li>
                       <li>Secure airway and confirm with continuous EtCO2.</li>
                       <li>Bilateral needle decompression as indicated (ex. high airway resistance, chest trauma, subcutaneous air).
                            <ul class=""list-disc pl-5"">
                               <li>Fourth or fifth intercostal space in the mid-axillary line</li>
                               <li>Second or third intercostal space in the mid-clavicular line (use nipple line as a guide)</li>
                               <li>P In patients less than 8 years old, decompression site choice will be limited to the 2nd or 3rd intercostal space at the mid-clavicular line</li>
                            </ul>
                       </li>
                       <li>Repeat needle decompression as indicated (continued high airway pressure).</li>
                       <li>Administer rapid IV fluid administration:
                            <ul class=""list-disc pl-5"">
                               <li>A Administer up to 1000 ml IV fluid</li>
                               <li>P Administer 20 ml/kg of IV fluid</li>
                            </ul>
                       </li>
                       <li>If ROSC is achieved, transport immediately.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Contact MCP for Field Termination</li>
                    <li>Be ready to provide the following information:
                        <ul class=""list-disc pl-5"">
                            <li>Duration of resuscitation</li>
                            <li>How long the patient was in arrest prior to EMS arrival</li>
                            <li>Witnessed or unwitnessed cardiac arrest</li>
                            <li>Capnography values</li>
                            <li>Presenting rhythm (for AEMT and Paramedic)</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>For pregnant patient in arrest consider need for manual uterine displacement.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3005,Burns and Smoke Inhalation ,3000,"<h3>3005.1 General Guidelines</h3>
    <ul>
        <li>It is strongly recommended that at dispatch, agencies immediately call for the nearest available cyanide antidote cache whenever any of the following occur:
            <ul class=""list-disc pl-5"">
                <li>Dispatched on a report of a person trapped with exposure to fire or smoke in an enclosed area.</li>
                <li>Dispatched on a report of an incident involving cyanide.</li>
                <li>Report of a Mayday or firefighter down with exposure to fire or smoke in an enclosed area.</li>
            </ul>
        </li>
        <li>Estimate and report total Body Surface Area (BSA) involved using universally accepted methods.
            <ul class=""list-disc pl-5"">
                <li>BSA estimates should include only full and partial thickness burns.</li>
            </ul>
        </li>
        <li>Inhalation injuries with an unsecured airway should be transported to the nearest facility.</li>
        <li>Chemical burns are hazardous material situations and must be grossly decontaminated at the scene.</li>
    </ul>

    <h3 class=""mt-6"">3005.2 Specific Care for Burns</h3>
    <ul>
        <li>Radiation burns:
            <ul class=""list-disc pl-5"">
                <li>If there is radioactive material on the patient, then they must be decontaminated.
                    <ul class=""list-disc pl-5"">
                        <li>Consider contacting a Hazardous Materials Team for assistance with decontamination.</li>
                        <li>Contact the hospital prior to arrival like with any other hazardous materials case.</li>
                    </ul>
                </li>
                <li>Treat critical medical conditions first.</li>
            </ul>
        </li>
        <li>Treat injuries like thermal burns once the area is decontaminated</li>
    </ul>

    <h3 class=""mt-6"">3005.3 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Burns, pain, swelling</li>
                    <li>Hypotension/shock</li>
                    <li>Airway compromise/distress</li>
                    <li>Singed facial or nasal hair</li>
                    <li>Hoarseness/wheezing</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Superficial burns</li>
                    <li>Partial thickness burns</li>
                    <li>Full thickness burns</li>
                    <li>Chemical, Thermal, Electrical, Radiation burns</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Stop the burning and minimize contamination.</li>
                        <li>Assess for respiratory distress, stridor, hoarseness, sooty sputum, singed eyebrows, and nares, or burns of the face or airway.</li>
                        <li>If available, use {CO oximeter}.</li>
                        <li>For inhalation burns: Administer high flow oxygen via non-rebreather mask.</li>
                        <li>Keep patient warm.</li>
                        <li>Superficial, partial thickness and full thickness burns should be covered with clean, dry sheets or dressings.</li>
                        <li>Do not apply ice or ice packs to burns, if ice was applied prior to arrival, then remove.</li>
                        <li>Remove clothing and jewelry from injured parts. Do not remove items which have adhered to the skin.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>If available deliver {humidified} oxygen.</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> For inhalation burns: If no humidifier is available, administer Saline 3 ml via nebulizer. Repeat as needed.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Apply cardiac monitor, especially if patient has suffered a lightning strike or electrical burn.</li>
                       <li>Provide endotracheal intubation if apneic.</li>
                       <li>Administer fluids to maintain perfusion, do not overhydrate. Fluids should be a balanced electrolyte solution when available.</li>
                       <li>IV access can be acquired in areas with burnt tissue if necessary and before intraosseous needle access.</li>
                       <li>Consider 1014 Pain Management Protocol.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Early intubation as indicated. Do not wait for complete airway obstruction or respiratory arrest.</li>
                        <li>For known or suspected cyanide poisoning, use 3008 Cyanide Poisoning and Antidotes</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">EMTs must call for orders to administer nebulized saline in the absence of humidified oxygen when treating inhalation burns.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Patients with severe burns should be transported to a Burn Center unless ETA greater than 30 minutes.</li>
                    <li>BP may be taken over damaged tissue if no other site is accessible.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3006,Carbon Monoxide Poisoning ,3000,"<h3 class=""mt-6"">3006.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Malaise, fatigue, drowsiness</li>
                    <li>Flu like symptoms</li>
                    <li>Headache</li>
                    <li>Dyspnea</li>
                    <li>Nausea/vomiting</li>
                    <li>Diarrhea</li>
                    <li>Abdominal pain</li>
                    <li>Syncope</li>
                    <li>Seizures</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Flu/Severe cold</li>
                    <li>Chronic fatigue</li>
                    <li>Myocardial infarction</li>
                    <li>Diabetic crisis</li>
                    <li>Altitude sickness</li>
                    <li>Ingested toxins</li>
                    <li>Hypothyroidism</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Remove patients from the environment.</li>
                        <li>Provide high flow O2 to all suspected carbon monoxide poisonings.</li>
                        <li>Pulse oximeter will give false readings and should not be utilized.</li>
                        <li>If not already on scene, consider requesting an apparatus with equipment to test for CO in the atmosphere</li>
                        <li>{CO oximeter}</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Contact MCP to discuss transport considerations.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>No additional orders at this level.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">Look to Medical Control for guidance on transport destination.</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>When determining destination, consider possible hyperbaric oxygen treatment for the following patients with suspected CO exposure:
                        <ul class=""list-disc pl-5"">
                            <li>Underlying cardiovascular disease or symptoms such as chest pain or shortness of breath</li>
                            <li>Greater than 60 years of age</li>
                            <li>Obvious neurological symptoms, such as any interval of unconsciousness, loss of time, inability to perform simple motor tasks, or loss of memory</li>
                            <li>Smoke inhalation victims</li>
                            <li>Pregnancy</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3007,Crush Syndrome Trauma ,3000,"<h3 class=""mt-6"">3007.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">No pediatric medication doses should exceed total adult doses.</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Patient entrapped</li>
                    <li>Patient under a heavy load and crushed</li>
                    <li>Hypotension</li>
                    <li>Hypothermia</li>
                    <li>Abnormal ECG findings</li>
                    <li>Pain</li>
                    <li>Anxiety</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Contact MCP immediately and prior to relieving the load.</li>
                        <li>Prepare for the patient to decompensate when extricated.</li>
                        <li>Monitor and reassess</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>{12-lead ECG} as soon as feasible.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>A 1 liter IV fluid bolus IV. Then 500 ml/hour IV</li>
                       <li>P IV fluid, 20 ml/kg IV</li>
                       <li>Follow 1014 Pain Management protocol</li>
                       <li>If hypotensive and the patient has been entrapped for more than 1 hour:
                            <ul class=""list-disc pl-5"">
                               <li>A Give additional IV fluid, 1 liter IV.</li>
                               <li>P Give additional IV fluid, 20 ml/kg IV.</li>
                            </ul>
                        </li>
                        <li>Consider sedation:
                            <ul class=""list-disc pl-5"">
                               <li>A Ketamine 250 mg IM, may repeat after 10 minutes</li>
                               <li>G For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half (%) of the adult doses</li>
                               <li>P Ketamine 5 mg/kg IM, max dose of 250 mg</li>
                            </ul>
                        </li>
                        <li>Monitor for fluid overload</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        
                        <li>Normal ECG and hemodynamically stable, immediately prior to extrication:
                            <ul class=""list-disc pl-5"">
                               <li>A Sodium Bicarbonate 100 mEq IV</li>
                               <li>P Sodium Bicarbonate 1mEq/kg IV</li>
                            </ul>
                        </li>
                        <li>Abnormal ECG and hemodynamically unstable:
                             <ul class=""list-disc pl-5"">
                               <li>If after release, hyperkalemia causes wide bizarre EKG complexes with:
                                    <ul class=""list-disc pl-5"">
                                       <li>Peaked T waves with a QRS greater than or equal to 0.12 seconds</li>
                                       <li>QT ≥ 0.46 seconds</li>
                                       <li>Loss of P wave</li>
                                       <li>Bundle Branch Blocks</li>
                                       <li>Premature ventricular contractions</li>
                                       <li>Bradycardia</li>
                                    </ul>
                               </li>
                               <li>Consider Calcium Chloride, 1 gm, flush line well before Sodium Bicarbonate</li>
                               <li>Albuterol 10 mg nebulized</li>
                               <li>A Sodium Bicarbonate 100 mEq IV</li>
                               <li>P Sodium Bicarbonate 1mEq/kg IV</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Contact MCP immediately and prior to relieving the load.</li>
                    <li>MCP orders needed for sedation.</li>
                    <li>The paramedic must call MCP for orders to give Calcium Chloride to the unstable patient.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Consider the potential for multiple system trauma</li>
                    <li>Consider the potential for hypo or hyperthermia</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3008,Cyanide Poisoning & Antidotes ,3000,"<h3>3008.1 General Guidelines</h3>
    <ul>
        <li>Cyanide antidotes are located in multiple caches in each of the counties throughout the region, and are available by contacting 937-333-USAR (8727).</li>
        <li>The cache agency closest to your incident will be dispatched, which will respond with both a Cyanokit and 3 doses of Sodium Thiosulfate, to provide for the potential of multiple patients.</li>
    </ul>

    <h3 class=""mt-6"">3008.2 Indications to Call for the Cache</h3>
    <ul>
        <li>It is strongly recommended that agencies immediately call for the nearest available cyanide antidote cache at the time of dispatch whenever any of the following occur:
            <ul class=""list-disc pl-5"">
                <li>Report of a person trapped with exposure to fire or smoke in an enclosed area.</li>
                <li>Report of an incident involving cyanide.</li>
                <li>Report of a Mayday or firefighter down with exposure to fire or smoke in an enclosed area.</li>
            </ul>
        </li>
    </ul>
    
    <h3 class=""mt-6"">3008.3 General Treatment</h3>
    <ul>
        <li>Treatment of cyanide poisoning must include immediate attention to airway patency, adequacy of oxygenation and hydration, cardiovascular support, and management of any seizure activity.</li>
    </ul>

    <h3 class=""mt-6"">3008.4 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <ul class=""text-sm italic"">
           <li>For pediatric administration of Hydroxocobalamin (Cyanokit):
                <ul class=""list-disc pl-5"">
                    <li>Mix 200 ml NaCl in 5 g vial (concentration is 25 mg/ml)</li>
                    <li>70 mg x patient weight in kg = total dose administered over 15 minutes.</li>
                    <li>Divide doses in half for repeat administration</li>
                </ul>
           </li>
           <li>See dosing chart at end of this tab for calculating pediatric doses</li>
        </ul>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Known or strongly suspected cyanide exposure</li>
                    <li>Altered mental status</li>
                    <li>Seizures</li>
                    <li>Shock</li>
                    <li>Difficulty breathing</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Provide 100% O2 via non-rebreather mask.</li>
                        <li>If unconscious, provide 100% O2 by BVM</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Consider CPAP for suspected smoke inhalation.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Intubate if patient is apneic</li>
                       <li>Establish one IV in each arm if possible.</li>
                       <li>It is critical to control any seizure activity, as defined in 4014 Seizures</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>If available consider {BiPAP} for suspected smoke inhalation.</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Hydroxocobalamin (Cyanokit):
                            <ul class=""list-disc pl-5"">
                               <li>A Administer 5 grams via slow IV infusion over 15 minutes at a rate of 15 ml/min., using supplied 20 ml/min infusion set</li>
                               <li>A May repeat 5 grams via slow IV infusion over 15 min to 2 hours, depending on clinical response.</li>
                               <li>P Administer 70 mg/kg slow IV over 15 minutes; max dose of 5000 mg (5 grams), using supplied 20 ml/min infusion set</li>
                               <li>P May repeat 35 mg/kg slow IV; max dose 2500 mg (2.5 grams), depending on clinical response.</li>
                            </ul>
                        </li>
                        <li class=""text-center font-bold"">or</li>
                        <li><span class=""font-bold text-blue-600"">&diams;</span> Sodium Thiosulfate:
                             <ul class=""list-disc pl-5"">
                               <li>A If greater than 25 kg: Administer 12.5 grams (50 ml) 25% solution slow IV.</li>
                               <li>P If less than 25 kg: Administer 412.5 mg/kg (1.65 ml/kg) 25% solution, slow IV (max dose 12.5 g (50 ml)).</li>
                            </ul>
                        </li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <ul>
                    <li>Orders for cyanide antidotes are not needed in cardiac arrest.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Contact MCP to administer both Hydroxocobalamin (Cyanokit) and Sodium Thiosulfate to the same patient.</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>If a patient is in arrest, administer Hydroxocobalamin as quickly as possible.</li>
                    <li>Only CAB, defibrillation, intubation, and epinephrine should precede use of the cyanide antidotes.</li>
                    <li>Hydroxocobalamin is incompatible with numerous drugs including Diazepam.</li>
                    <li>Whenever possible establish two IV lines in a different vein or limb, one for standard protocol drugs and one for cyanide antidotes.</li>
                    <li>While IV infusion is the preferred method of cyanide antidote administration, in extreme cases the medications could be given via IO.</li>
                    <li>If administering cyanide antidotes via IO, a traditional drip set may not be effective and measures may need to be taken to slowly push the medication in.</li>
                </ul>
            </div>
        </div>
    </div>
    
    <h3 class=""mt-6"">3008.5 Pediatric Hydroxocobalamin Dosing Chart</h3>
    <div class=""overflow-x-auto"">
        <table class=""min-w-full bg-white border"">
            <thead>
                <tr class=""bg-gray-200"">
                    <th class=""py-2 px-4 border"">Weight (kg)</th>
                    <th class=""py-2 px-4 border"">5</th>
                    <th class=""py-2 px-4 border"">10</th>
                    <th class=""py-2 px-4 border"">15</th>
                    <th class=""py-2 px-4 border"">20</th>
                    <th class=""py-2 px-4 border"">25</th>
                    <th class=""py-2 px-4 border"">30</th>
                    <th class=""py-2 px-4 border"">35</th>
                    <th class=""py-2 px-4 border"">40</th>
                    <th class=""py-2 px-4 border"">50</th>
                    <th class=""py-2 px-4 border"">60</th>
                    <th class=""py-2 px-4 border"">>70</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td class=""py-2 px-4 border font-semibold"">Dose (mg) Amount needed for 70mg/kg</td>
                    <td class=""py-2 px-4 border"">350<br>14 ml</td>
                    <td class=""py-2 px-4 border"">700<br>28 ml</td>
                    <td class=""py-2 px-4 border"">1050<br>42 ml</td>
                    <td class=""py-2 px-4 border"">1400<br>56 ml</td>
                    <td class=""py-2 px-4 border"">1750<br>70 ml</td>
                    <td class=""py-2 px-4 border"">2100<br>84 ml</td>
                    <td class=""py-2 px-4 border"">2450<br>98 ml</td>
                    <td class=""py-2 px-4 border"">2800<br>112 ml</td>
                    <td class=""py-2 px-4 border"">3500<br>140 ml</td>
                    <td class=""py-2 px-4 border"">4200<br>168 ml</td>
                    <td class=""py-2 px-4 border"">5000<br>200 ml</td>
                </tr>
            </tbody>
        </table>
    </div>

    <h3 class=""mt-6"">3008.6 Pediatric Sodium Thiosulfate Dosing Chart</h3>
    <div class=""overflow-x-auto"">
        <table class=""min-w-full bg-white border"">
            <thead>
                <tr class=""bg-gray-200"">
                    <th class=""py-2 px-4 border"">Weight (kg)</th>
                    <th class=""py-2 px-4 border"">5</th>
                    <th class=""py-2 px-4 border"">10</th>
                    <th class=""py-2 px-4 border"">15</th>
                    <th class=""py-2 px-4 border"">20</th>
                    <th class=""py-2 px-4 border"">25</th>
                    <th class=""py-2 px-4 border"">30</th>
                </tr>
            </thead>
            <tbody>
                <tr>
                    <td class=""py-2 px-4 border font-semibold"">Dose (Gm)</td>
                    <td class=""py-2 px-4 border"">2.06 g</td>
                    <td class=""py-2 px-4 border"">4.125 g</td>
                    <td class=""py-2 px-4 border"">6.18 g</td>
                    <td class=""py-2 px-4 border"">8.25 g</td>
                    <td class=""py-2 px-4 border"">10.3 g</td>
                    <td class=""py-2 px-4 border"">12.5 g</td>
                </tr>
                <tr>
                    <td class=""py-2 px-4 border font-semibold"">Amount needed for 70mg/kg</td>
                    <td class=""py-2 px-4 border"">8.25 ml</td>
                    <td class=""py-2 px-4 border"">16.5 ml</td>
                    <td class=""py-2 px-4 border"">24.75 ml</td>
                    <td class=""py-2 px-4 border"">33 ml</td>
                    <td class=""py-2 px-4 border"">41.25 ml</td>
                    <td class=""py-2 px-4 border"">50 ml</td>
                </tr>
            </tbody>
        </table>
    </div>"
protocol,3009,Drowning ,3000,"<h3 class=""mt-6"">3009.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>History of submersion</li>
                    <li>Period of unconsciousness</li>
                    <li>Decreased or absent vital signs</li>
                    <li>Vomiting</li>
                    <li>Coughing</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Trauma</li>
                    <li>Pre-existing medical problem</li>
                    <li>Barotrauma (diving)</li>
                    <li>Decompression sickness</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Consider Spinal Motion Restriction</li>
                        <li>Consider possibility of hypothermia. If present follow 3016 Hypothermia</li>
                        <li>Evaluate neurological status.</li>
                        
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Drowning patients should be transported to a Trauma Center.</li>
                        <li>If patients are in cardiac arrest or respiratory failure/arrest, consider transport to the closest appropriate hospital</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Establish vascular access</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>All submersion victims should be transported due to potential for worsening over the subsequent few hours.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3010,Extremity Injuries ,3000,"<h3 class=""mt-6"">3010.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Deformities</li>
                    <li>Inflammation</li>
                    <li>Pain upon movement</li>
                    <li>Immobility</li>
                    <li>Paresthesia</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>None</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>For open fractures, control bleeding with direct pressure and cover with dry, sterile dressing.</li>
                        <li>If practical, consider elevating the limb.</li>
                        <li>Apply appropriate splinting device.</li>
                        <li>If the extremity is severely angulated and pulses are absent, apply gentle traction in an attempt to bring the limb back into a natural anatomic position. If resistance is encountered, splint the extremity in the angulated position.</li>
                        <li>Apply cold pack to reduce swelling.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>No additional orders at this level</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Consider 1014 Pain Management Protocol</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>Document distal motor, sensation and circulation before and after splinting, or spinal motion restriction.</li>
                    <li>Open wounds should be covered with a sterile dressing before splinting.</li>
                    <li>Immobilize above and below the injury.</li>
                    <li>The patient who requires a load and go approach can be adequately immobilized by careful packaging on the long spine board. Do additional splinting enroute to the hospital as time and the patient's condition permit.</li>
                </ul>
            </div>
        </div>
    </div>"
protocol,3011,Eye Injuries ,3000,"<h3 class=""mt-6"">3011.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Irritation to eye</li>
                    <li>Visual disturbances or loss of vision</li>
                    <li>Obvious penetrating injury</li>
                    <li>Burns</li>
                    <li>Nausea</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Hypertension</li>
                    <li>Contact lens issue</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>If possible, contact lenses should be removed. Contacts should be transported with patient.</li>
                        <li>Use nasal cannula with IV tubing for irrigation.</li>
                        <li><strong>Chemical Burns:</strong>
                            <ul class=""list-disc pl-5"">
                                <li>Irrigate immediately with IV fluid or water for a minimum of 30 minutes or until patient transport is completed.</li>
                                <li>Determine chemical involved. Bring Safety Data Sheets, if available.</li>
                            </ul>
                        </li>
                        <li><strong>Major Eye Trauma:</strong>
                            <ul class=""list-disc pl-5"">
                                <li>Do not irrigate if there is penetrating trauma to the eye.</li>
                                <li>Cover both eyes to limit movement.</li>
                                <li>Do not use a pressure or absorbent dressing on or near any eye that may have ruptured or have any penetrating trauma.</li>
                                <li>The patient should be transported with head elevated at least 30°.</li>
                            </ul>
                        </li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>No additional orders at this level.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>No additional orders at this level.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>Prior to irrigation with IV fluid or for significant eye pain, Tetracaine 2 drops in affected eye.</li>
                        <li>Do not irrigate or use Tetracaine if penetrating trauma to the eye is present.</li>
                        <li>Use {Morgan Lens} or nasal cannula with IV tubing for irrigation.</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <p class=""text-sm"">None</p>
            </div>
        </div>
    </div>"
protocol,3012,Frostbite ,3000,"<h3 class=""mt-6"">3012.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>

        <div class=""grid md:grid-cols-2 gap-4 my-4"">
            <div>
                <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
                <ul>
                    <li>Cold, clammy skin</li>
                    <li>Shivering</li>
                    <li>Mental status changes</li>
                    <li>Extremity pain or sensory abnormality</li>
                    <li>Bradycardia</li>
                    <li>Hypotension or shock</li>
                </ul>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Differential Diagnosis</h4>
                <ul>
                    <li>Head Injury</li>
                    <li>Spinal cord injury</li>
                </ul>
            </div>
        </div>

        <div>
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Protect injured areas.</li>
                        <li>Remove clothing and jewelry from injured parts.</li>
                        <li>Do not attempt to thaw injured part with local heat.</li>
                        <li>Maintain core temperature.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Severe frostbite injuries should be transported to a Burn Center.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                       <li>Establish vascular access and consider {warmed} fluids.</li>
                       <li>Consider 1014 Pain Management Protocol.</li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                     <ul>
                        <li>No additional orders at this level</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <p class=""text-sm"">None</p>
            </div>
        </div>
    </div>"
protocol,3013,Head Injury ,3000,"<div>
    <h3>3013.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Evaluate level of consciousness, pupillary size and reaction.</li>
                    <li>Establish Glasgow Coma Score and reassess frequently.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Ventilate at 20 breaths per minute when signs of cerebral herniation are present:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>{Ventilate to maintain EtCO₂ readings of 30 mmHg (30 torr)}.</li>
                            <li>Never ventilate at less than 8 per minute.</li>
                        </ul>
                    </li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Ventilate at a rate of ten faster than normal respiratory rate when the signs of cerebral herniation are present.</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Clinical Pearls</h4>
            <ul class=""list-disc pl-5 text-sm"">
                <li>Signs of cerebral herniation can include: Decreased mental status, Dilated and/or unresponsive pupils, Bradycardia, Hypertension, Posturing.</li>
                <li>Hypoventilation increases the level of CO₂ in the brain, causing cerebral vasodilatation and increased swelling.</li>
                <li>Hyperventilation decreases the level of CO₂ and causes cerebral vasoconstriction, hypoxia, and ischemia.</li>
                <li>Both hyperventilation and hypoventilation could cause cerebral hypoxia and increased mortality.</li>
                <li>{Make every effort to maintain an EtCO₂ of 30 mmHg}.</li>
            </ul>
        </div>
    </div>
</div>"
protocol,3014,Heat Exposure ,3000,"<div>
    <h3>3014.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Move patient to a cool environment.</li>
                    <li>Remove patient's clothing.</li>
                    <li>Continuously apply water to the skin to cool the patient, use fan for evaporation if available.</li>
                    <li>Apply cold packs to underarms and groin area.</li>
                    <li>Cold water submersion is an acceptable method for cooling heat stroke patients. You may encounter patients in cooling body bags. The goal is to lower temperature to less than 102.5°F.</li>
                    <li>If conscious and not vomiting or extremely nauseous, provide oral fluids.</li>
                    <li>Be prepared for seizures.</li>
                    <li>Consider other medical conditions (e.g., overdose, hypoglycemia, CVA) and treat accordingly.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <p>Hyperthermia patients should be transported to a Trauma Center.</p>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li>If hypotensive or mental status changes:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> IV fluid 500 ml IV.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> IV fluid 20 ml/kg IV (max 500).</li>
                            <li>May repeat both adult and pediatric fluid bolus one time.</li>
                        </ul>
                    </li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Additional IV fluid, if indicated.</li>
                    <li>Consider other medical conditions (e.g., overdose, hypoglycemia, CVA) and treat accordingly.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,3015,Hemorrhage Control ,3000,"<div>
    <h3>3015.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800 col-span-full md:col-span-1"">EMR / EMT</div>
            <div class=""md:col-start-2"">
                <ul>
                    <li>Control of life-threatening external hemorrhage takes priority over any other treatment.</li>
                    <li>Constant, direct pressure is the primary method of bleeding control.</li>
                    <li>If direct pressure fails to control bleeding from extremities, use a tourniquet.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>{Commercial tourniquets such as the CAT or SOFTT are recommended}.</li>
                            <li>Only use wide, flat materials such as cravats or BP cuffs as improvised tourniquets.</li>
                            <li>Place a tourniquet as proximal as possible to the torso on the femur or humerus.</li>
                            <li>Tighten the tourniquet until the bleeding stops.</li>
                            <li>If bleeding persists, place another tourniquet abutted to the first tourniquet.</li>
                            <li>Document time and location.</li>
                            <li>Be sure that the ER staff is aware of the tourniquet.</li>
                        </ul>
                    </li>
                    <li class=""mt-2"">{For life-threatening hemorrhage that can't be controlled by tourniquets, consider hemostatic dressings}.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>Combat Gauze, or ChitoFlex PRO are examples.</li>
                            <li>These can be used on the chest or abdomen.</li>
                            <li><span class=""font-bold"">G</span> Place in direct contact with the source of bleeding and apply a pressure dressing or use Kerlix.</li>
                            <li>DO NOT USE GRANULAR AGENTS.</li>
                        </ul>
                    </li>
                     <li class=""mt-2"">Wound Packing may be performed by providers at any level, as long as they have received proper training.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>This procedure is not to be used on open wounds to the head, chest or abdomen.</li>
                            <li>Use sterile gauze or approved hemostatic products.</li>
                            <li>Gauze should be placed as deeply in the wound as possible using a gloved digit and continuous pressure.</li>
                            <li>Excessive force is not necessary and may be harmful.</li>
                            <li>Apply a pressure dressing and manual direct pressure over the packed wound for at least 3 minutes.</li>
                            <li>Do not remove wound packing once placed in the cavity.</li>
                            <li>Notify the ED staff of the use of wound packing on arrival at the destination.</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <p>Treat for hypovolemic shock as indicated.</p>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><span class=""font-bold"">A</span> For known or suspected hemorrhage secondary to trauma, consider Tranexamic Acid (TXA) 2 gram IV/IO over 1-2 minutes.</li>
                    <li>If unsure if TXA is indicated, contact Medical Control for advice.</li>
                    <li>In pediatric patients with uncontrolled bleeding from a recent tonsillectomy, consider Tranexamic Acid (TXA) nebulized:
                        <ul class=""list-disc pl-5 mt-1 text-pink-600"">
                            <li><span class=""font-bold"">P</span> Less than 25 kg: 250 mg, nebulized with an additional 3 ml normal saline, O₂ flowing at 8-10 LPM.</li>
                            <li><span class=""font-bold"">P</span> 25 kg or greater: 500 mg, nebulized with an additional 3 ml normal saline, O₂ flowing at 8-10 LPM.</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,3016,Hypothermia ,3000,"<div>
    <h3>3016.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Move patient to warm environment, remove all wet clothing, dry the patient, and cover with blankets.</li>
                    <li>Avoid any rough movement that may cause cardiac dysrhythmias or cardiac arrest.</li>
                    <li>It may be beneficial to consider spinal motion restriction measures.</li>
                    <li>Assess neurological status.</li>
                    <li>Oxygenate the patient with 100% O₂.</li>
                    <li>If patient goes into cardiac arrest:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>CPR continuously.</li>
                            <li>In severe hypothermia (less than 86°F [30°C]), limit defibrillation attempts to one except on orders from MCP.</li>
                            <li>If body temperature is (more than 86°F [30°C]) follow normal arrest protocols.</li>
                        </ul>
                    </li>
                    <li>If available, provide {warmed and humidified} 100% O₂.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li>Hypothermic patients should be transported to a Trauma Center.</li>
                    <li>Resuscitative efforts should be continued while in transit, even if there is no response.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li>Use the least invasive means possible to secure airway.</li>
                    <li>Intubate if necessary, as gently as possible.</li>
                    <li>Establish vascular access and consider {warmed} fluids.</li>
                    <li>Treat bradycardia only if patient is hypotensive.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,3017,Spinal Motion Restriction ,3000,"<div>
    <h3>3017.1 General Guidelines</h3>
    <ul>
        <li>Studies indicate traditional spinal restriction has risks and may even cause harm in some cases.</li>
        <li>Spinal Motion Restrictions allows for an assessment-based management of the injured patient.</li>
        <li>Spinal precautions should always be taken when dealing with at risk patients.</li>
        <li>This protocol does not indicate that providers do not immobilize the spine; it simply provides a different means of restriction in selected patients.</li>
        <li>These guidelines apply to providers at all certification levels.</li>
    </ul>

    <h3 class=""mt-6"">3017.2 Blunt Trauma Patients - Full Immobilization</h3>
    <ul>
        <li><span class=""font-bold"">A</span> All patients with clinical indications of a spinal injury and/or with altered levels of consciousness must be immobilized with both a C-collar and a spinal restriction device (e.g., spine board, KED, vacuum splint).</li>
        <li class=""text-pink-600""><span class=""font-bold"">P</span> Pediatric trauma patients less than 3 years of age with a GCS of less than 15 must be immobilized with both a C-collar and a spinal restriction device.</li>
    </ul>

    <h3 class=""mt-6"">3017.3 Blunt Trauma Patients - SMR</h3>
    <p>Other alert trauma patients, including all those listed below, should have a c-collar placed and moved with caution in-line as a unit to the cot. They would not need a backboard:</p>
    <ul class=""list-roman pl-6"">
        <li>Patients with neck pain</li>
        <li>Patients with midline neck or spinal tenderness</li>
        <li>Patients with pain upon motion of the neck</li>
        <li>Cases with high risk mechanism (high speed MVC, fall greater than 10 feet, axial loading injury)</li>
    </ul>
    
    <h3 class=""mt-6"">3017.4 Penetrating Trauma</h3>
    <ul>
        <li>Patients with penetrating trauma do not need immobilization with either a cervical collar or backboard.</li>
        <li>Delays in transport are to be minimized and place the patient at greater risk.</li>
    </ul>

    <h3 class=""mt-6"">3017.5 Airway or Ventilatory Management</h3>
    <ul>
        <li>Patients who are immobilized and require airway and or ventilatory interventions (including intubation) may have the cervical collar removed during the intervention.
            <ul class=""list-roman pl-6 mt-2"">
                <li>In-line stabilization should be maintained while the intervention is performed.</li>
            </ul>
        </li>
        <li>The cervical collar should be reapplied after the intervention is either accomplished or abandoned.</li>
    </ul>

    <h3 class=""mt-6"">3017.6 Equipment Issues</h3>
    <ul>
        <li>In an emergency situation with equipment intensive sports such as football, hockey and lacrosse, the protective equipment shall be removed prior to transport to an emergency facility.</li>
        <li>Helmets of any kind that prevent either effective SMR or airway management should be removed.</li>
    </ul>
    
    <h3 class=""mt-6"">3017.7 Other Considerations</h3>
     <ul>
        <li>Patients greater than 69 y/o should be considered ""high risk"" patients for spinal injury and require closer assessment. With these patients, lean towards applying a cervical collar.</li>
        <li>If the patient meets the standards for a Trauma Alert Activation, consider a cervical collar at a minimum.</li>
        <li>Patients who do not tolerate any level of restriction should have that restriction adjusted to the point of removal if necessary based on clinical response.
            <ul class=""list-roman pl-6 mt-2"">
                <li>Examples include shortness of breath, anxiety, and body habitus.</li>
                <li>They should be transported in the manner of restriction that they can tolerate.</li>
            </ul>
        </li>
        <li>Spinal restriction for the purpose of patient movement:
            <ul class=""list-roman pl-6 mt-2"">
                <li>Spinal restriction devices may be utilized for movement from a site of injury to the cot.</li>
                <li>Patients who do not require restriction should be removed from the device prior to transport.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,3018,Trauma Transport Guidelines ,3000,"<div>
    <h3>3018.1 Interpretation of Trauma Triage Guidelines</h3>
    <ul>
        <li>This guideline meets the requirement of OAC 4765-14, defining Trauma Triage Guidelines for the region.</li>
        <li>This guideline can separately provide direction as to when a provider should call a ""Trauma Alert"".</li>
        <li>Not all patients who meet Trauma Triage Criteria may need a trauma alert.</li>
    </ul>

    <h3 class=""mt-6"">3018.2 State of Ohio Trauma Triage Age Considerations</h3>
    <p>For the purposes of trauma guidelines, the criteria for patient age are:</p>
    <ul>
        <li class=""text-pink-600""><span class=""font-bold"">P</span> Less than 16 years old will be pediatric patients.</li>
        <li><span class=""font-bold"">A</span> 16 years old to 69 years old will be adult patients.</li>
        <li><span class=""font-bold"">G</span> Greater than 69 years old will be geriatric patients.</li>
    </ul>

    <h3 class=""mt-6"">3018.3 Trauma Center or Facility Capabilities</h3>
    <ul>
        <li>Level I and II Trauma Centers can care for the same trauma patients.</li>
        <li>Level III Trauma Centers offer services, based on individual hospital resources that provide for initial assessment, resuscitation, stabilization, and treatment of the trauma patient.</li>
        <li>In some areas of the region a Level III Trauma Center is the only trauma facility within 30 minutes ground transport time. This hospital may act as the primary receiving facility for the critically injured patient.</li>
        <li>In areas where the trauma patient is closer to a Level III Trauma Center, but a Level I or Level II Trauma Center is still within 30 minutes, the EMS Provider should decide whether the patient would benefit more from an immediate evaluation, stabilization, and treatment at the Level III Trauma Center, or from direct transport to a Level I or Level II Trauma Center.</li>
        <li>In areas of the region where there are no Trauma Centers within 30 minutes ground transport time, the acute care hospital may act as the primary receiving facility for critically injured trauma patients, or EMS Provider may arrange for air medical transport from the scene.</li>
        <li class=""text-pink-600""><span class=""font-bold"">P</span> If a pediatric patient meets the trauma triage guidelines, transport to a Pediatric Trauma Center. Pediatric patients should be transported in an appropriately sized child restraint system.</li>
        <li>If transportation time is greater than 30 minutes, transport to the nearest acute care hospital, or EMS providers may arrange for air medical transport from the scene.</li>
        <li>All pregnant trauma patients should be rapidly transported to the nearest Adult Trauma Center with labor and delivery capabilities, unless transport time is greater than 30 minutes.</li>
    </ul>
    
    <h3 class=""mt-6"">3018.4 Air Medical Transportation</h3>
     <ul>
        <li>Prolonged delays at the scene waiting for air medical transport should be avoided.</li>
        <li>Cardiac arrest is not appropriate for air transport.</li>
        <li>In the rural environment, direct transfer of trauma patients by air medical transport may be appropriate.</li>
    </ul>

    <h3 class=""mt-6"">3018.5 Exceptions to Transportation Guidelines</h3>
    <ul>
        <li>It is medically necessary to transport the victim to another hospital for initial assessment and stabilization before transfer to a Trauma Center.</li>
        <li>It is unsafe to transport the victim directly to a Trauma Center due to adverse weather or ground conditions or excessive transport time.</li>
        <li>Transporting the victim to a Trauma Center would cause a shortage of local EMS resources.</li>
        <li>No Trauma Center is able to receive and provide trauma care to the victim without undue delay.</li>
        <li>Before transport begins, the patient requests to be taken to a particular hospital even if it is not a Trauma Center. If the patient is a minor or otherwise considered incapable of making medical decisions, an adult relative or other legal representative may make this request.</li>
    </ul>

    <h3 class=""mt-6"">3018.6 Trauma Criteria</h3>
    <div class=""space-y-4"">
        <div>
            <h4 class=""font-bold"">a. Anatomical Criteria:</h4>
            <ul class=""list-roman pl-6"">
                <li>Penetrating trauma to head, neck, torso.</li>
                <li>Significant, penetrating trauma to extremities proximal to elbow or knee with evidence of neurovascular compromise.</li>
                <li>Injuries to the head, neck, or torso where the following physical findings are present: Visible crush injuries, Abdominal injury with tenderness, distention, or seat belt sign, Evidence of pelvic fracture, Flail chest.</li>
                <li>Injuries to extremities where the following physical findings are present: Amputation proximal to wrist or ankle, Visible crush injuries, Fractures of two or more proximal long bones (<span class=""font-bold"">G</span> One proximal long bone fracture in MVC only), Evidence of neurovascular compromise.</li>
                <li>Signs and symptoms of spinal cord injury.</li>
                <li>2nd or 3rd degree burns greater than 10% total body surface area (BSA) or other significant burns involving the face, feet, hands, genitals, or airway.</li>
                <li><span class=""font-bold"">G</span> Injury sustained in two or more body regions.</li>
                <li>Open skull fracture.</li>
            </ul>
            <p class=""mt-2 font-semibold"">Meets Above Criteria = Transport to Trauma Center. Call Trauma Alert if patient presentation indicates.</p>
            <p class=""mt-1"">Does Not Meet Above Criteria = Continue Assessment for Physiologic Criteria.</p>
        </div>
        <div>
            <h4 class=""font-bold"">b. Physiological Criteria:</h4>
             <ul class=""list-disc pl-6"">
                <li><strong>Adult Physiological Criteria:</strong> <span class=""font-bold"">A</span> GCS &le; 13, Loss of consciousness > 5 mins, Deterioration in LOC, Failure to localize pain, Respirations < 10 or > 29, Needs ventilatory support, Requires relief of tension pneumothorax, Pulse > 120 with evidence of hemorrhagic shock, SBP < 90 or absent radial pulse with carotid pulse present.</li>
                <li class=""mt-2 text-pink-600""><strong>Pediatric Physiological Criteria:</strong> <span class=""font-bold"">P</span> GCS &le; 13, Loss of consciousness > 5 mins, Deterioration in LOC, Failure to localize pain, Evidence of poor perfusion, Evidence of respiratory distress or failure, Respiratory rate < 20/min in infants < 1 year old.</li>
                <li class=""mt-2""><strong>Geriatric Physiological Criteria:</strong> <span class=""font-bold"">G</span> GCS &le; 13 (or &le; 14 with TBI), Loss of consciousness > 5 mins, Deterioration in LOC, Failure to localize pain, Respirations < 10 or > 29, Needs ventilatory support, Requires relief of tension pneumothorax, Pulse > 120 with evidence of hemorrhagic shock, SBP < 100 or absent radial pulse with carotid pulse present.</li>
             </ul>
            <p class=""mt-2 font-semibold"">Meets Physiological Criteria = Transport to Trauma Center. Call Trauma Alert if patient presentation indicates.</p>
            <p class=""mt-1"">Does Not Meet Above Criteria = Continue Assessment for Special Considerations.</p>
        </div>
        <div>
             <h4 class=""font-bold"">c. Special Considerations:</h4>
             <ul class=""list-roman pl-6"">
                <li>Vehicle telemetry provides data consistent with high risk of injury.</li>
                <li>On scene fatality in the same vehicle.</li>
                <li><span class=""font-bold"">G</span> Pedestrian struck by a motor vehicle.</li>
                <li><span class=""font-bold"">G</span> Falls from any height, including standing falls, with evidence of traumatic brain injury.</li>
             </ul>
            <p class=""mt-2 font-semibold"">Special Considerations = Transport to Trauma Center. Call Trauma Alert if patient presentation indicates.</p>
            <p class=""mt-1"">Does Not Meet Above Criteria = Consider MOI or Transport to most appropriate hospital.</p>
        </div>
         <div>
             <h4 class=""font-bold"">d. Mechanism of Injury:</h4>
             <ul class=""list-roman pl-6"">
                <li>Auto-pedestrian/auto-bicycle injury with significant (> 5 mph) impact.</li>
                <li>Ejection from motor vehicle or unrestrained rollover.</li>
                <li>Extrication time longer than 20 minutes.</li>
                <li>Fall of more than 20 feet (<span class=""text-pink-600 font-bold"">P</span> > 3 times child's height).</li>
                <li>High-speed auto crash (Estimated speed > 40 mph, Intrusion > 12 inches, Major deformity > 20 inches).</li>
                <li>Open motor vehicle crashes > 20 mph or with separation of rider from vehicle.</li>
                <li>Pedestrian thrown or run over.</li>
             </ul>
        </div>
         <div>
             <h4 class=""font-bold"">e. Special Situations:</h4>
             <ul class=""list-roman pl-6"">
                <li>Pre-existing cardiac or respiratory disease.</li>
                <li>Diabetes, cirrhosis, morbid obesity, seizure disorder.</li>
                <li>Patient with bleeding disorder or on anticoagulants or anti-platelets.</li>
                <li>Immuno-suppressed patients (renal dialysis, transplant, cancer, HIV).</li>
                <li>Congenital disorder.</li>
             </ul>
             <p class=""mt-2 font-semibold"">MOI or Special Considerations = Consider Trauma Center. No need to call Trauma Alert if no significant symptoms.</p>
             <p class=""mt-1"">No Significant MOI or Special Considerations = Transport to most appropriate hospital.</p>
        </div>
    </div>
</div>"
protocol,3019,SALT Triage Systems ,3000,"<div>
    <h3>3019.1 General Guidelines</h3>
    <ul>
        <li>SALT stands for Sort, Assess, Life-Saving Intervention, and Treatment/Transport.</li>
        <li>Developed by the Centers for Disease Control and Prevention to address limitations in other systems.</li>
        <li>The CDC has proposed SALT as the national standard for Mass Casualty Incident (MCI) triage.</li>
        <li>SALT has the advantage of being the fastest mass casualty triage system.</li>
        <li>Notify hospitals of any MCI, especially a MCI involving contaminated patients. Consider use of the 3020 Regional Hospital Notification System (RHNS).</li>
    </ul>

    <h3 class=""mt-6"">3019.2 Primary and Secondary Triage Prior to Transport</h3>
    <div class=""space-y-4"">
        <div>
            <h4 class=""font-bold"">a. Initial Triage:</h4>
            <ul class=""list-roman pl-6"">
                <li>Use triage ribbons (color-coded strips), not treatment tags, during initial triage. Treatment tags slow the process and should be used later, in the treatment areas. Treatment tags do need to be used at some point as they are sometimes the only documentation of EMS assessments and treatments.</li>
                <li>Tie the triage ribbon to an upper extremity in a VISIBLE location (on the right wrist, if possible).</li>
                <li>SALT Triage Levels: RED-Immediate, YELLOW-Delayed, GREEN-Minimal, GRAY-Expectant, BLACK-Dead, ORANGE/Polka Dot - Contaminated.</li>
                <li>Move as quickly and safely as possible; making quick decisions.</li>
                <li>Victims will be re-triaged, probably multiple times. Revise the triage category as often as indicated.</li>
                <li>Over-triage can be as harmful as under-triage. If everyone is tagged red, those who are truly red will receive delayed treatment, delayed transport, and delayed definitive care.</li>
                <li>Treatment and transport should NOT be delayed especially for critical patients. Get the reds out.</li>
                <li>If there are extensive delays in the field, consider requesting orders for palliative care, e.g., pain medications if time and resources allow.</li>
            </ul>
        </div>
        <div>
            <h4 class=""font-bold"">b. Secondary Triage:</h4>
            <ul class=""list-roman pl-6"">
                <li>Reassess as often as practical, including when the patient is moved to the Casualty Collection Point (CCP) or Treatment Area, and on all victims prior to transport. Also reassess patients when their condition or resources available change.</li>
                <li>Apply Treatment Tags after patients enter the CCP, or in the Transport Area.</li>
                <li>Crews can also fill in pertinent and available information on the Tag during transport.</li>
                <li>Use the patient's ribbon to tie on the treatment tag. Use treatment tags with individual barcodes consistent with this Standing Order and Juvare EMTrack, the patient tracking system used throughout Ohio.</li>
                <li>Orange & Polka-dot ribbons (indicating contaminated patients) are removed after decontamination. Mark treatment tags for contaminated patients with two check marks on the orange strip, marking both ""dirty"" and ""decontaminated"" boxes.</li>
            </ul>
        </div>
        <div>
            <h4 class=""font-bold"">c. Transport:</h4>
             <ul class=""list-roman pl-6"">
                <li>Treatment Area or Transport Group personnel determine priority for transport.</li>
                <li>Distribution of patients among various hospitals is one of EMS' most crucial tasks. Do not overload any hospital.</li>
                <li>In an MCI, transport trauma patients to non-Trauma Centers as necessary. Consider transporting minor (GREEN) patients to satellite EDs.</li>
                <li>When assigning patient allocation, consider the likelihood that the closest hospitals may be overwhelmed by patients who were not transported by EMS.</li>
                <li>In large scenarios, consider activation of the Forward Movement of Patients Plan as defined in 3021 Crisis Standards of Care in Massive Events.</li>
             </ul>
        </div>
    </div>
    
    <h3 class=""mt-6"">3019.3 Sort, Assess, Life-Saving Intervention, Treatment/Transport Process</h3>
    <div class=""space-y-4"">
        <div>
            <h4 class=""font-bold"">a. Sort (Global Sorting)</h4>
            <ul class=""list-disc pl-5"">
                <li><strong>Action 1:</strong> ""Everyone who can hear me please move to [designated area] and we will help you."" Those who follow are last priority (Green). Assign someone to keep them together.</li>
                <li><strong>Action 2:</strong> ""If you need help, wave."" Those who follow are second priority.</li>
                <li><strong>Result:</strong> Casualties are now prioritized: 1st - Still/obvious life threat, 2nd - Waving, 3rd - Walking.</li>
            </ul>
        </div>
         <div>
            <h4 class=""font-bold"">b. Assess</h4>
            <ul class=""list-disc pl-5"">
                <li><strong>Is the patient breathing?</strong> If not, open airway (in children, give 2 rescue breaths). If still not breathing, tag BLACK (dead).</li>
                <li><strong>Assess for the following:</strong> Can the patient follow commands or make purposeful movements? Does the patient have a peripheral pulse? Is the patient not in respiratory distress? Is hemorrhaging under control?</li>
                <li><strong>Grading:</strong> If ANY answer is NO and likely to survive, tag RED (Immediate). If ANY answer is NO and UNLIKELY to survive, tag GRAY (Expectant). If ALL are YES with more than minor injuries, tag YELLOW (Delayed). If ALL are YES with only minor injuries, tag GREEN (Minimal).</li>
            </ul>
        </div>
    </div>
    </div>"
protocol,3020,Regional Hospital Notification System ,3000,"<div>
    <h3>3020.1 General Guidelines</h3>
    <ul>
        <li>The purpose of the Regional Hospital Notification System (RHNS) is to provide one number for EMS, hospitals, and EMAs to call that will make rapid, simultaneous notifications in a Mass Casualty Incident or Event (MCI/MCE) or other major emergency.</li>
        <li>The system can be used when an incident could involve a significant number of the region's hospitals.</li>
        <li>RHNS is critical. Activation should be a high priority to alert hospitals and regional coordinators. Early warning will start processes essential to handle major events.</li>
    </ul>

    <h3 class=""mt-6"">3020.2 RHNS Activation</h3>
    <ul>
        <li>To activate the RHNS, call 937-333-USAR (8727).</li>
        <li>The agency calling must ask for a Dispatch Supervisor, request a ""Regional Hospital Notification"", and use the phrase ""Mass Casualty Page Hospitals"". Then the agency calling will provide the following:
            <ul class=""list-roman pl-6 mt-2"">
                <li>Name of agency</li>
                <li>Nature of emergency</li>
                <li>Location of emergency</li>
                <li>General statement on severity, such as approximate number of victims</li>
                <li>Any other information to be conveyed</li>
            </ul>
        </li>
        <li class=""mt-2"">The Montgomery County Regional Dispatch Center (RDC) will immediately put out a computerized message to the RHNS Group with the information provided.</li>
    </ul>
</div>"
protocol,3021,Crisis Standard of Care in MCI ,3000,"<div>
    <h3>3021.1 General Guidelines</h3>
    <ul>
        <li>Some incidents are so large as to require extraordinary EMS procedures. Those scenarios are sometimes referred to as Mass Casualty Events (MCEs), instead of Mass Casualty Incidents (MCIs).</li>
        <li>These EMS procedures should be utilized in very large emergency scenarios, or when the duration is extended.</li>
        <li>In the event of an MCE, especially one lasting days or longer, Greater Miami Valley EMS Council, with the approval of the Regional Physicians Advisory Board (RPAB), may promulgate ""Just in Time Standing Orders"" (JITSO).</li>
        <li>With approval from Ohio Department of Public Safety, these orders might include triage standards for transport to other healthcare facilities and other crisis standards of care; possibly exceeding the standard scope of practice for EMS.</li>
        <li>Full information on the process can be found in the Dayton MMRS Regional MCI Plan Template.</li>
    </ul>

    <h3 class=""mt-6"">3021.2 Alternate Transports</h3>
    <p>In some circumstances, EMS may be authorized to triage selected patients for transport to other healthcare facilities, including:</p>
    <ul class=""list-roman pl-6"">
        <li>Urgent Care Centers</li>
        <li>Acute Care Center (ACC)</li>
        <li>Neighborhood Emergency Help Center (NEHC)</li>
        <li>Disaster Medical Assistance Team (DMAT)</li>
    </ul>

    <h3 class=""mt-6"">3021.3 Forward Movement of Patients</h3>
    <ul>
        <li>Planned by Dayton MMRS.</li>
        <li>The intent is to relieve the burden on local hospitals by transporting patients, possibly directly from the scene, to more distant hospitals.</li>
    </ul>

    <h3 class=""mt-6"">3021.4 Functional Needs Shelter Triage</h3>
    <ul>
        <li>A regional protocol for Functional Needs Shelter Triage has been added to the Optional Standing Orders Manual and is also available at gmvemsc.org on the Training Materials page.</li>
        <li>Will help determine whether individuals with functional needs can be safely sheltered in a Red Cross Shelter during a disaster.</li>
        <li>This Shelter Triage Protocol is a pre-approved Just-In-Time Standing Order (JITSO), authorized by the RPAB for use by an EMS agency assisting the Red Cross with shelter triage.</li>
        <li>It is intended to be printed and given to paramedics, nurses, and other healthcare personnel at the time of a shelter operation.</li>
        <li>At the option of local department chiefs and medical directors, the same protocol can be used during a disaster to determine patients who would be more appropriate for transport to Red Cross Shelters than to hospitals.</li>
        <li>In those cases, EMS should, if possible, contact the shelter before transporting.</li>
        <li>If locations or contact information for shelters is not known, contact the County EMA or the Red Cross.</li>
        <li>When transporting these non-emergency patients to shelters, it is critical that the patients bring their medications and medical equipment with them.</li>
    </ul>
</div>"
protocol,4001,Abdominal Pain ,4000,"<div>
    <h3>4001.1 General Guidelines</h3>
    <ul>
        <li>Ensure an abdominal exam which includes inspection, auscultation and palpation is performed and documented on every patient with abdominal pain.</li>
        <li>Assess all abdominal pain patients for trauma, pregnancy, illness, or potential ingestion.</li>
    </ul>

    <h3 class=""mt-6"">4001.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Place patient in position of comfort.</li>
                    <li>Give nothing by mouth.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li><span class=""font-bold"">A</span> Consider Ondansetron (Zofran) 4 mg PO dissolving tablet for nausea or active vomiting.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Ondansetron (Zofran) 4 mg PO if patient is 12 y/o or older and weight is more than or equal to 40 kg.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><span class=""font-bold"">A</span> For pain relief, including with unilateral flank pain, consider 1014 Pain Management Protocol.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> For pain relief, call MCP for orders.</li>
                    <li><span class=""font-bold"">A</span> For active vomiting, Ondansetron 4 mg slow IV.</li>
                    <li><span class=""font-bold"">A</span> For nausea or if no IV access established, Ondansetron (Zofran) 4 mg PO (dissolving tablet) or consider administering 4 mg (2 ml) of the IV form PO by spraying it into the patient's mouth.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Ondansetron 0.1 mg/kg IV (max 4 mg) if patient is 12 y/o or older and weight is more than or equal to 40 kg.</li>
                </ul>
            </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
             <h4 class=""text-base font-bold"">Clinical Pearls</h4>
             <p class=""text-sm"">The Paramedic can administer the IV form of Ondansetron orally to adults by spraying it into the patient's mouth.</p>
        </div>
    </div>
</div>"
protocol,4002,Allergic Reactions/Anaphylaxis ,4000,"<div>
    <h3>4002.1 General Guidelines</h3>
    <ul>
        <li>Epinephrine is the mainstay of anaphylaxis in allergic reaction treatment.</li>
        <li>Epinephrine is particularly important in cases of any airway edema, hypotension, or when multiple body systems are involved.</li>
        <li>Advanced age is not a contraindication to epinephrine.</li>
    </ul>

    <h3 class=""mt-6"">4002.2 Clinical Management</h3>
     <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Provide O₂ as needed.</li>
                    <li>If allergic reaction:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>If equal to or greater than 30 kg, give both Adult EpiPen and EpiPen Jr. (adult and pediatric).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> If less than 15 kg, EpiPen Jr.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> If equal to or greater than 15 kg and less than 30 kg, Adult EpiPen.</li>
                        </ul>
                    </li>
                    <li>If applicable, apply ice pack.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> If symptoms persist, may repeat Epinephrine (adult and pediatric) in 10 minutes.</li>
                    <li>Call for transport.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                 <ul>
                    <li>If patient develops wheezing, assist them with their prescribed metered dose inhaler or <span class=""font-bold text-blue-600"">&diams;</span> Albuterol 2.5 mg and Ipratropium 0.5 mg, nebulized with O₂ flowing at 8-10 LPM. May repeat Albuterol 2.5 mg nebulized two times.</li>
                    <li>{If an allergic reaction and an absence of Epi-pens in the drug bag, EMTs are permitted to administer Epinephrine IM via a syringe}.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>{The EMT may only perform this skill after authorization and training from their Medical Director}.</li>
                            <li>{If equal to or greater than 30 kg, Epinephrine (1:1,000) 0.5 IM, (adult and pediatric)}.</li>
                            <li class=""text-pink-600"">{<span class=""font-bold"">P</span> If equal to or greater than 15 kg and less than 30 kg. Epinephrine (1:1,000) 0.3 mg IM}.</li>
                            <li class=""text-pink-600"">{<span class=""font-bold"">P</span> If less than 15 kg, Epinephrine (1:1,000) 0.15 mg IM}.</li>
                            <li><span class=""font-bold text-blue-600"">&diams;</span> {May repeat Epinephrine (1:1,000) 0.5 mg IM after 10 minutes (adult and pediatric)}.</li>
                            <li class=""text-pink-600""><span class=""font-bold text-blue-600"">&diams;</span> {<span class=""font-bold"">P</span> May repeat Epinephrine (1:1,000) (at weight appropriate dose) after 10 minutes}.</li>
                        </ul>
                    </li>
                 </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                 <ul>
                    <li>If an allergic reaction:
                         <ul class=""list-disc pl-5 mt-1"">
                            <li>If equal to or greater than 30 kg, give both Adult EpiPen and EpiPen Jr or Epi (1:1,000) 0.5 mg IM (adult and pediatric).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> If equal to or greater than 15 kg and less than 30 kg. Adult EpiPen or Epinephrine (1:1,000) 0.3 mg IM.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> if less than 15 kg, EpiPen Jr or Epinephrine (1:1,000) 0.15 mg IM.</li>
                            <li>May repeat Epinephrine (1:1,000) 0.5 mg IM after 10 minutes (adult and pediatric).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> May repeat Epinephrine (1:1,000) (at weight appropriate dose) after 10 minutes.</li>
                        </ul>
                    </li>
                    <li>If apneic, intubate, possibly with smaller than normal ET tube.</li>
                 </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li>For wheezing, no orders needed for Albuterol 2.5 mg and Ipratropium 0.5 mg, nebulized with O₂ flowing at 8-10 LPM.</li>
                    <li>If patient intubated, Albuterol 2.5 mg by nebulizer into the ETT. If Ipratropium not given before intubation, add to first Albuterol.</li>
                    <li>If hypotensive, IV fluid to maintain adequate BP. <span class=""text-pink-600 font-bold"">P</span> If hypotensive, IV fluid 20 ml/kg IV to maintain adequate BP.</li>
                    <li><span class=""font-bold"">A</span> Diphenhydramine 50 mg IM or IV.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Diphenhydramine 1 mg/kg IM or IV (max dose 50 mg).</li>
                    <li>If patient deteriorating or unresponsive, consider early intubation, possibly with a smaller than normal size endotracheal tube.</li>
                    <li>If a conscious patient requires intubation:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Lidocaine 100 mg IN half dose per nostril or added to nebulizer with breathing treatment.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Lidocaine 1.5 mg/kg nebulized with O₂ 8-10 LPM or IN. Maximum dose is 100 mg.</li>
                        </ul>
                    </li>
                    <li>If patient remains hypotensive after IV fluid, Epinephrine (1:10,000) 0.1 mg, slow IV, every 3 minutes up to 0.5 mg.</li>
                    <li><span class=""font-bold"">A</span> Solu-Medrol 125 mg IV.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Solu-Medrol 2 mg/kg IV, max dose 125 mg.</li>
                </ul>
            </div>
        </div>
     </div>
</div>"
protocol,4003,Asthma/Emphysema/COPD ,4000,"<div>
    <h3>4003.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Provide O₂ as needed.</li>
                    <li>Call for transport.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>If patient develops wheezing, assist them with taking their prescribed metered dose inhaler or <span class=""font-bold text-blue-600"">&diams;</span> Consider Albuterol 2.5 mg and Ipratropium 0.5 mg, nebulized with O₂ flowing at 8-10 LPM. May repeat Albuterol 2.5 mg nebulized two times.</li>
                    <li>For any patient who is bronchial constricted: CPAP.</li>
                    <li>Transport unless ALS intercept is less than 5 minutes.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li>No orders needed for Albuterol 2.5 mg and Ipratropium 0.5 mg, nebulized with O₂ flowing at 8-10 LPM.</li>
                    <li>If patient intubated, Albuterol 2.5 mg by nebulizer into the ETT. If Ipratropium not given before intubation, add to first Albuterol.</li>
                    <li>After intubation of an asthma patient, limit rate of ventilation to avoid auto-PEEP and hypotension, provided that you can adequately oxygenate the patient at below rate:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> 8-10 breaths per minute for adults.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> 10-15 breaths per minute for pediatric patients.</li>
                        </ul>
                    </li>
                    <li>Consider needle decompression in the presence of auto-PEEP or hyperinflation:
                         <ul class=""list-disc pl-5 mt-1"">
                            <li>If the patient is in cardiac arrest, perform bilateral needle decompression.</li>
                            <li>If unilateral or bilateral diminished breath sounds and the patient is hemodynamically unstable, consider decompression of only the affected sides.</li>
                            <li>Decompression sites: Second or third intercostal space in the mid-clavicular line (use nipple line as a guide), Fourth or fifth intercostal space in the mid-axillary line.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> in patients less than 8 years old, decompression site choice will be limited to the 2nd or 3rd intercostal space at the mid-clavicular line.</li>
                         </ul>
                    </li>
                    <li>Asthmatics in severe distress (NOT for emphysema or COPD):
                        <ul class=""list-disc pl-5 mt-1"">
                            <li>If equal to or greater than 30 kg, give both Adult EpiPen and EpiPen Jr or Epi (1:1,000) 0.5 mg IM (adult and pediatric).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> If equal to or greater than 15 kg and less than 30 kg. Adult EpiPen or Epinephrine (1:1,000) 0.3 mg IM.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> If less than 15 kg, EpiPen Jr or Epinephrine (1:1,000) 0.15 mg IM.</li>
                            <li>May repeat Epinephrine (1:1,000) 0.5 mg IM after 10 minutes (adult and pediatric).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> May repeat Epinephrine (1:1,000) (at weight appropriate dose) after 10 minutes.</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                 <ul>
                    <li>If a conscious patient requires intubation:
                         <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Lidocaine 100 mg IN half dose per nostril or added to nebulizer with breathing treatment.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Lidocaine 1.5 mg/kg nebulized with O₂ LPM or IN. Maximum dose is 100 mg.</li>
                        </ul>
                    </li>
                    <li>For any persistent bronchial constriction consider CPAP or {Bi-PAP}.</li>
                    <li><span class=""font-bold"">A</span> Solu-Medrol 125 mg IV.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Solu-Medrol 2 mg/kg IV, max dose 125 mg.</li>
                    <li>Bronchoconstriction due to asthma refractory to Albuterol, Ipratropium, and Epinephrine:
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Magnesium Sulfate 2 gm (half bag) infused with macro-drip tubing over 10 minutes.</li>
                        </ul>
                    </li>
                 </ul>
            </div>
        </div>
    </div>
</div>"
protocol,4004,Behavioral Emergencies ,4000,"<div>
    <h3>4004.1 General Guidelines</h3>
    <ul>
        <li>Per Ohio Revised Code, EMS providers may not ""pink slip"" an individual even if they are threatening harm to themselves or others.</li>
        <li>Only a police officer, crisis worker, health officer, psychiatrist or licensed physician can administer an involuntary admission form (""pink slip"") for a patient.</li>
        <li>Each EMS department, in consultation with its medical director and local law enforcement, should have a procedure to deal with these types of situations.</li>
    </ul>

    <h3 class=""mt-6"">4004.2 Precautions</h3>
    <ul>
        <li>Consider staging until law enforcement has made the scene safe.</li>
        <li>Have law enforcement search patient for weapons.</li>
        <li>Consider possible medical causes for patient's condition.</li>
    </ul>

    <h3 class=""mt-6"">4004.3 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Determine patient capacity and consent.</li>
                    <li>Take actions to prevent imminent harm to the patient or others, if it is safe to do so.</li>
                    <li>Do not judge, just treat.</li>
                    <li>Consider possible medical causes for patient's condition.</li>
                    <li>If patient is unwilling to go to a facility, consider whether they are a candidate for a ""pink slip"".</li>
                    <li>Transport all patients who are not making rational decisions and who are a threat to themselves or others for medical evaluation.</li>
                    <li><span class=""font-bold"">A</span> If possible, transport a mental health patient to the facility where the individual has been previously treated.</li>
                    <li><span class=""font-bold"">A</span> In all other cases, patients greater than or equal to 18 years old should be transported to the closest ED.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Patients less than 18 years old, with mental health issues should be transported to a facility with pediatric mental health capabilities. (see 4004.5 c. Dayton Children's Hospital for specific instructions).</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <p>Severe agitation is a medical emergency, and should be treated. See 4005 Behavioral Emergencies - Combative Patient/Emergency Sedation.</p>
            </div>
        </div>
    </div>
    
    <h3 class=""mt-6"">4004.4 Transport Guidelines</h3>
    <ul>
        <li><strong>Adults:</strong> Can be transported to any facility. Considerations should be given to the capabilities of the receiving facility, combativeness of the patient and length of transport time.</li>
        <li><strong>Pediatrics:</strong>
            <ul class=""list-roman pl-6 mt-2"">
                <li>Transporting pediatric patients to Dayton Children's Hospital should be a priority.</li>
                <li>For excessive transport times, consider transport to a closer facility which can facilitate transfer after an initial assessment, stabilization, and a consult with DCH.</li>
                <li>While GMVEMSC Standing Orders consider a pediatric patient to be less than 16 years old, DCH will accept behavioral patients up to the age of 17 years old.</li>
                <li>Pregnant patients of any age should be transported to an adult facility.</li>
            </ul>
        </li>
    </ul>
    
    <h3 class=""mt-6"">4004.5 Pre-Arrival Notification of Behavioral Patients</h3>
    <ul>
        <li><strong>Premier Health Facilities:</strong> Use ""ACE Alert"".</li>
        <li><strong>Kettering Health Network Facilities:</strong> Use ""Dr. White"".</li>
        <li><strong>Dayton Children's Hospital (Main Campus only):</strong> Use ""ACE Alert"".
            <ul class=""list-disc pl-5 mt-1"">
                <li>Between 1000-0000 hrs, transport to DCH Mathile Center.</li>
                <li>Between 0001-0959 hrs, transport to Main Campus ED.</li>
                <li>Transport to Main Campus ED also for: need for medical care, intoxication, sexual assault, strangulation, patient received Ketamine, pregnancy.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,4005,Behavioral Emergencies - Combative Patients/Emergency Sedation ,4000,"<div>
    <h3>4005.1 General Guidelines</h3>
    <ul>
        <li>Restrained patients must not be transported in a prone position with hands & feet behind their back.</li>
        <li>Restrained patients must not be sandwiched between backboards or other items.</li>
        <li>Always maintain the ability to remove restraints if the patient vomits or develops respiratory distress.</li>
    </ul>

    <h3 class=""mt-6"">4005.2 Combative Patients</h3>
    <ul>
        <li>Identified as irrational behavior, examples include aggression, violence, and/or paranoia in the patient.</li>
        <li>This state can result from causes including, but not limited to: Stimulant intoxication, Psychiatric illness, Hypoglycemia, Other medical illnesses.</li>
        <li>The combative patient often becomes significantly hyperthermic and/or hypoxic, even after the episode has subsided.</li>
    </ul>

    <h3 class=""mt-6"">4005.3 Collaboration with Law Enforcement</h3>
    <ul>
        <li>Providers should get as much information as possible from LE as to the reason for the encounter, observed behaviors, medical history, use of force and/or less-than-lethal weapons, etc.</li>
        <li>Decisions to use pharmacological interventions will be made solely by the EMS provider based on their own assessment and not at the behest of the law enforcement officers on scene.</li>
        <li>Consideration should be given to transitioning the patient from police restraints to medical restraints prior to transport.</li>
        <li>If restraint devices require a key, that key should be transported with the patient whenever possible. Provider agencies should work with their law enforcement partners beforehand to establish SOPs to address this concern.</li>
    </ul>
    
    <h3 class=""mt-6"">4005.4 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Explain the need for restraint to the patient.</li>
                    <li>Recheck often a restrained patient's ability to breathe and distal circulation.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><span class=""font-bold"">A</span> Ketamine 250 mg IM (in anterolateral thigh) or Ketamine 100 mg slow IV.</li>
                    <li><span class=""font-bold"">A</span> No change after 10 minutes with IM dose or 5 minutes with IV dose, consider additional medication: <span class=""important-note"">DO NOT ADMINISTER KETAMINE AND MIDAZOLAM SIMULTANEOUSLY.</span> Give the administered sedative time to work before moving on to a secondary medication and dosing.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Ketamine 250 mg IM (in opposite anterolateral thigh) or repeat Ketamine 100 mg IV.</li>
                            <li class=""text-center font-bold my-1"">AND/OR</li>
                            <li><span class=""font-bold"">A</span> Midazolam 10 mg IN (5 mg in each nostril), or Midazolam 2.5 mg slow IV, or Midazolam 5 mg IM.</li>
                            <li><span class=""font-bold"">A</span> If necessary, repeat Midazolam doses: Repeat Midazolam 5 mg IN (2.5 mg in each nostril) after 10 minutes, or repeat Midazolam 2.5 mg slow IV after 5 minutes, or repeat Midazolam 5 mg IM after 10 minutes.</li>
                        </ul>
                    </li>
                    <li class=""mt-2 text-pink-600""><span class=""font-bold"">P</span> If the patient is age 8 or greater, consider Ketamine 1 mg/kg slow IV (max dose 100 mg) or Ketamine 5 mg/kg IM (max dose 250), OR Midazolam 0.2 mg/kg IN (max IN dose 10 mg) or Midazolam 0.1 mg/kg slow IV (max IV dose 2.5 mg) or Midazolam 0.2 mg/kg IM (max IM dose 4 mg).</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Call MCP for additional Ketamine or Midazolam.</li>
                    <li><span class=""font-bold"">A</span> If an excited delirium patient goes into arrest: Consider Sodium Bicarbonate 100 mEq IV.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,4006,Childbirth ,4000,"<div>
    <h3>4006.1 General Guidelines</h3>
    <ul>
        <li>Obtain history of patient condition and pregnancy, including: Contraction duration and interval, Gestation age, Due date, First day of last menstrual period, Number of pregnancies and live births (gravida/para), Prenatal care, Possibility of multiple births, Any possible complications, Any drug use by the mother.</li>
        <li>The patient should be transported to a hospital with obstetrical capabilities, unless delivery is imminent (crowning). <span class=""important-note"">ABSOLUTELY NO PREGNANT PATIENTS TO DAYTON or CINCINNATI CHILDREN'S HOSPITALS.</span></li>
        <li>Visualize the perineal area only when contractions are less than five minutes apart.</li>
        <li>Run reports must be completed for each patient. The newborn is a separate patient from the mother.</li>
    </ul>

    <h3 class=""mt-6"">4006.2 Clinical Management</h3>
     <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Apply gentle pressure on the baby's head with a flat hand to prevent an explosive delivery.</li>
                    <li>Place a gloved hand inside the birth canal only in the case of: Breech delivery with entrapped head, or Prolapsed umbilical cord limiting fetal circulation.</li>
                    <li>Keep the newborn warm with blankets and (if available) a head cover.</li>
                    <li>Cut the umbilical cord and then place the baby to suckle at the mother's breast.</li>
                </ul>
            </div>
             <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
             <div>
                <ul>
                    <li>Obtain one, five and ten minute APGAR scores if time and patient condition permit. (see table below)</li>
                </ul>
             </div>
             <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
             <div>
                <p>Establish an IV for patients in active labor.</p>
             </div>
        </div>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">APGAR Score</h4>
            <div class=""overflow-x-auto"">
                <table class=""w-full text-sm text-left"">
                    <thead class=""text-xs text-gray-700 uppercase bg-gray-100"">
                        <tr><th class=""px-2 py-2"">APGAR Score</th><th class=""px-2 py-2"">0</th><th class=""px-2 py-2"">1</th><th class=""px-2 py-2"">2</th></tr>
                    </thead>
                    <tbody>
                        <tr class=""border-b""><td class=""px-2 py-2 font-semibold"">Appearance</td><td class=""px-2 py-2"">Full body cyanosis</td><td class=""px-2 py-2"">Cyanosis at the extremities</td><td class=""px-2 py-2"">No cyanosis present</td></tr>
                        <tr class=""border-b bg-gray-50""><td class=""px-2 py-2 font-semibold"">Pulse</td><td class=""px-2 py-2"">Absent</td><td class=""px-2 py-2"">Slow (less than 100)</td><td class=""px-2 py-2"">Greater than 100</td></tr>
                        <tr class=""border-b""><td class=""px-2 py-2 font-semibold"">Grimace</td><td class=""px-2 py-2"">Flaccid</td><td class=""px-2 py-2"">Grimace with stimulation</td><td class=""px-2 py-2"">Cough or sneeze with stimulation</td></tr>
                        <tr class=""border-b bg-gray-50""><td class=""px-2 py-2 font-semibold"">Activity</td><td class=""px-2 py-2"">Absent</td><td class=""px-2 py-2"">Some flexion of extremities</td><td class=""px-2 py-2"">Active motion</td></tr>
                        <tr class=""border-b""><td class=""px-2 py-2 font-semibold"">Respiratory Effort</td><td class=""px-2 py-2"">Absent</td><td class=""px-2 py-2"">Slow or irregular</td><td class=""px-2 py-2"">Good, vigorous cry</td></tr>
                    </tbody>
                </table>
            </div>
        </div>
     </div>
</div>"
protocol,4007,Childbirth with Complications ,4000,"<div>
    <h3>4007.1 General Guidelines</h3>
    <ul>
        <li>With all complicated childbirth scenarios, evaluate the need for rapid transport to a birthing center or possibly, the nearest hospital.</li>
        <li>These guidelines apply to all levels of certification, except where noted.</li>
        <li>In all complicated childbirth scenarios, place the mother on oxygen by non-rebreather mask.</li>
    </ul>

    <h3 class=""mt-6"">4007.2 Clinical Management</h3>
    <div class=""space-y-4"">
        <div>
            <h4 class=""font-bold"">a. Cord around Baby's Neck:</h4>
            <ul class=""list-roman pl-6"">
                <li>As baby's head passes out of the vaginal opening, feel for the cord.</li>
                <li>Initially try to slip cord over baby's head.</li>
                <li>If too tight, clamp cord in two places and cut between clamps.</li>
            </ul>
        </div>
        <div>
            <h4 class=""font-bold"">b. Breech Delivery:</h4>
            <ul class=""list-roman pl-6"">
                <li>When an appendage or buttocks first becomes visible, position patient to discourage delivery, coach patient to avoid pushing and transport patient immediately.</li>
                <li>If the delivery is in progress, take care to support the baby's body.</li>
                <li>If the head is caught in the birth canal:
                    <ol class=""list-decimal pl-6 mt-1"">
                        <li>Apply gentle pressure above the pubis symphysis as the mother pushes.</li>
                        <li>If the head will not deliver, you must create an airway for the baby.</li>
                        <li>Support the body and insert two fingers into the birth canal, forming a ""V"" around the mouth and nose.</li>
                    </ol>
                </li>
            </ul>
        </div>
        <div>
            <h4 class=""font-bold"">c. Prolapsed Cord:</h4>
             <ul class=""list-roman pl-6"">
                <li>When the umbilical cord is exposed prior to delivery, check cord for pulse.</li>
                <li>Transport immediately with hips elevated and a moist dressing around cord.</li>
                <li>Insert two fingers into the birth canal to displace the presenting part away from cord, distribute pressure evenly if occiput presents.</li>
                <li>Do not attempt to reinsert cord.</li>
             </ul>
        </div>
         <div>
            <h4 class=""font-bold"">d. Excessive Bleeding:</h4>
             <ul class=""list-roman pl-6"">
                <li>Treat for shock.</li>
                <li>Post-delivery, massage uterus firmly and put baby to mother's breast.</li>
                <li>The AEMT and Paramedic may consider the use of Tranexamic Acid (TXA) 2 grams IV/IO over 1-2 minutes as outlined in 3015 Hemorrhage Control.</li>
             </ul>
        </div>
    </div>
</div>"
protocol,4008,Diabetic  Emergencies - Hypoglycemia ,4000,"<div>
    <h3>4008.1 General Guidelines</h3>
    <ul>
        <li>Hypoglycemia is defined as a blood glucose level less than 60 mg/dL, or there is strong suspicion of hypoglycemia despite glucometer readings.</li>
        <li>Hyperglycemia is defined as a blood glucose level at or above 250 mg/dL. EMS will treat patients with a BGL greater than 400 mg/dL or when the glucometer reads ""High"".</li>
    </ul>

    <h3 class=""mt-6"">4008.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Provide basic care.</li>
                    <li>Call for transport.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                 <ul>
                    <li>Obtain blood sample via finger stick and measure blood glucose level.</li>
                    <li>If Hypoglycemic: Administer 1 tube of Oral Glucose.</li>
                    <li>Maintain normothermia. Unconscious diabetics are often hypothermic.</li>
                 </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li>In a diabetic patient with an insulin pump and blood glucose less than 60 mg/dL, treat the hypoglycemia.</li>
                    <li>Monitor and transport.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><strong>If Hypoglycemic:</strong>
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Administer Dextrose 10% (D10), 250 ml at wide open rate, (250 ml = 25 g of Dextrose).</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Administer Dextrose 10% (D10) 5 ml/kg, maximum single dose of 250 ml.</li>
                            <li class=""text-pink-600"">For newborn, Dextrose 10% (D10) 2 ml/kg if BGL is less than 40 mg/dL.</li>
                            <li>Dextrose 10% (D10) may be repeated in ten minutes if blood sugar remains less than 60 mg/dL.</li>
                        </ul>
                    </li>
                    <li class=""mt-2""><strong>If Hyperglycemic:</strong>
                         <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> If BGL reads over 400 mg/dL or ""High"" on glucometer, administer 500 ml fluid IV - wide open.</li>
                            <li>Do not administer fluid to a hyperglycemic pediatric patient, unless otherwise indicated.</li>
                            <li><span class=""font-bold"">A</span> If an excited delirium patient goes into arrest: Consider Sodium Bicarbonate 100 mEq IV.</li>
                         </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,4009,Diabetic Emergencies - Refusal of Transport ,4000,"<div>
    <h3>4009.1 General Guidelines</h3>
    <ul>
        <li>EMTs and above may allow for diabetic patients to refuse transport after treatment.</li>
        <li>EMRs should call for transport or a provider of a higher-level certification.</li>
    </ul>

    <h3 class=""mt-6"">4009.2 Refusal Procedures</h3>
    <ul>
        <li>Patients 18 years of age or older may be permitted to refuse. Follow these guidelines:
            <ul class=""list-roman pl-6 mt-2"">
                <li>Repeat physical examination and vital signs.</li>
                <li>Patient must be Alert & Oriented x3.</li>
                <li>Warn the patient that there is a significant risk of going back into a hypoglycemic state, especially if on oral hypoglycemics.</li>
                <li>Advise the patient to eat something substantial immediately.</li>
                <li>Advise the patient to contact their family physician as soon as possible to minimize future episodes.</li>
                <li>Advise the patient to stay with someone.</li>
                <li>Follow normal patient refusal procedures.</li>
            </ul>
        </li>
        <li class=""mt-2"">If the diabetic patient is under 18, but a parent or guardian is present, then the responsible adult may refuse patient transportation under the same guidelines as listed above in 4009.2.a.</li>
    </ul>
</div>"
protocol,4010,Extrapyramidal Reactions ,4000,"<div>
    <h3>4010.1 General Guidelines</h3>
    <ul>
        <li>A patient who is currently on a phenothiazine (e.g., Phenergan, Thorazine, Compazine) or a butyrophenone (e.g., Haldol, Droperidol) and exhibiting signs of acute muscle spasm or motor restlessness may be suffering from an Extrapyramidal Reaction.</li>
        <li>Extrapyramidal reactions can occur with ingestion of recreational drugs.</li>
        <li>Physical examination findings may include any of the following: Oculogyric crisis, Buccolingual crisis, Trismus, Difficulty in speaking, Facial grimacing, Torticollis crisis, Opisthotonus, Tortipelvic crisis. Mental status is unaffected. Vital signs are usually normal.</li>
    </ul>

    <h3 class=""mt-6"">4010.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Provide basic care.</li>
                    <li>Call for transport.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <p>If blood glucose less than 60, or there is strong suspicion of hypoglycemia despite glucometer readings, then follow 4008 Diabetic Emergencies - Hypoglycemia protocol.</p>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li>Initiate IV fluid to maintain adequate BP.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span>
                        <ul class=""list-disc pl-5"">
                            <li><span class=""font-bold"">A</span> Diphenhydramine 50 mg IV or IM.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Diphenhydramine 1 mg/kg IV or IM (max dose 50 mg).</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><span class=""font-bold"">A</span> Diphenhydramine 50 mg IV or IM.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> Diphenhydramine 1 mg/kg IV or IM (max dose 50 mg).</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,4011,Obstetrical Emergencies ,4000,"<div>
    <h3>4011.1 General Guidelines</h3>
    <ul>
        <li>Consider the possibility of ectopic pregnancy in females of child-bearing age.</li>
        <li>Ask for first day of last menstrual period.</li>
        <li>Gestational age should be expressed in weeks whenever possible.</li>
        <li>Aggressively treat for hypovolemic shock (do not rely on standard vital sign parameters).</li>
        <li>Give psychological support to patient and family.</li>
        <li>Be sure to take all expelled tissue with you to the hospital.</li>
    </ul>

    <h3 class=""mt-6"">4011.2 Transport Decisions</h3>
    <ul>
        <li><strong>Transport to Maternity Department if:</strong> Pregnant patients, 20 weeks, or greater gestation with obstetric complaints. If unsure of time of gestation, then consider transport to a maternity department.</li>
        <li><strong>Transport to Emergency Department if:</strong> Pregnant patients with minor trauma or medical (non-obstetric) complaints. Pregnant patients less than 20 weeks gestation.</li>
        <li>Pregnant trauma patients should be rapidly transported to the Emergency Department at an Adult Trauma Center with labor and delivery capabilities.</li>
        <li><strong>Positional transport considerations:</strong> Prepare for postural hypotension. Place in left lateral recumbent position or place a pillow under the right hip/lower back. Apply continuous manual displacement of the uterus towards the patient's left side.</li>
    </ul>

    <h3 class=""mt-6"">4011.3 Clinical Management</h3>
    <ul>
        <li>Causes of cardiac arrest in pregnant patients can include: Pulmonary embolism, Trauma, Hemorrhage, Congenital or acquired cardiac disease.</li>
        <li>Load and go to the closest hospital and follow all cardiac arrest protocols enroute.</li>
    </ul>
    
    <h3 class=""mt-6"">4011.4 Aspirin and the Pregnant Patient</h3>
    <p>Aspirin is contraindicated in third trimester due to possibility of pre and post-partum hemorrhaging and protentional fetal harm.</p>
</div>"
protocol,4012,Overdose/Poisonings ,4000,"<h3>General Guidelines</h3>
    <ul>
      <li>EMS personnel should contact and confer with MCP for direction on suspected poisonings.</li>
      <li>Poison Control is intended for use by the general public.</li>
      <li>If possible, provide receiving facility all available information about the substance:
        <ul>
            <li>Safety data sheets (SDS)</li>
            <li>The container (if it is safe to do so)</li>
            <li>The label or an image of the label and warning information if it is unsafe or unpractical to transport the actual substance container</li>
        </ul>
      </li>
      <li>See Clinical Pearls for recommendations on treatment for button battery ingestion.</li>
    </ul>

    <h3>Clinical Management</h3>
    <h4>Pediatric Considerations</h4>
    <ul>
        <li>Most pediatric patients with respiratory depression do not have narcotic overdose. They are either septic or have respiratory failure.</li>
        <li>Treatment for button battery ingestion is for patients greater to or equal to 12 months of age.</li>
    </ul>
    
    <h4>Signs & Symptoms</h4>
    <ul>
      <li>Mental status changes</li>
      <li>Hypo/hypertension</li>
      <li>Decreased respiratory rate</li>
      <li>Tachycardia or bradycardia</li>
      <li>Cardiac dysrhythmias</li>
      <li>Seizures</li>
    </ul>

    <h3>Treatment Algorithm</h3>
    
    <h4>EMR / EMT</h4>
    <ul>
        <li>If respirations are impaired or there is suspicion of narcotic overdose:</li>
        <li><b>Adult:</b> Administer Naloxone, up to 4 mg IN (half dose per nostril). May repeat Naloxone doses in 2 minutes.</li>
        <li><b>Pediatric Naloxone:</b>
            <ul>
                <li>Less than or equal to 20 kg then 0.1 mg/kg IN, (max dose 2 mg), may repeat x one.</li>
                <li>Greater than 20 kg: 2 mg, IN, may repeat as needed.</li>
            </ul>
        </li>
        <li>Titrate Naloxone to adequate respirations.</li>
        <li>Consider patient restraint before administration of Naloxone.</li>
    </ul>

    <h4>AEMT</h4>
    <ul>
        <li>If patient has a pulse, Naloxone should be administered before inserting an ETT.</li>
        <li>When given IV or IN, the onset of action for Naloxone is approximately 2 minutes.</li>
        <li>If respirations are impaired or there is suspicion of narcotic overdose:</li>
        <li><b>Adult:</b> Administer Naloxone, up to 4 mg IN, 2mg IV or 4 mg IM. May repeat Naloxone doses in 2 minutes. Consider repeat IV dosing if no or inadequate response is noted.</li>
        <li><b>Pediatric Naloxone:</b>
            <ul>
                <li>Less than or equal to 20 kg then 0.1 mg/kg IN, IV, IM (max dose 2 mg), may repeat x one.</li>
                <li>Greater than 20 kg: 2 mg, IN, IV, IM, may repeat as needed.</li>
                <li>Naloxone slow IV is preferred, but it may be given IN or IM before IV is established.</li>
                <li>If using IN route and respirations don't improve after 2 minutes, establish IV and administer IV dose.</li>
            </ul>
        </li>
        <li>Titrate to adequate respirations.</li>
    </ul>

    <h4>Paramedic</h4>
    <ul>
        <li>Follow AEMT guidelines for Naloxone administration.</li>
        <li><b>Stimulant Overdose (cocaine, methamphetamines, etc.) with chest pain:</b>
            <ul>
                <li><b>Adult:</b> Nitroglycerin 0.4 mg SL, if SBP >100, every 5 minutes to a total of three doses.</li>
                <li><b>Adult:</b> Midazolam 10 mg, IN (5 mg in each nostril) or 2.5 mg slow IV, or 5 mg IM.</li>
                <li>Repeat Midazolam 5 mg IN (2.5 mg in each nostril) or 2.5 mg slow IV or 5 mg IM for unrelieved chest pain.</li>
                <li>For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half of the adult doses.</li>
            </ul>
        </li>
        <li><b>Tricyclic Antidepressant Overdose:</b> (May be evidenced by bradycardia, tachycardia, hypotension and prolonged QRS)
            <ul>
                <li><b>Adult:</b> Sodium Bicarbonate 100 mEq, slow IV. May repeat 50 mEq, slow IV for persistent QRS prolongation.</li>
                <li><b>Pediatric:</b> Sodium Bicarbonate 1 mEq/kg slow IV. May repeat 0.5 mEq/kg slow IV for persistent QRS prolongation.</li>
            </ul>
        </li>
        <li><b>Calcium Channel Blocker Overdose:</b>
            <ul>
                <li><b>Adult:</b> Calcium Chloride, 1 Gm slow IV.</li>
                <li><b>Pediatric:</b> Calcium Chloride, 0.2 ml/kg (20 mg/kg) slow IV (max dose 500 mg).</li>
            </ul>
        </li>
    </ul>

    <h3>Consult</h3>
    <ul>
        <li>For guidance on suspected poisonings contact MCP.</li>
        <li>Calcium Channel Blocker, Beta Blocker and Tricyclic antidotes in this protocol are by MCP order only.</li>
    </ul>

    <h3>Clinical Pearls</h3>
    <ul>
      <li>Consider other causes of altered mental status such as hypoglycemia, head trauma, sepsis, and stroke.</li>
      <li>When Naloxone is given intranasal (IN), the onset of action is approximately 2 minutes.</li>
      <li>Naloxone is not felt to be effective in the reversal of cardiac arrest from opioid overdose. Airway control, ventilation, and quality CPR are still the mainstay of treatment.</li>
      <li>Naloxone is not indicated in the management of newborns as it can cause withdrawal and secondary issues.</li>
      <li>Ondansetron (Zofran) is NOT to be given prophylactically with Naloxone.</li>
      <li><b>For ingestion of lithium button batteries:</b> If honey is at the scene, patients > 12 months old may be given ~10 ml every 10 minutes (up to 6 times) to coat the battery. Document as ""self or family administered"".</li>
    </ul>

    <h3>Medication Examples</h3>
    <h4>Tricyclic Antidepressant Examples:</h4>
    <ul>
        <li>Amitriptyline (Elavil, Endep)</li>
        <li>Nortriptyline (Pamelor, Aventyl)</li>
        <li>Amoxapine (Asendin)</li>
        <li>Clomipramine (Anafranil)</li>
        <li>Desipramine (Norpramine)</li>
        <li>Doxepin (Sinequan)</li>
        <li>Imipramine (Tofranil)</li>
        <li>Protriptyline (Vivactil)</li>
        <li>Trimipramine (Surmontil)</li>
    </ul>
    <h4>Calcium Channel Blocker examples:</h4>
    <ul>
        <li>Amlodipine (Norvasc)</li>
        <li>Diltiazem (Cardizem)</li>
        <li>Felodipine (Plendil)</li>
        <li>Isradipine (Dynacirc)</li>
        <li>Nifedipine (Procardia, Adalat)</li>
        <li>Verapamil (Calan, Isoptin)</li>
    </ul>
    <h4>Beta Blocker examples</h4>
    <ul>
        <li>Acebutolol (Sectral)</li>
        <li>Atenolol (Tenormin)</li>
        <li>Carvedilol (Coreg)</li>
        <li>Labetalol (Normodyne, Trandate)</li>
        <li>Metoprolol (Toprol, Lopressor)</li>
        <li>Nadolol (Corgard)</li>
        <li>Pindolol (Viskin)</li>
        <li>Propranolol (Inderal)</li>
        <li>Sotalol (Betapace)</li>
        <li>Timolol (Blocadren)</li>
    </ul>"
protocol,4013,Respiratory Distress/Pulmonary Edema ,4000,"<h3>General Guidelines</h3>
    <ul>
      <li>This protocol is for patients with respiratory distress secondary to pulmonary edema.</li>
      <li>For patients with wheezing, see Medical Protocol 4003 - Asthma/COPD/Emphysema.</li>
    </ul>

    <h3>Clinical Management</h3>
    <div class=""grid md:grid-cols-2 gap-4"">
      <div>
        <h4>Signs & Symptoms</h4>
        <ul>
          <li>Cyanosis</li>
          <li>Clammy skin</li>
          <li>Presence/Absence of fever</li>
          <li>Coughing</li>
          <li>Wheezing</li>
          <li>Labored breathing</li>
          <li>Diaphoresis</li>
          <li>Pitting edema</li>
          <li>Bilateral lower lobe rales</li>
          <li>Tachypnea</li>
          <li>Apprehension</li>
          <li>Jugular vein distension (JVD)</li>
          <li>Inability to talk</li>
        </ul>
      </div>
      <div>
        <h4>Differential Diagnosis</h4>
        <ul>
          <li>Myocardial infarction</li>
          <li>Congestive heart failure</li>
          <li>Asthma</li>
          <li>Anaphylaxis</li>
          <li>Aspiration</li>
          <li>Chronic obstructive pulmonary disease</li>
          <li>Pleural effusion</li>
          <li>Pneumonia</li>
          <li>Pulmonary embolus</li>
          <li>Pericardial tamponade</li>
        </ul>
      </div>
    </div>

    <h3>Treatment Algorithm</h3>

    <h4>EMT</h4>
    <ul>
      <li>Position patient upright with legs dependent, as tolerated.</li>
      <li>Administer Oxygen to maintain SpO2 > 94%.</li>
      <li>If patient exhibits signs of severe respiratory distress, apply CPAP.</li>
      <li>Assist patient with their own prescribed Nitroglycerin, if SBP is greater than 100 mmHg.</li>
    </ul>

    <h4>AEMT</h4>
    <ul>
      <li>Administer Nitroglycerin 0.4 mg SL every 5 minutes as long as SBP remains > 100 mmHg.</li>
      <li>Establish IV access.</li>
    </ul>

    <h4>Paramedic</h4>
    <ul>
      <li>If SBP is greater than 100 mmHg, administer Nitroglycerin 0.4 mg SL every 5 minutes. There is no maximum dose as long as SBP remains above 100 mmHg.</li>
      <li>If patient is in severe respiratory distress, consider IV Nitroglycerin if available and trained.</li>
    </ul>

    <h3>Clinical Pearls</h3>
    <ul>
      <li>Evaluate breath sounds:
        <ul>
          <li><strong>Clear:</strong> treat cause (e.g. MI, pulmonary embolism, metabolic disturbance, and hyperventilation).</li>
          <li><strong>Wheezes:</strong> treat cause (e.g. pulmonary edema, FBAO, asthma, allergic reaction).</li>
          <li><strong>Rales:</strong> treat cause (e.g. pulmonary edema, pneumonia).</li>
          <li><strong>Diminished or absent:</strong>
            <ul>
              <li>Unilateral: treat cause (e.g., pneumothorax, hemothorax, pneumonia, surgically removed lung).</li>
              <li>Bilateral: treat cause (e.g., respiratory failure, COPD, asthma).</li>
            </ul>
          </li>
        </ul>
      </li>
      <li>Pneumonia may look like CHF with pulmonary edema. However, the pneumonia patient is often dehydrated and has an elevated temperature.</li>
    </ul>"
protocol,4014,Seizures,4000,"<h3>Clinical Management</h3>
    <div class=""grid md:grid-cols-2 gap-4 mb-4"">
      <div>
        <h4>Signs & Symptoms</h4>
        <ul>
          <li>Decreased mental status</li>
          <li>Sleepiness</li>
          <li>Incontinence</li>
          <li>Observed seizure activity</li>
          <li>Evidence of trauma</li>
        </ul>
      </div>
      <div>
        <h4>Differential Diagnosis</h4>
        <ul>
          <li>Head trauma</li>
          <li>Tumor</li>
          <li>Metabolic, hepatic or renal failure</li>
          <li>Hypoxia</li>
          <li>Electrolyte abnormality</li>
          <li>Drugs, medications</li>
          <li>Infection/fever</li>
          <li>Alcohol withdrawal</li>
          <li>Eclampsia</li>
          <li>Stroke/TIA</li>
          <li>Hyperthermia</li>
          <li>Psychogenic Non-epileptic Seizures</li>
        </ul>
      </div>
    </div>

    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Pediatric Considerations</h4>
        <p class=""text-sm italic"">None</p>
        
        <div class=""mt-4"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>BVM and nasopharyngeal airway during seizure as needed.</li>
                        <li>Maintain normothermia.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div>
                    <ul>
                        <li>Obtain Pulse Oximeter and Capnography reading.</li>
                        <li>If glucose less than 60, or there is strong suspicion of hypoglycemia despite glucometer readings, then follow 4008 Hypoglycemia/Hyperglycemia.</li>
                        <li>Place patient in the recovery position during assessment and transport.</li>
                    </ul>
                </div>

                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div>
                    <ul>
                        <li>Cardiac monitor</li>
                        <li><strong>For actively seizing adult patients:</strong>
                            <ul class=""list-disc pl-5"">
                                <li><strong>For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half ( ) of the adult doses</strong></li>
                                <li>Midazolam 10 mg IN (5 mg in each nostril), or Midazolam 2.5 mg slow IV, or Midazolam 5 mg IM</li>
                                <li>If still seizing, repeat Midazolam doses:
                                    <ul class=""list-decimal pl-5"">
                                        <li>Repeat Midazolam 5 mg IN (2.5 mg in each nostril) after 10 minutes.</li>
                                        <li>Or repeat Midazolam 2.5 mg slow IV after 5 minutes.</li>
                                        <li>Or repeat Midazolam 5 mg IM after 10 minutes.</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                        <li class=""mt-2""><strong>For actively seizing pediatric patients:</strong>
                            <ul class=""list-disc pl-5"">
                                <li>Midazolam 0.2 mg/kg IN (max IN dose 10 mg) or Midazolam 0.1 mg/kg slow IV (max IV dose 2.5 mg) or Midazolam 0.2 mg/kg IM (max IM dose 5 mg)</li>
                                <li>If still seizing, repeat Midazolam doses:
                                    <ul class=""list-decimal pl-5"">
                                        <li>Repeat Midazolam 0.2 mg/kg IN (max IN dose 5 mg) after 10 minutes</li>
                                        <li>Or repeat Midazolam 0.1 mg/kg slow IV (max IV dose 2.5 mg) after 5 minutes</li>
                                        <li>Or repeat Midazolam 0.2 mg/kg IM (max IM dose 5 mg) after 10 minutes</li>
                                    </ul>
                                </li>
                            </ul>
                        </li>
                    </ul>
                </div>
                
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <ul>
                        <li>If seizing pregnant patient with gestation greater than 20 weeks or postpartum less than 6 weeks, administer Magnesium Sulfate 4 grams (whole bag) infused with macro-drip tubing over 20 min.</li>
                        <li>If seizing pregnant or postpartum patient is less than 16 years old but meets criteria above, then administer Magnesium Sulfate 4 grams (whole bag) infused with macro-drip tubing over 20 min</li>
                    </ul>
                </div>
            </div>
        </div>

        <div class=""mt-4 pt-4 border-t space-y-4"">
            <div>
                <h4 class=""text-base font-bold"">Consult</h4>
                <p class=""text-sm"">None</p>
            </div>
            <div>
                <h4 class=""text-base font-bold"">Clinical Pearls</h4>
                <ul>
                    <li>When obtaining history be sure to include the following:
                        <ul class=""list-disc pl-5"">
                            <li>Description of seizures, areas of body involved, and duration</li>
                            <li>Other known medical history (e.g., head injury, diabetes, drugs, alcohol, stroke, heart disease, recent fever or illness, possible toxicological agents)</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>"
protocol,4015,Sepsis,4000,"<div>
    <h3>4015.1 General Guidelines</h3>
    <ul>
        <li>Severe sepsis is characterized by poor perfusion, leading to a buildup of serum lactate and resulting metabolic acidosis. To compensate, patients increase their minute ventilation, which ""blows off"" carbon dioxide and lowers EtCO₂.</li>
        <li>EtCO₂ levels decline in the setting of both poor perfusion and metabolic acidosis.</li>
        <li>Sepsis is often associated with a high mortality rate. The key to improve patient outcomes is early recognition, fluid resuscitation, O₂ therapy and rapid transport.</li>
    </ul>

    <h3 class=""mt-6"">4015.2 Clinical Management</h3>
     <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Signs & Symptoms</h4>
        <p>Known or suspected infection. EtCO₂ less than 32 or greater than 47 with 2 or more of the following criteria:</p>
        <ul class=""list-disc pl-5 text-sm"">
            <li>Respiratory rate &ge; 22</li>
            <li>Altered mental status (GCS &lt; 13)</li>
            <li>Temperature over 100.4°F (38°C) or under 96.8°F (36°C)</li>
            <li>Heart rate > 90</li>
            <li>Systolic BP < 100 or Mean Arterial Pressure (MAP) below 65</li>
        </ul>
        <div class=""mt-4 pt-4 border-t"">
            <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
            <div class=""skill-level-grid mt-2"">
                <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
                <div>
                    <ul>
                        <li>Administer oxygen.</li>
                        <li>Call for transport immediately.</li>
                    </ul>
                </div>
                <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
                <div><p>If possible, obtain blood sample via finger stick and measure blood glucose level.</p></div>
                <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
                <div><p><span class=""font-bold text-blue-600"">&diams;</span> Administer a bolus of 1 liter of IV fluid.</p></div>
                <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
                <div>
                    <p>For additional fluid administration:</p>
                    <p><span class=""font-bold"">A</span> Consider Norepinephrine by adding 4 mg to 250 ml of IV fluids. Infuse starting at 30 drops per minute (max 45 drops) with 60 drop tubing and titrate to effect. Increase by 5 drops/minute every 5 minutes.</p>
                </div>
            </div>
        </div>
     </div>
</div>"
protocol,4016,Shock,4000,"<div>
    <h3>4016.1 General Guidelines</h3>
    <ul>
        <li>Shock is inadequate tissue perfusion.</li>
        <li>Be proactive in treatment of shock. Do not wait for symptoms to present.</li>
        <li>Management of shock should include trying to find and correct the underlying cause (if possible).</li>
    </ul>

    <h3 class=""mt-6"">4016.2 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Call for transport immediately.</li>
                    <li>Provide O₂ as appropriate.</li>
                    <li>Keep patient warm.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>Control external bleeding and treat for hypovolemic shock as indicated.</li>
                    <li>Transport immediately unless ALS intercept is less than 5 minutes.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <ul>
                    <li>Only give fluids for specific signs and symptoms of shock and not to every trauma patient.</li>
                    <li>For persistent shock, establish additional vascular access.</li>
                    <li><strong>Non-traumatic shock without Pulmonary Edema:</strong>
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> IV fluid 500 ml IV. Maintain adequate perfusion.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> IV fluid 20 ml/kg IV. Titrate to maintain adequate perfusion.</li>
                            <li><span class=""font-bold"">A</span> Additional IV fluid 500 ml IV, if needed.</li>
                             <li class=""text-pink-600""><span class=""font-bold"">P</span> Additional IV fluid 20 ml/kg IV if needed.</li>
                        </ul>
                    </li>
                    <li class=""mt-2""><strong>Non-traumatic shock with Pulmonary Edema:</strong>
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Consider IV fluid 250 ml IV.</li>
                        </ul>
                    </li>
                    <li class=""mt-2""><strong>Exsanguinating Hemorrhage:</strong>
                         <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> IV fluid to maintain approximately 100 SBP or a radial pulse. Do not allow blood pressure to get too high.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> IV fluid 20 ml/kg IV. May repeat x 2. Titrate to maintain adequate perfusion.</li>
                        </ul>
                    </li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <p>For non-traumatic shock:</p>
                <ul>
                    <li><span class=""font-bold"">A</span> Treat arrhythmias as indicated.</li>
                    <li><span class=""font-bold"">A</span> If SBP remains less than 100, begin Norepinephrine by adding 4 mg to 250 ml of IV fluids. Infuse starting at 30 drops per minute (max 45 drops) with 60 drop tubing and titrate to effect. Increase by 5 drops/minute every 5 minutes.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,4017,Stroke,4000,"<div>
    <h3>4017.1 General Guidelines</h3>
    <ul>
        <li>If one or more signs of the Cincinnati Prehospital Stroke Scale (CPSS) are abnormal, and less than 24 hours since patient was last seen normal, call a ""Stroke Alert"", and transport to the closest appropriate Stroke Center.</li>
        <li>Providers should screen for large vessel occlusions (LVO) before making transport destination decisions.</li>
        <li>If greater than 24 hours since last known well, consider transport to a Comprehensive or Thrombectomy Capable facility.</li>
        <li>When reporting last known well, state actual clock time.</li>
        <li>Agencies may use alternative stroke screening scales (RACE, MEND, LAPSS, etc.) and make transport destination decisions based on their proximity to stroke management facilities with Medical Director approval.</li>
    </ul>

    <h3 class=""mt-6"">4017.2 Clinical Management</h3>
     <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Perform a Cincinnati Pre-hospital Stroke Scale (or alternative) assessment.</li>
                    <li>A patient in respiratory distress with pale, moist skin and altered mental status should get oxygen via NRB mask.</li>
                    <li>Be prepared to assist ventilations with OPA/NPA and Bag-valve-mask.</li>
                    <li>If signs of cerebral herniation are present, ventilate at: <span class=""font-bold"">A</span> Approx. 20 times/min, or <span class=""text-pink-600 font-bold"">P</span> 10 faster than normal rate. {If numeric EtCO₂ available, maintain ~30 mmHg}. Never ventilate at less than 8 per minute.</li>
                    <li>A patient with indications of stroke with a SpO₂ less than 94%, should be given oxygen via NC and titrated to 94%. If SpO₂ > 94%, they should not get oxygen.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>The presence of a single abnormal finding in the CPSS should dictate a stroke alert and transport to the closest stroke center (unless contraindicated).</li>
                    <li>Perform a Large Vessel Occlusion (LVO) screening looking for: Difficulty in balance or gait, Eye deviation, Visual disturbances, Aphasia, Denial/Neglect.</li>
                    <li>Consider the following contradictions to thrombolytics: Neurosurgery, head trauma or stroke in the last 3 months; Major surgery or serious non-head trauma in previous 14 days; History of GI/urinary tract hemorrhage within 21 days; Current (within 48 hours) use of anticoagulants.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                 <ul>
                    <li>Patients with onset greater than 24 hours, clinical findings indicative of LVO or with contraindications to thrombolytics consider transport to a Comprehensive Stroke Center or Thrombectomy Capable Facility.</li>
                    <li>Patients with signs or symptoms that strongly indication a possible hemorrhagic stroke should not be transported to a Thrombectomy Capable Facility.</li>
                    <li>Transport the patient with the bed flat, if able to tolerate. If showing signs of increased ICP, do not lay patient flat.</li>
                    <li>If glucose is less than 60, or there is strong suspicion of hypoglycemia despite glucometer readings, then follow 4008 Diabetic Emergencies - Hypoglycemia protocol.</li>
                 </ul>
            </div>
        </div>
     </div>

    <h3 class=""mt-6"">4017.3 Stroke Centers</h3>
    <ul>
        <li><strong>Telemedicine Stroke Center:</strong> Drip and ship, has thrombolytic capabilities and immediate access to a Neurologist via telemedicine.</li>
        <li><strong>Primary Stroke Center:</strong> Facility with capability to administer thrombolytics and has an ICU.</li>
        <li><strong>Comprehensive Stroke Centers or Thrombectomy Capable:</strong> Facilities with 24/7 endovascular capabilities.
            <ul class=""list-disc pl-5 mt-1"">
                <li>Miami Valley Hospital (Comprehensive)</li>
                <li>Kettering (Comprehensive)</li>
                <li>Mercy Health - Springfield (Thrombectomy Capable)</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,5001,Brief Resolved Unexplained Event ,5000,"<div>
    <h3>5001.1 General Guidelines</h3>
    <ul>
        <li>A Brief Resolved Unexplained Event (BRUE) involves any infant under 1 year of age reported by a bystander as sudden, brief (less than 1 minute), unexplained, and completely resolved upon EMS arrival that includes one or more of the following: Breathing change, Color change, Change in muscle tone, Altered level of responsiveness.</li>
        <li>Children who experience a BRUE event often have a normal exam on assessment. A cause will be difficult to determine in most BRUE cases.</li>
    </ul>

    <h3 class=""mt-6"">5001.2 Important Information to Gather</h3>
    <ul>
        <li>Document the symptoms of the event given by the observer: Was the child apneic, cyanotic, or limp? Infant’s color, respirations, and muscle tone. Was seizure-like activity noted? Was any resuscitation attempted? How long did the event last?</li>
        <li>Obtain past pertinent medical history: Recent trauma, infection, GERD, congenital heart disease, seizures, medication history, birth defects.</li>
    </ul>

    <h3 class=""mt-6"">5001.3 Clinical Management</h3>
    <ul>
        <li>Support airway, breathing, circulation. Keep warm.</li>
        <li>Head-to-Toe exam for trauma, bruising, or skin lesions.</li>
        <li>Check anterior fontanel: is it bulging, flat or sunken?</li>
        <li>Pupillary exam.</li>
        <li>Respiratory exam for rate, pattern, work of breathing and lung sounds.</li>
        <li>Cardiovascular exam symmetry of brachial and femoral pulses.</li>
        <li>Neuro exam for level of consciousness.</li>
        <li>Observe for repetition of reported occurrences.</li>
        <li>The patient should be transported to the hospital for further assessment.</li>
    </ul>
    
    <h3 class=""mt-6"">5001.4 Management and Transport of Febrile Pediatric Patients</h3>
    <p>Transport all infants less than 2 months of age with a history or reported temperature of greater than 38.0 C (100.4 F) or less than 35.6 C (96.0 F).</p>
</div>"
protocol,5002,Newborn Care and Resuscitation ,5000,"<div>
    <h3>5002.1 General Guidelines</h3>
    <ul>
        <li>Maintain airway. Place in the sniffing position (1” towel under shoulders).</li>
        <li>If drying and suctioning has not provided enough tactile stimulation, flick the infant’s feet or rub the infant’s back.</li>
        <li>Suction only infants in distress, until airway is clear of all secretions. Bulb suctioning is preferred.</li>
        <li>If meconium staining is present: If newborn is vigorous, monitor and maintain patent airway. If depressed with poor respiratory effort, decreased muscle tone, or HR < 100, clear the airway by suctioning before other resuscitative steps.</li>
        <li>Avoid direct application of cool oxygen to infant’s facial area.</li>
        <li>If stimulation does not improve breathing, then BVM assist may be necessary.</li>
    </ul>
    
    <h3 class=""mt-6"">5002.2 Viable Fetus</h3>
    <ul>
        <li>If the fetus is greater than 23 weeks gestation, follow normal resuscitative procedures.</li>
        <li>A fetus is viable if: Eyelids not fused, and if measurable or known, must be greater 500 grams.</li>
    </ul>

    <h3 class=""mt-6"">5002.3 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <ul>
                    <li>After delivery of the infant; Assess the airway and breathing.</li>
                    <li>Warm, dry and stimulate.</li>
                    <li>Position head lower than body.</li>
                    <li>Ventilate with BVM at 40-60/minute to increase HR (if less than 100) or for apnea or persistent central cyanosis.</li>
                    <li>If heart rate is less than 60 bpm begin CPR. Compress at 120/min. Compression to Ventilation ratio of 3:1.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                <p>Obtain APGAR scores at 1, 5 and 10 minutes post-delivery.</p>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> If hypovolemic, IV fluid 10 ml/kg over 5-10 minutes.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> NEWBORN: D10 (2 ml/kg) if blood glucose less than 40.</li>
                    <li>If heart rate remains less than 60 bpm after CPR:
                        <ul class=""list-disc pl-5 mt-1 text-pink-600"">
                           <li><span class=""font-bold"">P</span> Epinephrine 1:10,000, 0.01 mg/kg IV.</li>
                           <li><span class=""font-bold"">P</span> If no response, repeat Epinephrine 1:10,000, 0.01 mg/kg IV, every 3-5 minutes.</li>
                        </ul>
                    </li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,5003,Pediatric Assessment Triangle ,5000,"<div>
    <h3>5003.1 General Guidelines</h3>
    <ul>
        <li>The Pediatric Assessment Triangle establishes a level of severity, assists in determining urgency for life support measures, and identifies key physiological problems using observational & listening skills.</li>
        <li>This assessment tool can be utilized by providers of all certification levels.</li>
    </ul>

    <h3 class=""mt-6"">5003.2 Appearance</h3>
    <p>Appearance reflects adequacy of: oxygenation ventilation, brain perfusion, CNS function. The mnemonic used is TICLS:</p>
    <ul class=""list-disc pl-5"">
        <li><strong>T</strong>one - Moves spontaneously, sits or stands (age appropriate)</li>
        <li><strong>I</strong>nteraction - Alert, interacts with environment</li>
        <li><strong>C</strong>onsolability - Stops crying with comfort measures</li>
        <li><strong>L</strong>ook/gaze – Makes eye contact, tracks objects</li>
        <li><strong>S</strong>peech/cry – Uses age-appropriate speech or crying</li>
    </ul>

    <h3 class=""mt-6"">5003.3 Work of Breathing</h3>
    <ul>
        <li>WOB is a more accurate indicator of oxygenation and ventilation than respiratory rate or breath sounds.</li>
        <li>Assess for effort in breathing, accessory muscle use, and depth of breathing.</li>
        <li>Capillary refill is an accurate predictor of pediatric oxygenation.</li>
    </ul>

    <h3 class=""mt-6"">5003.4 Circulation</h3>
    <ul>
        <li>Circulation reflects adequacy of cardiac output and perfusion of vital organs.</li>
        <li>Cyanosis reflects decreased oxygen levels, vasoconstriction, and respiratory failure.</li>
        <li>Mottling of the skin indicates hypoxemia, vasoconstriction, and respiratory failure.</li>
    </ul>
    </div>"
protocol,5004,Safe Harbor ,5000,"<div>
    <h3>5004.1 General Guidelines</h3>
    <ul>
        <li>Safe Harbor is for the voluntary separation of newborn infant.</li>
        <li>It is designed to allow desperate parents to separate from their babies to hospitals, EMS, or law enforcement agencies, confidentially.</li>
    </ul>

    <h3 class=""mt-6"">5004.2 Clinical Management</h3>
    <ul>
        <li><strong>Stipulations of separation:</strong>
            <ul class=""list-roman pl-6 mt-1"">
                <li>Infant can be no older than be 30 days old.</li>
                <li>Infant can have no signs of abuse or neglect.</li>
            </ul>
        </li>
        <li class=""mt-2""><strong>History which should be obtained:</strong>
             <ul class=""list-roman pl-6 mt-1"">
                <li>Date and time of birth</li>
                <li>Any pertinent family medical history</li>
                <li>Information regarding prenatal care</li>
                <li>Information concerning the birth.</li>
            </ul>
        </li>
        <li class=""mt-2"">Information should be obtained in a manner, which will not lead to the revealing of the identity of the parents.</li>
        <li>Information collected should be based on patient (infant) care needs and assure confidentiality.</li>
        <li>Transport the infant to the hospital.</li>
    </ul>
</div>"
protocol,6001,General Management for Haz Mat ,6000,"<div>
    <h3>6001.1 General Guidelines</h3>
    <ul>
        <li>This section will provide the responders with direction toward the management and mitigation of Hazardous Material events.</li>
        <li>The initial goal of any hazardous materials release is to isolate and identify.</li>
    </ul>

    <h3 class=""mt-6"">6001.2 Initial Actions</h3>
    <ul>
        <li><strong>Personnel safety:</strong> Consider potential for secondary devices, Don appropriate PPE, Stage personnel & equipment.</li>
        <li>Call for additional resources (Haz Mat Teams, Decon crews, Law Enforcement, etc.).</li>
        <li><strong>Field decontamination:</strong> Remove all contaminated clothing, thoroughly wash the patient with {Dawn} dishwashing detergents, pay special attention to skin folds. If contaminated with fuel, irrigate well.</li>
        <li>Contact Medical Control and the hospital immediately. Provide: Estimated number of patients, signs and symptoms, name of contaminant if known, form of contaminant, and routes of exposure. Obtain permission from hospital before entering with a potentially contaminated patient or crew.</li>
        <li><span class=""font-bold text-blue-600"">&diams;</span> In the event of an MCI involving cyanide or nerve agents, request an “Antidote free” order, allowing you to treat all patients on the scene with the appropriate antidote, rather than calling for patient orders individually.</li>
        <li>Do not transport a patient until gross decontamination is completed.</li>
        <li>Decontaminate EMS vehicles prior to leaving hospital.</li>
    </ul>
</div>"
protocol,6002,Antidote Resources ,6000,"<div>
    <h3>6002.1 Antidote Options</h3>
    <ul>
        <li>{EMS Departments are authorized to stockpile Atropine, 2-PAM, auto-injectors, and antidote delivery supplies at their own expense}.</li>
        <li><strong>Dayton MMRS Caches:</strong> Stores additional supplies of cyanide antidotes in each county. To obtain, call 937-333-USAR (8727).</li>
        <li><strong>CHEMPACK Resources:</strong> Store of antidotes to treat about 500 victims of a nerve agent or organophosphate incident.
            <ul class=""list-disc pl-5 mt-2"">
                <li><strong>EMS CHEMPACK contents:</strong> Atropine, Pralidoxime Chloride (2-PAM), Midazolam or Diazepam (Valium).</li>
                <li><strong>Hospital CHEMPACK contents:</strong> Same drugs, more multi-dose vials.</li>
                <li><strong>Limitations:</strong> Only for nerve agents or organophosphates and when other resources are inadequate.</li>
                <li><strong>Procurement:</strong> <span class=""font-bold text-blue-600"">&diams;</span> Obtain MCP approval, then contact OSP Central Dispatch at 866-599-LERP (5377) and request a CHEMPACK. You must indicate the agent is identified (or patients show S/S) and the need exceeds available resources.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,6003,Hazardous Drug Exposure ,6000,"<div>
    <h3>6003.1 Identification or Recognition of a Hazardous Drug Situation</h3>
    <ul>
        <li>Hazardous drug situations include: Patients who have had IV chemotherapy within 48 hours, patients on oral chemo drugs, or patients with continuous IV chemo at home.</li>
        <li>Potential routes of exposure include: Absorption, accidental injection, inhalation, ingestion.</li>
        <li>Don PPE when handling leakage, disposing of drugs, handling body fluids of a patient who received hazardous drugs in the past 48 hours, or cleaning spills.</li>
    </ul>

    <h3 class=""mt-6"">6003.2 Guidelines for Personal Protective Equipment:</h3>
    <ul>
        <li><strong>Gloves:</strong> Two sets of nitrile gloves are recommended. Change gloves every 30 minutes.</li>
        <li>Disposable, non-permeable gowns.</li>
        <li>NIOSH-approved respirator masks.</li>
        <li><strong>Eye and face protection:</strong> Wear a face shield whenever there is a possibility of splashing.</li>
    </ul>
    
    <h3 class=""mt-6"">6003.3 Procedures:</h3>
    <ul>
        <li>Wipe up liquids with an absorbent pad or spill-control pillow.</li>
        <li>If necessary, consult with the appropriate Haz-Mat team.</li>
        <li>Dispose of hazardous drugs or contaminated materials per MSDS or Haz Mat Team direction.</li>
        <li>Report and document spills as required.</li>
        <li><strong>For accidental skin exposure:</strong> Remove contaminated garments and immediately wash contaminated skin with soap and water.</li>
        <li><strong>For accidental eye exposure:</strong> Immediately flush eye with saline solution or water for at least 30 minutes or until patient transport is completed.</li>
    </ul>
</div>"
protocol,6004,Hydrofluoric Acid Exposure ,6000,"<div>
    <h3>6004.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Ensure the safety of all responders.</li>
                    <li>Begin decontamination and irrigate the chemical burn with water as quickly as possible.</li>
                    <li>Flush affected eyes and skin with copious amounts of water or IV Fluids for a minimum of 30 minutes, or until transport is completed.</li>
                    <li>If ingested, do not induce vomiting. Dilute with water or milk.</li>
                    <li>Monitor for cardiac arrest.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-blue-200 text-blue-800"">EMT</div>
            <div>
                <p>{Perform a 12-lead EKG and transmit it to the hospital}.</p>
            </div>
            <div class=""skill-level-indicator bg-green-200 text-green-800"">AEMT</div>
            <div>
                 <ul>
                    <li>Intubate if apneic.</li>
                    <li>Consider 1014 Pain Management Protocol.</li>
                 </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li>When feasible, use {Epsom Salt solution} as an additional irrigating solution for affected skin. Not for eyes or mucous membranes. Do not delay water irrigation.</li>
                    <li>If ingested, in addition to water or milk, give {3-4 ounces of magnesium-containing antacid (i.e., Maalox or Mylanta)}.</li>
                    <li>Intubate if unconscious or at first sign of pulmonary edema or respiratory distress.</li>
                    <li>Perform a 12-lead EKG and monitor for prolonged QT interval.</li>
                    <li>Apply {magnesium-containing antacid (Maalox or Mylanta)} topically to burned areas. Omit if topical agents have already been applied.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> If patient with HF exposure experiences tetany or cardiac arrest, administer Calcium Chloride 10% 1 g (10 ml) 10%, IV. This should be considered a first line drug in cardiac arrest associated with Hydrofluoric Acid.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> If patient was exposed to high concentration HF (> 40%), discuss prophylactic Calcium Chloride 10% 400 mg (4 ml), slow IV with MCP.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,6005,Organophosphate Exposure ,6000,"<div>
    <h3>6005.1 Clinical Management</h3>
    <div class=""mt-4 border rounded-lg p-4 bg-gray-50"">
        <h4 class=""text-base font-bold"">Treatment Algorithm</h4>
        <div class=""skill-level-grid mt-2"">
            <div class=""skill-level-indicator bg-gray-200 text-gray-800"">EMR</div>
            <div>
                <ul>
                    <li>Administer oxygen.</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Administer Atropine by DouDote every 5 minutes, as available until the lungs are clear to auscultation. Can be given to adult and pediatric (>40 kgs) patients.</li>
                </ul>
            </div>
            <div class=""skill-level-indicator bg-yellow-200 text-yellow-800"">Paramedic</div>
            <div>
                <ul>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Treat seizures with Midazolam or Diazepam. <span class=""font-bold"">G</span> For patients > 69 y/o, reduce dosing to one half (½).</li>
                    <li><span class=""font-bold text-blue-600"">&diams;</span> Administer Atropine every 5 minutes (up to 3 doses), as available until lungs are clear.
                        <ul class=""list-disc pl-5 mt-1"">
                            <li><span class=""font-bold"">A</span> Adults and children > 40 kgs, give DuoDote, or Atropine 2 mg, IV, IM.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Children 20–40 kg, give 1.0 mg Atropine, or the 1.0 mg AtroPen auto-injector.</li>
                            <li class=""text-pink-600""><span class=""font-bold"">P</span> Children < 20 kg, give 0.5 mg Atropine, or the 0.5 mg AtroPen auto-injector.</li>
                        </ul>
                    </li>
                    <li class=""mt-2""><span class=""font-bold"">A</span> <span class=""font-bold text-blue-600"">&diams;</span> Follow Atropine with 2-PAM (Pralidoxime) 600 mg IM.</li>
                    <li class=""text-pink-600""><span class=""font-bold"">P</span> <span class=""font-bold text-blue-600"">&diams;</span> Infants and young children should recieve Pralidoxime, 25-50 mg/kg IV or IM, if available.</li>
                    <li>Treat seizures with Midazolam or Diazepam.</li>
                </ul>
            </div>
        </div>
    </div>
</div>"
protocol,6006,Other Hazardous Materials ,6000,"<div>
    <h3>6006.1 General Guidelines</h3>
    <ul>
        <li>These guidelines are for the management of specific materials.</li>
        <li>Unless otherwise noted, these orders apply to all certification levels.</li>
    </ul>

    <h3 class=""mt-6"">6006.2 Specific Materials</h3>
    <ul>
        <li><strong>Biological materials:</strong>
            <ul class=""list-disc pl-5 mt-1"">
                <li><span class=""font-bold text-blue-600"">&diams;</span> {For the possibility of a bioterrorist attack, agencies may store their own supply of Ciprofloxacin (Cipro) or Doxycycline.}</li>
                <li>They can also provide prophylaxis against Anthrax, Cholera, and some protection against Plague.</li>
            </ul>
        </li>
        <li class=""mt-2""><strong>Pepper Spray:</strong>
             <ul class=""list-disc pl-5 mt-1"">
                <li>{Sudecon Wipes} can assist in the decontamination of patients or public safety personnel who have been sprayed with Pepper Spray.</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,7001,Drug Bag Program: General Operating Guidelines ,7000,"<div>
    <h3>7001.1 Drug Bag Exchange Committee Make-up</h3>
    <ul>
        <li><strong>Co-Chairpersons:</strong> One Hospital EMS coordinator and One Hospital pharmacy representative or one Greater Miami Valley EMS Council member.</li>
        <li><strong>Members:</strong> EMS Coordinator and Pharmacy representative from each participating hospital, and any interested GMVEMSC member.</li>
        <li><strong>Meetings:</strong> One scheduled meeting per year, and unscheduled as needed.</li>
    </ul>

    <h3 class=""mt-6"">7001.2 General Operating Guidelines</h3>
    <ul>
        <li>Agencies must have the capability to communicate with Medical Control to participate.</li>
        <li>There are two types of drug bags: ALS/BLS (navy) and BLS only (red fanny-pack).</li>
        <li>All drug bags are property of the GMVEMSC and are only for use by EMS providers within the GMVEMSC’s region.</li>
        <li>Except in extreme circumstances, a drug bag should not be used on multiple runs.</li>
        <li>There are initiation and annual maintenance fees for each bag.</li>
        <li>Compartments are sealed with a blue plastic device by pharmacy. After use, the bag should be cleaned and re-sealed with the red plastic device found inside.</li>
        <li>Non-compliance may result in notification of agency leadership, governing agencies, and ultimately, removal from the program.</li>
    </ul>

    <h3 class=""mt-6"">7001.3 Participation Requirements</h3>
    <ul>
        <li>Active membership in the GMVEMS Council.</li>
        <li>Provide at least one functioning email contact for the GMVEMSC Listserve and Agency Contacts list.</li>
        <li>Submit the annual Attestation Form.</li>
        <li>Provide a copy of the agency's drug license to the Council by March 31 of each renewal year.</li>
        <li>Complete drug bag updates when scheduled.</li>
        <li>Signed agreement to abide by the Drug Bag Exchange Program Operating Guidelines.</li>
        <li>No participating department shall possess a DEA License.</li>
        <li>Complete the GMVEMSC annual skills and written test between March 1 and May 31.</li>
        <li>Maintain all drugs in a clean, temperature-controlled environment (59-86°F).</li>
        <li>Required equipment must be available to utilize the drug bags.</li>
        <li>Departments must have a system to track all drug bag exchanges.</li>
    </ul>
    
    <h3 class=""mt-6"">7001.5 Three Strike Policy</h3>
    <ul>
        <li>An agency may be issued a strike for failure to comply with participation requirements.</li>
        <li>The infraction will remain for a minimum of 1 year and will be reviewed for removal.</li>
        <li>An agency can appeal an infraction with proper documentation.</li>
        <li>If an agency reaches three strikes, they will be removed from the Drug Bag Program.</li>
    </ul>

    <h3 class=""mt-6"">7001.6 Levels of Participation</h3>
    <ul>
        <li><strong>Paramedic Level:</strong> Can access any compartment.</li>
        <li><strong>AEMT Level:</strong> Can access Airway, BLS, Intermediate, and Naloxone compartments. Cannot access the Center Inside Compartment.</li>
        <li><strong>EMT Level:</strong> Can only access the BLS Only fanny-pack, or the Airway, BLS, and Naloxone pouches of the ALS/BLS bag. Cannot access Intermediate and Center compartments.</li>
    </ul>
</div>"
protocol,7002,Drug Bag Program: Wasted Drug Procedure ,7000,"<div>
    <h3>7002.1 Guideline</h3>
    <ul>
        <li>Most hospitals require the GMVEMSC approved Controlled Drug Usage Form in addition to the run sheet.</li>
        <li>This form must be filled out for any controlled drug use, even without wastage.</li>
        <li>A completed run sheet must be provided to the hospital within 3 hours.</li>
    </ul>

    <h3 class=""mt-6"">7002.2 Procedure</h3>
    <ul>
        <li>Fentanyl, Ketamine, Morphine, Versed and Valium are controlled drugs.</li>
        <li>If a controlled medication from a GMVEMSC Drug Bag is partially administered, the unused portion must be accounted for.</li>
        <li>When wasting, providers will waste the drug directly into a secure sharps container in the ambulance. Wasting into hospital sharps containers is not permitted.</li>
        <li>Private organizations with different approved procedures may use them if they provide the policy in writing to GMVEMSC.</li>
        <li>To ensure accountability, all paramedics and AEMTs will document:
            <ul class=""list-disc pl-5 mt-1"">
                <li>The drug name</li>
                <li>The amount used</li>
                <li>The amount wasted (if none, list ""none"")</li>
                <li>The specific location of the waste (e.g., ""into sharps container"")</li>
                <li>The signature of a second witness if there is wastage (can be another crew member).</li>
            </ul>
        </li>
    </ul>
</div>"
protocol,7003,Drug Bag Program: Exchange Process ,7000,"<div>
    <h3>7003.1 Guideline</h3>
    <ul>
        <li>Each department is assigned a ""home"" hospital for initial fulfillment and wholesale exchanges.</li>
        <li>Drug bags can be exchanged at any participating hospital or within the same department.</li>
        <li>ALS/BLS bags are exchanged for ALS/BLS bags; BLS for BLS. It is not permissible to exchange bags between different Fire/EMS Agencies.</li>
        <li>The primary care provider is responsible for inventorying the drug bag before sealing it.</li>
        <li>EMS personnel must complete the Sign In and Out log for exchanges. Each agency must also track exchanges internally.</li>
        <li>The drug bag must be exchanged at the time of patient delivery, except for non-transports or transports to non-participating hospitals, in which case it must be exchanged within 8 hours.</li>
    </ul>

    <h3 class=""mt-6"">7003.2 Drug Bag Seals</h3>
    <ul>
        <li><strong>Blue Seals:</strong> Used by the pharmacy to seal restocked bags. They will have a hospital sticker identifying the hospital, pharmacist, and the next expiration date. EMS should verify the blue seal is intact before accepting a bag. When a compartment is opened, the blue seal must be retained and placed inside the compartment before resealing with a red tag.</li>
        <li><strong>Red Seals:</strong> Identify a used bag. EMS providers must inventory each opened pouch, clean it, and seal the used compartment with the red seal provided inside.</li>
    </ul>
</div>"
protocol,7004,Drug Bag Program: Drug Bag Discrepancies ,7000,"<div>
    <h3>7004.1 General Guidelines</h3>
    <ul>
        <li>EMS providers must inventory each opened pouch before applying the red seal.</li>
        <li>All discrepancies must be reported to GMVEMSC using the Drug Bag Discrepancy Report.</li>
        <li>If a discrepancy is found, notify an EMS Officer, retain the blue seal and sticker, log the bag in at the hospital, and inform the pharmacist or EMS Coordinator that a report is being initiated.</li>
    </ul>

    <h3 class=""mt-6"">7004.2 Discrepancies Involving Controlled Drugs or Potential Tampering</h3>
    <ul>
        <li>If an issue with a controlled drug, stolen bag, or tampering cannot be resolved, specific reporting is required.</li>
        <li>Notify your State of Ohio Board of Pharmacy agent immediately if theft is suspected.</li>
        <li>Notify the Drug Bag Exchange Committee Chairs immediately.</li>
        <li>File a report with law enforcement.</li>
        <li>Notify the DEA within 24 hours using DEA Form 106.</li>
        <li>Submit a completed GMVEMSC Drug Bag Discrepancy Report.</li>
    </ul>

    <h3 class=""mt-6"">7004.3 Discrepancies Not Involving Controlled Drugs or Potential Tampering</h3>
    <ul>
        <li>Examples include missing non-controlled drugs, wrong doses, expired meds, empty vials, unsealed pouches, etc.</li>
        <li>If discovered by EMS, the EMS Officer initiates the Discrepancy Form and provides copies to the Hospital EMS Coordinator and GMVEMSC.</li>
        <li>If discovered by the Hospital, the EMS Coordinator initiates the form and submits it to GMVEMSC, notifying the responsible agency.</li>
    </ul>
</div>"
protocol,7005,Drug Bag Program: Lost or Stolen Drug Bag Policy ,7000,"<div>
    <h3>7005.1 Purpose</h3>
    <p>To provide a uniform mechanism for the investigation and reporting of lost or stolen drug bags.</p>

    <h3 class=""mt-6"">7005.2 Notification</h3>
    <ul>
        <li>Upon discovery of a missing bag, agencies will notify the GMVEMSC Drug Bag Committee Chair(s).</li>
        <li>Initiate the Drug Bag Discrepancy Form and follow reporting instructions.</li>
        <li>The agency or the Committee Chair will notify the State of Ohio Board of Pharmacy (SOBP) at 614-466-4143.</li>
    </ul>

    <h3 class=""mt-6"">7005.3 Investigation</h3>
    <ul>
        <li>The EMS agency shall implement an internal search (check scene, last hospital, wrong vehicle).</li>
        <li>The GMVEMSC will assist by checking with all hospitals.</li>
        <li>The GMVEMSC will coordinate with the assigned hospital for a replacement bag after all paperwork is submitted. A replacement fee will be assessed.</li>
    </ul>
</div>"
protocol,7006,Drug Bag Program: Hospital Participation Policy ,7000,"<div>
    <h3>7006.1 Purpose</h3>
    <p>To assure uniformity of hospital pharmacy participation in the Drug Bag Exchange Program.</p>

    <h3 class=""mt-6"">7006.2 The Hospital Shall:</h3>
    <ul>
        <li>Purchase, fill, and maintain a sufficient supply of drug bags.</li>
        <li>Accept responsibility for filling new drug bags for assigned departments.</li>
        <li>Assign one licensed pharmacist and an EMS coordinator to participate in the committees.</li>
        <li>Agree to pay annual dues and any assessed fees related to the program.</li>
    </ul>

    <h3 class=""mt-6"">7006.3 The Greater Miami Valley EMS Council shall:</h3>
    <ul>
        <li>Maintain current State Drug Licenses for all participants.</li>
        <li>Furnish hospital pharmacy with a current listing of all authorized departmental personnel.</li>
        <li>Assign departments to hospitals in a geographic and equitable fashion.</li>
    </ul>
</div>"
protocol,7007,Drug Bag Program: New Member Agency Policy ,7000,"<div>
    <h3>7007.1 Purpose</h3>
    <p>To establish the procedures required for new agency members to receive a drug bag.</p>

    <h3 class=""mt-6"">7007.2 Procedure:</h3>
    <p>Agencies needing a drug bag for OMTB inspection may request one 24 hours prior. To receive a bag, the agency must:</p>
    <ul>
        <li>Have applied for GMVEMSC membership.</li>
        <li>Provide a copy of their State Pharmacy License.</li>
        <li>Have all agency personnel checked off on Standing Orders.</li>
        <li>Have the Medical Director submit a notarized letter to the State Pharmacy Board approving use of the protocols.</li>
        <li>Show proof of a temporary permit from the OMTB within 72 hours of inspection.</li>
    </ul>

    <h3 class=""mt-6"">7007.3 Agreement Letter</h3>
    <p>An agency must provide a signed agreement letter to the GMVEMSC to participate in the program.</p>
</div>"
protocol,7008,Drug Bag Program: GMVEMSC Drug Bag Discrepancy Report ,7000,"<div>
    <h3>7008.1 General Guideline</h3>
    <p>If an EMS provider encounters a discrepancy, they will notify their EMS Officer. If at a hospital, the bag should be logged in normally, and the pharmacist or EMS Coordinator should be advised that a Discrepancy Report is being filed. The blue seal and sticker should be retained. The form should be completed in triplicate with copies for the GMVEMS Council, the receiving pharmacy, and the reporting EMS agency.</p>
    
    <h4 class=""mt-4 font-bold"">GMVEMSC Drug Bag Discrepancy Report</h4>
    <div class=""mt-2 border p-4 rounded"">
        <p><strong>Date of report:</strong> _____________ <strong>Bag Number:</strong> _______ <strong>Date Discrepancy discovered:</strong> _____________</p>
        <p><strong>Discovered by:</strong> ________________________________ <strong>Hospital/EMS Dept making discovery:</strong> _____________________</p>
        <p><strong>Have blue Hospital seal?</strong> YES / NO (If yes - Attach seal to report)</p>
        <h5 class=""font-semibold mt-2"">Tracking:</h5>
        <p><strong>Date bag was logged out:</strong> __________ from (hospital)__________________ To (EMS agency)______________________</p>
        <p><strong>Date Bag turned in:</strong> __________ to (hospital)________________________</p>
        <h5 class=""font-semibold mt-2"">Description of the discrepancy:</h5>
        <p class=""border-b h-12"">____________________________________________________________________________________________________________</p>
        <h5 class=""font-semibold mt-2"">Describe efforts to resolve the discrepancy:</h5>
        <p class=""border-b h-12"">____________________________________________________________________________________________________________</p>
        <p><strong>Was the discrepancy satisfactorily resolved?</strong> ___________ <strong>If not, what steps are to be taken:</strong></p>
        <p class=""border-b h-12"">____________________________________________________________________________________________________________</p>
        <p><strong>Who will be responsible for any required reporting:</strong>___________________________________________</p>
    </div>
</div>"
protocol,7009,"Drug Bag Program: Report of Theft or Loss of Dangerous Drugs, Controlled Substances and Drug Documents ",7000,"<div>
    <h3>7009.1 OAC 4729-9-15</h3>
    <div class=""mt-2 pl-4 border-l-4 border-gray-300"">
        <p>(A) Each prescriber, terminal distributor, or wholesale distributor shall notify the following upon discovery of the theft or significant loss of any dangerous drug or controlled substance:</p>
        <ol class=""list-decimal pl-6"">
            <li>The state board of pharmacy, by telephone immediately upon discovery;</li>
            <li>If a controlled substance, the DEA pursuant to section 1301.76(b), Code of Federal Regulations;</li>
            <li>Law enforcement authorities pursuant to section 2921.22 of the Revised Code.</li>
        </ol>
        <p class=""mt-2"">(B) Controlled substance thefts must also be reported by using the Federal DEA Report form... A copy of the federal form...shall be filed with the State Board of Pharmacy within thirty days following the discovery of such theft or loss.</p>
        <p class=""mt-2"">(C) Each prescriber, terminal distributor, or wholesale distributor immediately upon discovery of any theft or loss of uncompleted prescription blanks, written prescriptions not yet dispensed, and original prescriptions that have been dispensed, shall notify the state board of pharmacy and law enforcement authorities.</p>
    </div>
</div>"
protocol,7010,Ambulance Restocking Policy ,7000,"<div>
    <h3>7010.1 History</h3>
    <ul>
        <li>In 1998, GDAHA received permission (Advisory Opinion No. 98.7) to exchange drugs and supplies with EMS agencies, avoiding violation of the anti-kickback statute.</li>
        <li>In December 2001, the Centers for Medicare and Medicaid Services issued an Ambulance Final Rule on Ambulance Restocking Safe Harbor.</li>
    </ul>

    <h3 class=""mt-6"">7010.2 EMS Supply Exchange Program:</h3>
    <ul>
        <li>EMS agencies must adhere to the agreement. For all transports to member hospitals, EMS agencies will provide copies of written records describing all medical supplies/medications used.</li>
        <li>Participating hospitals will restock ambulances at no charge with the supplies/medications used during the transport to that receiving hospital.</li>
        <li>Hospitals will not restock items used on patients delivered to another hospital.</li>
        <li>Hospitals will restock drug bags.</li>
        <li>Hospitals will not provide initial stock for new or returning ambulances.</li>
    </ul>
</div>"
protocol,7011,Diversion of Emergency Patients ,7000,"<div>
    <h3>7011.1 EMS and Dispatch Procedures:</h3>
    <ul>
        <li>When a hospital is on ""Diversion of Emergency Patients,"" EMS should transport to hospitals in normal status to avoid jeopardizing patient care.</li>
        <li>If a patient requests transport to a hospital on diversion, EMS must advise them that care may be jeopardized.</li>
    </ul>

    <h3 class=""mt-6"">7011.2 Monitoring Emergency Department Status</h3>
    <ul>
        <li>Dispatch centers should monitor Juvare EMResources for hospital status changes and notify EMS units.</li>
    </ul>
    
    <h3 class=""mt-6"">7011.3 Diversion Categories:</h3>
    <ul>
        <li><strong>CLOSED:</strong> The hospital cannot accept any emergency patients due to an internal disaster or other situation. EMS will not transport to a CLOSED facility.</li>
        <li><strong>DIVERSION OF CERTAIN TYPES OF PATIENTS:</strong>
            <ul class=""list-disc pl-5 mt-1"">
                <li><strong>Limited Divert/Operations:</strong> The facility has limited ability to handle some situations (e.g., CT scanner downtime, no ICU beds).</li>
                <li><strong>Divert/At Capacity:</strong> The facility is at capacity and has paused inbound EMS traffic.</li>
            </ul>
        </li>
    </ul>

    <h3 class=""mt-6"">7011.4 Hospital and Satellite ED Procedures:</h3>
    <ul>
        <li>Hospitals will update Juvare EMResources with their status daily and whenever the status changes.</li>
        <li>The diverting hospital must review and update its status hourly.</li>
    </ul>
</div>
"
protocol,7012,Hospital Capabilities Chart ,7000,"<div class=""mb-8"">
        <h3 class=""text-2xl font-bold mb-2"">7012 Hospital Capabilities Chart</h3>
        <p class=""text-sm italic mb-4"">Notes: Comprehensive stroke centers have 24/7 endovascular intervention. Primary stroke centers have CT and tPA capabilities. Telemedicine with tPA ready offers immediate Neurologist access.</p>
        <div class=""overflow-x-auto"">
            <table class=""min-w-full bg-white text-sm"">
                <thead class=""bg-gray-800 text-white"">
                    <tr>
                        <th class=""py-2 px-3 text-left"">HOSPITAL</th>
                        <th class=""py-2 px-3 text-center"">Trauma Center</th>
                        <th class=""py-2 px-3 text-center"">Burn Center</th>
                        <th class=""py-2 px-3 text-center"">24hr Interventional Cath</th>
                        <th class=""py-2 px-3 text-center"">Stroke Comprehensive</th>
                        <th class=""py-2 px-3 text-center"">L & D</th>
                    </tr>
                </thead>
                <tbody class=""text-gray-700"">
                    <tr class=""border-b"">
                        <td class=""py-2 px-3"">Atrium Medical Center</td><td class=""py-2 px-3 text-center"">Adult 3</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b bg-gray-50"">
                        <td class=""py-2 px-3"">Dayton Children’s Hospital</td><td class=""py-2 px-3 text-center"">Pedi 1</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                     <tr class=""border-b"">
                        <td class=""py-2 px-3"">Kettering Health Dayton</td><td class=""py-2 px-3 text-center"">Adult 3</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td>
                    </tr>
                    <tr class=""border-b bg-gray-50"">
                        <td class=""py-2 px-3"">Kettering Health Hamilton</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b"">
                        <td class=""py-2 px-3"">Kettering Health Main Campus</td><td class=""py-2 px-3 text-center"">Adult 2</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b bg-gray-50"">
                        <td class=""py-2 px-3"">Mercy Health – Springfield</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">(Thrombectomy Capable)</td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b"">
                        <td class=""py-2 px-3"">Miami Valley Hospital</td><td class=""py-2 px-3 text-center"">Adult 1</td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                     <tr class=""border-b bg-gray-50"">
                        <td class=""py-2 px-3"">Miami Valley Hospital South</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b"">
                        <td class=""py-2 px-3"">Soin Medical Center</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td>
                    </tr>
                    <tr class=""border-b bg-gray-50"">
                        <td class=""py-2 px-3"">Upper Valley Medical Center</td><td class=""py-2 px-3 text-center"">Adult 3</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center"">Y</td><td class=""py-2 px-3 text-center""></td><td class=""py-2 px-3 text-center""></td>
                    </tr>
                </tbody>
            </table>
        </div>
    </div>"
protocol,7013,Hospital Contact Information ,7000,"<div class=""mb-8"">
        <h3 class=""text-2xl font-bold mb-2"">7013 Hospital Contact Information</h3>
        <p class=""text-sm italic mb-4"">Hospitals in <strong>bold</strong> ask to be called for every patient.</p>
        <div class=""overflow-x-auto"">
            <table class=""min-w-full bg-white text-sm"">
                <thead class=""bg-gray-800 text-white"">
                    <tr>
                        <th class=""py-2 px-3 text-left"">HOSPITAL</th>
                        <th class=""py-2 px-3 text-left"">PHONE</th>
                        <th class=""py-2 px-3 text-left"">FAX</th>
                    </tr>
                </thead>
                <tbody class=""text-gray-700"">
                    <tr class=""border-b""><td class=""py-2 px-3""><strong>Atrium Medical Center, Middletown</strong></td><td class=""py-2 px-3"">513-424-3924</td><td class=""py-2 px-3"">513-420-5133</td></tr>
                    <tr class=""border-b bg-gray-50""><td class=""py-2 px-3"">Austin Boulevard Emergency Center</td><td class=""py-2 px-3"">937-865-9663</td><td class=""py-2 px-3"">937-641-2608</td></tr>
                    <tr class=""border-b""><td class=""py-2 px-3"">Dayton Children’s Hospital</td><td class=""py-2 px-3"">937-641-4444</td><td class=""py-2 px-3"">937-641-5301</td></tr>
                    <tr class=""border-b bg-gray-50""><td class=""py-2 px-3"">Kettering Health Dayton</td><td class=""py-2 px-3"">937-723-3419</td><td class=""py-2 px-3"">937-723-4609</td></tr>
                    <tr class=""border-b""><td class=""py-2 px-3""><strong>Kettering Health Main Campus</strong></td><td class=""py-2 px-3"">937-395-8080</td><td class=""py-2 px-3"">937-395-8347</td></tr>
                    <tr class=""border-b bg-gray-50""><td class=""py-2 px-3""><strong>Mercy Health – Springfield</strong></td><td class=""py-2 px-3"">937-523-1902</td><td class=""py-2 px-3"">937-523-1950</td></tr>
                    <tr class=""border-b""><td class=""py-2 px-3"">Miami Valley Hospital</td><td class=""py-2 px-3"">937-208-2440</td><td class=""py-2 px-3"">937-641-2608</td></tr>
                    <tr class=""border-b bg-gray-50""><td class=""py-2 px-3"">Soin Medical Center</td><td class=""py-2 px-3"">937-702-4525</td><td class=""py-2 px-3"">937-702-4509</td></tr>
                    <tr class=""border-b""><td class=""py-2 px-3""><strong>Upper Valley Medical Center</strong></td><td class=""py-2 px-3"">937-440-9444</td><td class=""py-2 px-3"">937-440-4346</td></tr>
                    <tr class=""border-b bg-gray-50""><td class=""py-2 px-3"">Regional Hospital Notification System</td><td class=""py-2 px-3"">937-333-8727</td><td class=""py-2 px-3""></td></tr>
                </tbody>
            </table>
        </div>
    </div>"
protocol,7014,Infectious Disease Exposure Policy ,7000,"<div>
        <h3 class=""text-2xl font-bold mb-2"">7014 Infectious Disease Exposure Reporting Policy</h3>
        
        <h4 class=""text-xl font-semibold mt-4"">7014.1 General Guidelines</h4>
        <p>This policy provides public safety personnel and hospitals with standard guidelines for defining, responding to, and following up on an infection control exposure incident involving an emergency response provider.</p>

        <h4 class=""text-xl font-semibold mt-6"">7014.2 Blood-borne Exposure</h4>
        <ul>
            <li><strong>Definition:</strong> A percutaneous injury (e.g., a needlestick or cut), or contact of mucous membrane or non-intact skin with blood, tissue, or other body fluids that are potentially infectious.</li>
            <li><strong>Post Exposure Procedure:</strong> Immediately irrigate the involved area. Report the exposure to the receiving hospital and a supervisor. The exposed employee must register as a patient at the same hospital as the source and complete the ""Request for Information by Emergency Care Workers (RIECW)"" form.</li>
            <li><strong>Testing The Source Patient:</strong> The hospital ED obtains patient consent and a blood specimen for HIV, HBV, and HCV testing. If the patient refuses consent, a hospital committee can authorize testing after a significant exposure.</li>
            <li><strong>Source Patient Results:</strong> HIV test results should be available within an hour. The exposed employee should remain in the ED until results are received. Written notification of positive results will be provided within 3 days.</li>
            <li><strong>Prophylaxis (PEP):</strong> Post-exposure prophylaxis may be offered based on a risk assessment. HIV PEP should be started as soon as possible. Hepatitis prophylaxis depends on the public safety worker's vaccine status. There is no prophylaxis for HCV.</li>
        </ul>

        <h4 class=""text-xl font-semibold mt-6"">7014.3 Respiratory Exposure</h4>
         <ul>
            <li><strong>Definition:</strong> Contamination via airborne infectious agents (e.g., tuberculosis) or droplet infectious agents (e.g., meningitis, influenza).</li>
            <li><strong>Immediate Actions:</strong> Don PPE. If secretions are splashed into mucous membranes, flush with copious amounts of IV fluids. Notify the department Infection Control Officer (ICO) and the ED charge nurse, and complete the Request for Notification of Test form.</li>
            <li><strong>Source Patient Results:</strong> The hospital ICO will notify the department ICO of the infectious agent as soon as possible.</li>
        </ul>

        <h4 class=""text-xl font-semibold mt-6"">7014.4 Blood or Body Fluid & Airborne Exposures by Coroner’s Cases</h4>
        <ul>
            <li><strong>Exposure during resuscitation:</strong> It is recommended that crews transport the patient to the hospital for source testing rather than following field termination procedures.</li>
            <li><strong>Actions of the ICO:</strong> The Coroner shall be notified as soon as possible that an exposure has occurred. A Request for Information form shall be forwarded to the Coroner's Office.</li>
            <li><strong>Testing the source patient:</strong> The Coroner shall make every effort to test a source patient by the next business day.</li>
        </ul>
    </div>
</div>"
medication,8001,Adenosine,," <h3>Packaging</h3>
      <ul>
        <li>6 mg (1 in drug bag) and 12 mg (2 in drug bag) prefilled syringes</li>
      </ul>
      <h3>Indications</h3>
      <ul>
        <li>Stable Paroxysmal Supraventricular Tachycardia (PSVT)</li>
      </ul>
      <h3>Adult Dosing</h3>
      <ul>
        <li>A 6 mg rapid IV as quickly as possible</li>
        <li>If not successful, may repeat 12 mg rapid IV.</li>
        <li>All doses of Adenosine are followed by 20 ml bolus of IV fluid.</li>
        <li>Go directly to 12 mg if patient with history of PSVT advises it takes 12 mg. May repeat once.</li>
      </ul>
      <h3>Pediatric Dosing</h3>
      <ul>
        <li>0.1 mg/kg rapid IV followed by 10 ml rapid saline flush. Max single dose 6 mg.</li>
        <li>If unsuccessful, 0.2 mg/kg rapid IV followed by 10 ml rapid saline flush. Max single dose 12 mg. May repeat x one.</li>
      </ul>
      <h3>Therapeutic Action</h3>
      <ul>
        <li>Decreases electrical conduction through the AV node without causing negative inotropic effects</li>
        <li>Acts directly on SA node to decrease chronotropic activity</li>
      </ul>
      <h3>Contraindications</h3>
      <ul>
        <li>Second or third degree AV block or sick sinus syndrome</li>
        <li>Hypersensitivity to Adenosine</li>
      </ul>
      <h3>Precautions And Side Effects</h3>
      <ul>
        <li>Lightheadedness, Paresthesia, Headache, Diaphoresis, Palpitations, Chest pain, Hypotension</li>
        <li>Shortness of breath, Transient periods of sinus bradycardia, sinus pause, or asystole</li>
        <li>Ventricular ectopy, Nausea, Metallic taste.</li>
        <li>May produce bronchoconstriction in patients with asthma and in patients with bronchopulmonary disease</li>
      </ul>
      <h3>Protocols</h3>
      <ul>
        <li>Cardiac Protocol 2011 - Tachycardia</li>
      </ul>"
medication,8002,Albuterol ,,"<h3>Packaging</h3>
      <ul>
        <li>2.5 mg in 3 ml plastic ampule (4 in drug bag)</li>
      </ul>
      <h3>Indications</h3>
      <h4>For the EMT, AEMT and Paramedic:</h4>
      <ul>
        <li>Exacerbation of Asthma, Emphysema, or COPD</li>
        <li>Bronchospasm in Asthma, COPD</li>
        <li>Allergic reaction with wheezing</li>
      </ul>
      <h4>For the Paramedic only:</h4>
      <ul>
        <li>Hyperkalemia in the presence of Crush Syndrome Trauma</li>
      </ul>
      <h3>Adult Dosing</h3>
      <ul>
        <li>2.5 mg (3 ml), nebulized with O2 at 8-10 LPM.</li>
        <li>Combine Ipratropium with first dose of Albuterol.</li>
        <li>May repeat Albuterol up to 2 times for a total of 3 doses</li>
        <li>Give all 4 doses for hyperkalemia</li>
        <li>In Crush syndrome: administer 10 mg nebulized</li>
      </ul>
      <h3>Pediatric Dosing</h3>
      <ul>
        <li>2.5 mg (3 ml), nebulized with O2 at 8-10 LPM.</li>
        <li>Combine Ipratropium with first dose of Albuterol.</li>
        <li>May repeat Albuterol up to 2 times for a total of 3 doses</li>
        <li>In Crush syndrome: administer 10 mg nebulized</li>
      </ul>
      <h3>Therapeutic Action</h3>
      <ul>
        <li>Bronchodilator</li>
      </ul>
      <h3>Contraindications</h3>
      <ul>
        <li>Prior hypersensitive reaction to Albuterol</li>
        <li>Cardiac dysrhythmias associated with tachycardia.</li>
      </ul>
      <h3>Precautions And Side Effects</h3>
      <ul>
        <li>Once initiated, the patient should be removed by EMS.</li>
        <li>Side Effects: Restlessness, Apprehension, Dizziness, Palpitations, Tachycardia, Dysrhythmias</li>
        <li>May precipitate angina pectoris</li>
      </ul>
       <h3>Protocols</h3>
      <ul>
        <li>General Protocol 1008-Advanced Airway Management</li>
        <li>Medical Protocol 4002 - Allergic Reaction/Anaphylaxis</li>
        <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
        <li>Trauma Protocol 3007 - Crush Syndrome Trauma (Paramedic only)</li>
      </ul>"
medication,8003,Amiodarone ,,"<h3>Packaging</h3>
      <ul>
        <li>150 mg in 3 ml vial, 50 mg/ml</li>
        <li>3 vials in drug bag</li>
      </ul>
      <h3>Indications</h3>
      <ul>
        <li>Ventricular Fibrillation or Pulseless Ventricular Tachycardia</li>
        <li>Stable Wide-Complex Tachycardia</li>
      </ul>
      <h3>Adult Dosing</h3>
      <h4>Ventricular Fibrillation or Pulseless Ventricular Tachycardia</h4>
      <ul>
        <li>300 mg IV or IO.</li>
        <li>May repeat with half the initial dose (150 mg IV or IO) no sooner than 10 minutes after first dose.</li>
        <li>If patient converts with ROSC from a ventricular arrhythmia and no anti-arrhythmic has been given: 150 mg in 250 ml NS, IV wide open over 10 minutes using 60 gtt/ml tubing & 18 g angiocath</li>
      </ul>
       <h4>Stable Wide-Complex Tachycardia:</h4>
      <ul>
        <li>150 mg in 250 ml NS, IV wide open over 10 minutes using 60 gtt/ml tubing & 18 g angiocath</li>
      </ul>
      <h3>Pediatric Dosing</h3>
       <h4>Ventricular Fibrillation or Pulseless Ventricular Tachycardia</h4>
      <ul>
        <li>5 mg/kg IV or IO (max first dose 300 mg).</li>
        <li>May repeat 5 mg/kg IV or IO no sooner than 10 minutes after first dose. Max repeat dose is 150 mg</li>
        <li>Not indicated for stable wide complex tachycardia</li>
      </ul>
      <h3>Therapeutic Action</h3>
      <ul>
        <li>Antidysrhythmic agent with multiple mechanisms of action</li>
      </ul>
      <h3>Contraindications</h3>
      <ul>
        <li>Pulmonary congestion</li>
        <li>Cardiogenic shock</li>
        <li>Hypotension (SBP less than 100)</li>
        <li>Sensitivity to Amiodarone</li>
      </ul>
      <h3>Precautions And Side Effects</h3>
      <ul>
        <li>Continuous EKG monitoring is required.</li>
        <li>Side Effects: Hypotension, Headache, Dizziness, Bradycardia, AV conduction abnormalities, Flushed skin, Abnormal salivation</li>
      </ul>
       <h3>Protocols</h3>
      <ul>
        <li>Cardiac Protocol 2005 - Cardiac Arrest: Ventricular Fib or Pulseless V-Tach</li>
        <li>Cardiac Protocol 2011-Tachycardia</li>
      </ul>"
medication,8004,Aspirin ,,"<h3>Packaging</h3>
        <ul>
            <li>81mg tablets in a blister pack (4 tablets total)</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Given as soon as possible to the patient with AMI.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>324 mg chewed (Four 81 mg tablets)</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Not applicable to pediatric patients</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Anti-platelet</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity to salicylates</li>
            <li>Active ulcer disease</li>
            <li>Bleeding disorders</li>
            <li>Third trimester pregnancy</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Suspected cardiac chest pain must be at least 25 years old.</li>
            <li>Patient must chew the tablets</li>
            <li>Side Effects: Stomach irritation, Heartburn or indigestion, Nausea or vomiting, Allergic reactions</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2008 - Suspected Cardiac Chest Pain</li>
            <li>Medical Protocol 4011-Obstetrical Emergencies</li>
        </ul>"
medication,8005,Atropine ,,"<h3>Packaging</h3>
        <ul>
            <li>1mg in 10 ml prefilled syringe; (3 in drug bag)</li>
            <li>In Haz Mat/WMD Security Bag: Duodote: 2 mg auto-injector (along with 2-Pam 600 mg autoinjector)</li>
            <li>In WMD Drug Caches and Chempacks: 2 mg, 1mg and 0.5 mg AtroPen auto-injectors; Multidose vial 8 mg in 20 ml, 0.4 mg/ml</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Symptomatic bradycardia</li>
            <li>Organophosphate or Nerve Agent poisoning (regardless of cardiac rate)</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Bradycardia: 1 mg IV up to 3 mg</li>
            <li>Organophosphate or Nerve Gas poisoning: EMR, EMT, AEMT, Paramedic: 2 mg Duodote auto-injector. Paramedic only: 2 mg IV, IO or IM. No max dose, given every 5 min or until lungs are clear to auscultation.</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Bradycardia: 0.02 mg/kg IV or IO every 5 min. Minimum single dose of 0.1 mg, max single dose 0.5 mg. Maximum total dose 1 mg</li>
            <li>Organophosphate or Nerve Gas poisoning: For EMR, EMT, AEMT or Paramedic: Less than 20 kgs: 0.5 mg AtroPen auto-injector; 20-40 kgs: 1.0 mg AtroPen auto-injector; Greater than 40 kgs: 2.0 mg AtroPen auto-injector. Paramedic only: May give atropine doses listed IV or IM. No max dose, given every 5 minutes or until lungs are clear to auscultation.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Anticholinergic</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None for severe organophosphate exposure.</li>
            <li>Tachycardia</li>
            <li>Hypersensitivity to atropine</li>
            <li>Obstructive disease of Gl tract</li>
            <li>Obstructive neuropathy</li>
            <li>Unstable cardiovascular status in acute hemorrhage with myocardial ischemia</li>
            <li>Narrow angle glaucoma</li>
            <li>Thyrotoxicosis</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>EMR, EMT and AEMT can only administer the Duodote auto-injector to Organophosphate or Nerve Agent patients</li>
            <li>Pupillary dilation rendering the pupils nonreactive. Pupil response may not be useful in monitoring CNS status.</li>
            <li>Side Effects: Dysrhythmias, tachycardia, palpitations, Paradoxical bradycardia when pushed too slowly or when used at doses less than 0.5 mg, Headache or dizziness, Anticholinergic effects (dryness, photophobia, blurred vision, urinary retention, constipation), Nausea and vomiting, Flushed, hot, dry skin, Allergic reactions.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2010-Bradycardia</li>
            <li>Special Operations Protocol 6002-Antidote Resources</li>
            <li>Special Operations Protocol 6005- Organophosphate or Nerve agent Exposure</li>
        </ul>"
medication,8006,Calcium Chloride ,,"<h3>Packaging</h3>
        <ul>
            <li>1 gram in 10 ml vial, 100 mg/ml (1 in drug bag)</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Renal dialysis patient in cardiac arrest or with bradycardia</li>
            <li>Calcium Channel Blocker OD</li>
            <li>Hydrofluoric Acid exposure with tetany or cardiac arrest. Tetany may present as: overactive neurological reflexes, spasms of the hands and feet, cramps, and laryngospasm.</li>
            <li>May be given prophylactically, after exposure to high concentration (> 40%) Hydrofluoric Acid</li>
            <li>Adults with Crush Syndrome presenting with abnormal ECG or hemodynamic instability</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>1 gm (10 ml) IV for: Cardiac arrest in renal dialysis patients, Calcium Channel Blocker OD, Hydrofluoric Acid exposure with tetany or cardiac arrest</li>
            <li>For prophylaxis in high concentration Hydrofluoric Acid exposure: 400 mg (4 ml) IV</li>
            <li>Renal dialysis patient with bradycardia: 1 gm (10 ml) IV</li>
            <li>Crush syndrome: 1 gm (10 ml) IV</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>20 mg/kg IV (max dose 500 mg) for: Cardiac arrest in renal dialysis patients, Calcium Channel Blocker OD</li>
            <li>Call in advance to treat crush syndrome or hydrofluoric acid exposures in pediatric patients</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Antagonizes cardiac toxicity in hyperkalemia associated with dialysis patients.</li>
            <li>Reverses symptoms of Calcium Channel Blocker</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Do not administer with Sodium Bicarbonate because if mixed, a precipitate develops. Flush tubing between drugs.</li>
            <li>Side Effects: Bradycardia (may cause asystole), Hypotension, Metallic taste, Severe local necrosis and sloughing following IV infiltration, May produce vasospasm in coronary and cerebral arteries, Hypertension and bradycardia may occur with rapid administration.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2004-Cardiac Arrest - Renal Failure/Dialysis</li>
            <li>Cardiac Protocol 2010-Bradycardia</li>
            <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
            <li>Medical Protocol 4012-Overdose or Poisoning</li>
            <li>Special Operations Protocol 6004 - Hydrofluoric Acid Exposure</li>
        </ul>"
medication,8007,Calcium Gluconate ,,"<h3>Packaging</h3>
    <ul>
      <li>1 gram in 10 ml vial, 100 mg/ml. Only in the drug bag in the event of Calcium Chloride 10% shortage</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Renal dialysis patient in cardiac arrest or with bradycardia</li>
      <li>Calcium Channel Blocker OD</li>
      <li>Hydrofluoric Acid exposure with tetany or cardiac arrest.</li>
      <li>Tetany may present as: overactive neurological reflexes, spasms of the hands and feet, cramps, and laryngospasm.</li>
      <li>May be given prophylactically, after exposure to high concentration (> 40%) Hydrofluoric Acid</li>
      <li>Adults with Crush Syndrome presenting with abnormal ECG or hemodynamic instability</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>1 gm (10 ml) IV for: Cardiac arrest in renal dialysis patients, Calcium Channel Blocker OD, Hydrofluoric Acid exposure with tetany or cardiac arrest</li>
      <li>For prophylaxis in high concentration Hydrofluoric Acid exposure: 400 mg (4 ml) IV</li>
      <li>Renal dialysis patient with bradycardia: 1 gm (10 ml) IV</li>
      <li>Crush syndrome: 1 gm (10 ml) IV</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>20 mg/kg IV (max dose 500 mg) for: Cardiac arrest in renal dialysis patients, Calcium Channel Blocker OD</li>
      <li>Call in advance to treat crush syndrome or hydrofluoric acid exposures in pediatric patients</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Antagonizes cardiac toxicity in hyperkalemia associated with dialysis patients.</li>
      <li>Reverses symptoms of Calcium Channel Blocker</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Do not administer with Sodium Bicarbonate because if mixed, a precipitate develops. Flush tubing between drugs.</li>
      <li>Side Effects: Bradycardia (may cause asystole), Hypotension, Metallic taste, Severe local necrosis and sloughing following IV infiltration, May produce vasospasm in coronary and cerebral arteries, Hypertension and bradycardia may occur with rapid administration.</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Cardiac Protocol 2004 - Cardiovascular Emergencies: Renal Failure/Dialysis</li>
      <li>Cardiac Protocol 2010-Bradycardia</li>
      <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
      <li>Medical Protocol 4012-Overdose or Poisoning</li>
      <li>Special Operations Protocol 6004 - Hydrofluoric Acid Exposure</li>
    </ul>"
medication,8008,Ciprofloxacin ,,"<h3>Packaging</h3>
        <ul>
            <li>Tablets</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>As prophylaxis against Anthrax, Cholera or Plague</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>500 mg tablet by mouth, twice a day</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Dosage will be specified at time of incident.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Antibiotic</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Allergy to quinolones</li>
            <li>Tendon pain or inflammation</li>
            <li>Pediatrics</li>
            <li>Pregnancy</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Side Effects: Atrial flutter, Hypotension, Premature Ventricular Contractions, QT prolongation, Torsade De Pointes, Tendon pain/inflammation</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Special Operations Protocol 6006-Other Hazardous Materials</li>
        </ul>"
medication,8009,Dextrose 10% ,,"<h3>Packaging</h3>
        <ul>
            <li>500 ml of D10W, contains 50 g Dextrose</li>
            <li>1 bag of solution in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Diabetic with mental status changes</li>
            <li>Evidence of hypoglycemia in cardiac arrest</li>
            <li>Generalized hypothermia with or without arrest</li>
            <li>Altered level of consciousness of unknown cause</li>
            <li>Seizures with BGL of less than 60 mg/dl</li>
            <li>No blood sugar monitor is available or suspicion of hypoglycemia despite glucometer readings.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>250 ml IV at wide open rate</li>
            <li>May repeat in 10 minutes if patient fails to respond or BGL remains less than 60 mg/dl.</li>
            <li>Maximum dose is 500 ml.</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Pediatric patients: 5 ml/kg, Maximum dose is 250 ml</li>
            <li>Newborn patients: 2 ml/kg if BGL is less than 40 mg/dl</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Principal form of carbohydrate utilized by the body</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Known or suspected CVA in the absence of hypoglycemia</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>May precipitate severe neurologic symptoms in thiamine deficient patients</li>
            <li>Side Effects: Warmth, Pain, Hyperglycemia, Burning from medication infusion, Thrombophlebitis</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 4008- Diabetic Emergencies - Hypoglycemia</li>
            <li>Pediatric Considerations 5002 - Newborn Care and Resuscitation</li>
        </ul>"
medication,8010,Dextrose 25% ,,"<h3>Packaging</h3>
    <ul>
      <li>10 ml prefilled syringe of Dextrose 25%, contains 2.5 g Dextrose</li>
      <li>1 in drug bag in the absence of Dextrose 10%</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Diabetic with mental status changes</li>
      <li>Evidence of hypoglycemia in cardiac arrest</li>
      <li>Generalized hypothermia with or without arrest</li>
      <li>Altered level of consciousness of unknown cause</li>
      <li>Seizures with BGL of less than 60 mg/dl</li>
      <li>No blood sugar monitor is available or suspicion of hypoglycemia despite glucometer readings.</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Not indicated in adult patients</li>
      <li>For pediatric patients greater than 25 kg, see 8011 Dextrose 50%</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Pediatric patients at or less than 25 kg: 2 ml/kg of Dextrose 25% (D25)</li>
      <li>Newborn patients: 2 ml/kg of Dextrose 25% (D25) diluted in equal volume of saline solution. Only administer if BGL is less than 40 mg/dl</li>
      <li>If no Dextrose 25% (D25) found in the drug bag, contact Medical Control for advice</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Principal form of carbohydrate utilized by the body</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>Known or suspected CVA in the absence of hypoglycemia</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>May precipitate severe neurologic symptoms in thiamine deficient patients</li>
      <li>Side Effects: Warmth, Pain, Hyperglycemia, Burning from medication infusion, Thrombophlebitis</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
        <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia</li>
        <li>Pediatric Considerations 5002 - Newborn Care and Resuscitation</li>
    </ul>"
medication,8011,Dextrose 50% ,,"<h3>Packaging</h3>
    <ul>
      <li>50 ml prefilled syringe of Dextrose 50%, contains 25 g Dextrose</li>
      <li>2 in drug bag in the absence of Dextrose 10%</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Diabetic with mental status changes</li>
      <li>Evidence of hypoglycemia in cardiac arrest</li>
      <li>Generalized hypothermia with or without arrest</li>
      <li>Altered level of consciousness of unknown cause</li>
      <li>Seizures with BGL of less than 60 mg/dl</li>
      <li>No blood sugar monitor is available or suspicion of hypoglycemia despite glucometer readings.</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>One 50 ml (25 gm) IVP</li>
      <li>May repeat in 10 minutes if patient fails to respond or BGL remains less than 60 mg/dl.</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Pediatric patients greater than 25 kg: 1 ml/kg of Dextrose 50% (D50)</li>
      <li>For pediatric patients at or less than 25 kg, see 8010 Dextrose 25% or 1 ml/kg of Dextrose 50% (D50) diluted in equal volume of IV solution (if no D25 present)</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Principal form of carbohydrate utilized by the body</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>Known or suspected CVA in the absence of hypoglycemia</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>May precipitate severe neurologic symptoms in thiamine deficient patients</li>
      <li>Side Effects: Warmth, Pain, Hyperglycemia, Burning from medication infusion, Thrombophlebitis</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
        <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia</li>
        <li>Pediatric Considerations 5002 - Newborn Care and Resuscitation</li>
    </ul>"
medication,8012,Diazepam ,,"<h3>Packaging</h3>
        <ul>
            <li>Vial for AEMT and Paramedic only: 10 mg in 2 ml vial (5 mg/1 ml). One vial present in the drug bag in the event of Midazolam shortage</li>
            <li>WMD Drug Cache & CHEMPACK resource for all certification levels: Convulsive Antidote, Nerve Agent (CANA) 10 mg carpuject</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Vial for AEMT and Paramedic only: Seizures, Chest pain associated with stimulant overdose (adults only)</li>
            <li>CANA carpujects for all certifications: Seizures associated with Organophosphate or Nerve Agent event</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Vial for AEMT and Paramedic only: Seizures: 5 mg slow IV; may repeat dose once. Cocaine or crack use: 5 mg slow IV, may repeat dose once.</li>
            <li>CANA carpujects for all certifications: 10 mg IM</li>
            <li>For patients 70y/o or older, reduce dosing for sedatives and analgesics to one half ( ) of the adult doses</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Vial for AEMT and Paramedic: Seizures: 0.2 mg/kg slow IV over 2 min. (maximum dose 5 mg IV) or 0.5 mg/kg rectally, (maximum dose 10 mg rectally). May repeat 0.2 mg/kg slow IV over 2 min (maximum 5 mg)</li>
            <li>CANA carpujects for all certifications: 10 mg IM by auto-injector</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Treats alcohol withdrawal and grand mal seizure activity</li>
            <li>Used to treat anxiety and stress.</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Side Effects: Hypotension, Reflex tachycardia (rare), Respiratory depression, Ataxia, Psychomotor impairment, Confusion, Nausea, May cause local venous irritation</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Trauma Protocol 3008 - Cyanide Poisoning</li>
            <li>Medical Protocol 4012-Overdose/Poisoning</li>
            <li>Special Operations Protocol 6002 - Antidote Resources</li>
            <li>Special Operations Protocol 6005- Organophosphate or Nerve Agent Exposure</li>
        </ul>"
medication,8013,Diphenhydramine ,,"<h3>Packaging</h3>
        <ul>
            <li>50 mg in 1ml vial</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Allergic reaction or Anaphylaxis</li>
            <li>In anaphylaxis, for the patient who goes into cardiac arrest if not previously given</li>
            <li>Extrapyramidal reaction</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>50 mg IM or slow IV</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>1 mg/kg (max dose 50 mg) IM or slow IV</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Prevents the physiologic actions of histamine by blocking histamine receptors</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use cautiously in patients with CNS depression or lower respiratory diseases such as asthma.</li>
            <li>Side Effects: Dose related drowsiness, Sedation, Disturbed coordination, Hypotension, Palpitations, tachycardia or bradycardia, Thickening of bronchial secretions, Dry mouth and throat</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 4002 - Allergic Reactions/Anaphylaxis</li>
            <li>Medical Protocol 4010 - Extrapyramidal (Dystonic) Reactions</li>
        </ul>"
medication,8014,Dopamine ,,"<h3>Packaging</h3>
    <ul>
      <li>Premixed 250 ml bag (400 mg/250 ml)</li>
      <li>Concentration: 1600 mcg/ml</li>
      <li>Only present in the drug bag in the event of Norepinephrine shortage</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Shock with or without Pulmonary Edema</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>IV drip rate, 5 to 20 mcg/kg/min of 400 mg/250 ml; increase by increments of 5 mcg/kg/min.</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>IV drip rate, 5 to 20 mcg/kg/min of 400 mg/250 ml; start at 5 mcg/kg/min.</li>
      <li>Titrate to maintain adequate perfusion</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Acts on alpha, beta and dopaminergic receptors in dose dependent fashion</li>
      <li>Increases cardiac output in higher doses</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Correct hypovolemia prior to using Dopamine.</li>
      <li>Infuse through large stable vein to avoid possibility of extravasation injury.</li>
      <li>Side Effects: Dose related tachydysrhythmias, Hypertension, Increased myocardial oxygen demand (ischemia)</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>As a replacement for Norepinephrine:</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
      <li>Medical Protocol 4015-Sepsis</li>
      <li>Medical Protocol 4016-Shock</li>
    </ul>"
medication,8015,Doxycycline ,,"<h3>Packaging</h3>
        <ul>
            <li>Tablets</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>As prophylaxis against Anthrax, Cholera or Plague</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>100 mg tablet by mouth, twice a day</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Dosage will be specified at time of incident</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Antibiotic</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Allergies to Tetracycline anibiotics</li>
            <li>Pregnancy</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>May make birth control pills less effective</li>
            <li>Use with caution in patients with liver disease, kidney disease and asthma</li>
            <li>Can cause headache, blurred vision and flu-like symptoms</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Special Operations Protocol 6006 Other Hazardous Materials</li>
        </ul>"
medication,8016,Duodote ,,"<h3>Packaging</h3>
        <ul>
            <li>Auto-injector Atropine 2 mg and Pralidoxime Chloride (2-Pam) 600 mg</li>
            <li>In WMD Drug Caches and CHEMPACKS</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Organophosphate or Nerve Agent poisoning</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Single auto-injector containing Atropine 2 mg and 2-Pam 600 mg</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Single auto-injector containing Atropine 2 mg and 2-Pam 600 mg</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Anticholinergic as a result of WMD MCI; also reactivates cholinesterase.</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use with caution in myasthenia gravis, renal impairment, pregnancy, lactation or children.</li>
            <li>Atropine causes pupillary dilation rendering the pupils nonreactive. Pupil response may not be useful in monitoring CNS status.</li>
            <li>Side Effects: Tachycardia, Paradoxical bradycardia when pushed too slowly or when used at doses less than 0.5 mg, Palpitations or dysrhythmias, Headache, Dizziness, Anticholinergic effects (dry mouth, nose, skin, photophobia. blurred vision, urinary retention, constipation), Nausea & vomiting, Flushed, hot, dry skin, Allergic reactions</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Special Operations Protocol 6005 - Organophosphate or Nerve Agent Exposure</li>
        </ul>"
medication,8017,Epinephrine Auto-Injector ,,"<h3>Packaging</h3>
        <ul>
            <li>EpiPen auto-injector: 0.3 mg (one in BLS Only small drug bag)</li>
            <li>EpiPen Jr. auto-injector: 0.15 mg (one in BLS Only small drug bag)</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For the EMR, EMT, AEMT and Paramedic: Anaphylaxis or allergic reaction</li>
            <li>The EMR and the EMT cannot treat Asthma with Epinephrine</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Asthma (AEMT and Paramedic) or Anaphylaxis (EMR, EMT, AEMT and Paramedic)</li>
            <li>If equal to or greater than 30 kg, give both Adult EpiPen 0.3 mg and EpiPen Jr 0.15 mg</li>
            <li>May repeat after 10 minutes</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Asthma (AEMT and Paramedic) or Anaphylaxis (EMR, EMT, AEMT and Paramedic)</li>
            <li>If less than 15 kg, EpiPen Jr 0.15 mg</li>
            <li>If equal to or greater than 15 kg and less than 30 kg, Adult EpiPen 0.3 mg</li>
            <li>If greater than 30 kg, give both Adult EpiPen 0.3 mg and EpiPen Jr 0.15 mg</li>
            <li>May repeat after 10 minutes</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Directly stimulates alpha and beta adrenergic receptors in dose-related fashion</li>
            <li>Causes bronchodilation, vasoconstriction, and increased cardiac output.</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>While the protocol lists those patients under 15 kg as pediatric, it is understood that patients equal to or greater than 30 kg will get both the Adult EpiPen and the EpiPen Jr., no matter what their age.</li>
            <li>Epinephrine dosing for Asthma, Allergies and Anaphylaxis is based on weight, not age</li>
            <li>Side Effects: Headache, Nausea, Restlessness, Weakness, Dysrhythmias, including ventricular tachycardia and ventricular fibrillation, Hypertension, Tachycardia, May increase myocardial oxygen demand or precipitation of angina pectoris, Syncope has occurred following epinephrine administration to asthmatic children.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 4002-Allergic Reactions/Anaphylaxis</li>
            <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
        </ul>"
medication,8018,"Epinephrine 1:1,000 ",," <h3>Packaging</h3>
    <ul>
      <li>1:1,000-1mg/ml ampule (One in BLS compartment)</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>For the EMT, AEMT and Paramedic: Anaphylaxis or allergic reaction</li>
      <li>For the AEMT and Paramedic: Asthma in severe distress</li>
      <li>The EMT cannot treat Asthma with Epinephrine</li>
      <li>{The EMT may only administer 1:1,000 IM after authorization and training from their medical director}</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Asthma (AEMT or Paramedic) or anaphylaxis (EMT, AEMT and Paramedic)</li>
      <li>If equal to or greater than 30 kg, Epinephrine (1:1,000) 0.5 mg IM</li>
      <li>May repeat in 10 minutes</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Asthma (AEMT and Paramedic) or Anaphylaxis (EMT, AEMT and Paramedic)</li>
      <li>If equal to or greater than 30 kg, Epi (1:1,000) 0.5 mg IM</li>
      <li>If equal to or greater than 15 kg and less than 30 kg, Epi (1:1,000) 0.3 mg IM</li>
      <li>If less than 15 kg, Epi (1:1,000) 0.15 mg IM</li>
      <li>May repeat Epi (1:1,000) (at weight appropriate dose) IM after 10 min.</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Directly stimulates alpha and beta adrenergic receptors in dose-related fashion</li>
      <li>Causes bronchodilation, vasoconstriction, and increased cardiac output.</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>While the protocol lists those patients under 15 kg as pediatric, it is understood that patients equal to or greater than 30 kg will get 0.5 mg IM., no matter what their age.</li>
      <li>Epinephrine dosing for Asthma, Allergies and Anaphylaxis is based on weight, not age.</li>
      <li>Side Effects: Headache, Nausea, Restlessness, Weakness, Dysrhythmias, including ventricular tachycardia and ventricular fibrillation, Hypertension, Tachycardia, May increase myocardial oxygen demand or precipitation of angina pectoris, Syncope has occurred following epinephrine administration to asthmatic children.</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Medical Protocol 4002-Allergic Reactions/Anaphylaxis</li>
      <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
    </ul>"
medication,8019,"Epinephrine 1:10,000 ",,"<h3>Packaging</h3>
    <ul>
      <li>1:10,000-1 mg/10ml prefilled syringes (six in drug bag)</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>For the Paramedic only:</li>
      <li>Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Asystole, and PEA in all patients</li>
      <li>Bradycardia in pediatric patients</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Asystole, and PEA (Paramedic)</li>
      <li>1 mg (1:10,000) IV, repeat every 3-5 minutes</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Ventricular Fibrillation, Pulseless Ventricular Tachycardia, Asystole, PEA, and Bradycardia</li>
      <li>0.01 mg/kg (1:10,000) IV; repeat every 3-5 minutes (max single dose 1 mg)</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Directly stimulates alpha and beta adrenergic receptors in dose-related fashion</li>
      <li>Causes bronchodilation, vasoconstriction, and increased cardiac output.</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Side Effects: Headache, Nausea, Restlessness, Weakness, Dysrhythmias, including ventricular tachycardia and ventricular fibrillation, Hypertension, Tachycardia, May increase myocardial oxygen demand or precipitation of angina pectoris, Syncope has occurred following epinephrine administration to asthmatic children.</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Cardiac Protocol 2003 - Cardiac Arrest: Asystole or PEA</li>
      <li>Cardiac Protocol 2005 - Cardiac Arrest: V-Fib or Pulseless V-Tach</li>
      <li>Cardiac Protocol 2010 - Bradycardia</li>
      <li>Pediatric Considerations 5002 - Newborn Care and Resuscitation</li>
      <li>Special Operations Protocol 6004-Hydrofluoric Acid Exposure</li>
    </ul>"
medication,8020,Etomidate,,"<h3>Packaging</h3>
        <ul>
            <li>40 mg in 20 ml vial (2 mg/ml)</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>To provide sedation prior to (Sedate-to-Intubate) or (Rapid Sequence Intubation) procedures</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>0.3 mg/kg IV</li>
            <li>May repeat within 2 minutes if patient resistant to intubation.</li>
            <li>Average dose is 15 mg -25 mg</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Not applicable to pediatric patients</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Short-acting, potent sedative</li>
            <li>Hypnotic</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Not to be administered to pediatric patients</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Must be authorized for use by the agencies' Medical Director</li>
            <li>Side Effects: Bradycardia, Respiratory depression or tachypnea, Sinus tachycardia, Hypotension, Nausea and vomiting</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1010- (Sedate to Intubate and Rapid Sequence Intubation)</li>
        </ul>"
medication,8021,Fentanyl ,,"<h3>Packaging</h3>
        <ul>
            <li>100 mcg/2 ml (50 mcg/ml) vial</li>
            <li>One in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Suspected Cardiac Chest Pain</li>
            <li>Pain associated with traumatic events</li>
            <li>Extremity Fractures</li>
            <li>Dislocations or Sprains</li>
            <li>Frostbite</li>
            <li>Abdominal Pain</li>
            <li>Hydrofluoric Acid (Hf) exposure</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>50-100 mcg slow IV, provided SBP is greater than 100.</li>
            <li>May repeat 50-100 mcg slow IV, after 5 minutes provided SBP greater than 100.</li>
            <li>If no IV, Fentanyl 50-100 mcg IN, SQ or IM</li>
            <li>May repeat Fentanyl 50-100 mcg IN, SQ or IM after 10 minutes</li>
            <li>Patient greater than 69 y/o, reduce dosing for sedatives and analgesics to one half ( ) of the adult dose</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Fentanyl is not to be administered to anyone less than 2 years of age.</li>
            <li>If unable to obtain a blood pressure, look for evidence adequate perfusion prior to administration.</li>
            <li>Contact MCP prior to treatment of abdominal pain</li>
            <li>First choice treatment for pain: 1 mcg/kg IN, max dose 100 mcg., provided age appropriate normal SBP ( (80+2x age in years). Repeat 1 mcg/kg IN after 10 minutes, if an additional drug bag is available.</li>
            <li>Second choice treatment for pain: 1 mcg/kg slow IV, max dose 100 mcg. Repeat 1 mcg/kg, slow IV after 5 minutes, max dose 100 mcg. Maintain age appropriate blood pressure</li>
            <li>If unable to obtain IV: SQ or IM for pediatric patients is a last resort: 1 .mcg/kg SQ or IM, max dose 100 mcg. Repeat 1 1 mcg/kg SQ or IM, max dose 100 mcg, no sooner than 10 minutes after first dose.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Provides analgesia</li>
            <li>Reduces cardiac preload by increasing venous capacitance and decreasing afterload</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Chest wall rigidity (""wooden chest syndrome"") may occur: Prevents adequate chest wall excursion and ventilation. Typically occurs with high doses ( (6-7 mcg/kg) or with rapid administration. Reversible with naloxone.</li>
            <li>Provide continuous cardiac monitoring, EtCO2 and pulse oximetry with sedated patients.</li>
            <li>Geriatric & debilitated patients require lower doses & are more prone to side effects.</li>
            <li>Apnea</li>
            <li>CNS depression</li>
            <li>Bradycardia which may be transient. Ensure adequate ventilation and oxygenation first. Atropine only if bradycardia is symptomatic and hemodynamically significant. For the Paramedic, follow bradycardia protocol.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1014-Pain Management</li>
            <li>Cardiac Protocol 2006-AICD Activations</li>
            <li>Cardiac Protocol 2008 - Suspected Cardiac Chest Pain</li>
            <li>Cardiac Protocol 2009-Cardiac Alert Program</li>
        </ul>"
medication,8022,Hydroxocobalamin ,,"<h3>Packaging</h3>
        <ul>
            <li>1 vial, containing 5 g lyophilized Hydroxocobalamin dark red crystalline powder for injection.</li>
            <li>After reconstitution with 200 ml fluid, the vial contains Hydroxocobalamin for injection, 25 mg/mL</li>
            <li>Available in caches located in each county in Homeland Security Region 3.</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Known or strongly suspected cyanide intoxication</li>
            <li>Smoke inhalation with suspected cyanide component.</li>
            <li>Victim exposed to fire or smoke who presents with altered mental status, seizures, shock, or difficulty breathing.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>To reconstitute follow package directions: Place the vial in an upright position. Add 200 mL of NS or LR to the vial using the transfer spike. Fill to the line. Mix: The vial should be inverted or rocked, not shaken, for at least 1 min. before infusion. Infuse Vial: Use vented intravenous tubing, hang and infuse over 15 minutes.</li>
            <li>5 gram vial via slow IV infusion over 15 minutes (Can be given IO as a last resort)</li>
            <li>May repeat 5 grams IV via slow IV infusion over 15 minutes to 2 hours depending on clinical response</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>70 mg/kg slow IV over 15 minutes; max dose of 5 grams (Can be given IO as a last resort)</li>
            <li>May repeat a dose of 35 mg/kg IV; max dose 2.5 g, depending on severity of poisoning and clinical response.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Binds to cyanide molecules and is eliminated as waste</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Must not be used in conjunction with other Cyanide antidotes</li>
            <li>May cause hypertension</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Trauma Protocol 3008 - Cyanide Poisoning & Antidotes</li>
        </ul>"
medication,8023,Ipratropium ,,"<h3>Packaging</h3>
        <ul>
            <li>0.5 mg in 2.5 ml plastic ampule</li>
            <li>1 in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Bronchospasm in Asthma, COPD, Emphysema</li>
            <li>Allergic reaction/Anaphylaxis with wheezing</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>0.5 mg (2.5 ml), nebulized with O2 at 8-10 LPM</li>
            <li>Combined with first dose of Albuterol</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>0.5 mg (2.5 ml), nebulized with O2 at 8-10 LPM</li>
            <li>Combined with first dose of Albuterol</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Causes bronchodilation by anticholinergic effect</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Once initiated, the patient should be removed by EMS.</li>
            <li>Use with caution in patients with narrow-angle glaucoma and lactating mothers.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 1008-Advanced Airway Management</li>
            <li>Medical Protocol 4002 - Allergic Reactions/Anaphylaxis</li>
            <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
        </ul>"
medication,8024,Ketamine ,,"<h3>Packaging</h3>
        <ul>
            <li>500 mg/10 mL vial (50 mg/ml)</li>
            <li>One in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For the AEMT and Paramedic: Chemical restraint for combative patient, including excited delirium; Pain control (should be considered a second line medication for the management of pain)</li>
            <li>For the Paramedic: (Sedate-to-Intubate) or (RSI); Conscious adult patient requiring pacing or cardioversion (preferred method)</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>For pain: 25 mg IV, may repeat 25 mg IV after 5 minutes. If unable to obtain IV: 25 mg IN or 50 mg IM, may repeat 25 mg IN or 50 mg IM after 10 minutes.</li>
            <li>For combative patients: 250 mg IM anterolateral thigh or 100 mg slow IV. If no change in 10 minutes for IM or 5 minutes for IV, repeat: 250 mg IM anterolateral thigh or 100 mg slow IV</li>
            <li>For the Paramedic performing Sedate to Intubate or (Rapid Sequence Intubation): 100 mg slow IV, may repeat 100 mg IV after 5 minutes</li>
            <li>Do not reduce geriatric dosing to half dose when attempting to achieve complete sedation</li>
            <li>For the Paramedic preparing the conscious adult patient for pacing or cardioversion: 25 mg IV</li>
            <li>Do not reduce geriatric dosing to half dose when sedating for pacing and cardioversion</li>
            <li>For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half ( ) of the adult doses (Exceptions: RSI or sedate-to-intubate), combative patients, pacing or cardioversion)</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Not to be administered for pain to any patient less than 16 y/o</li>
            <li>Emergency sedation for combative patient, including excited delirium: Limited to use in patients age 8 or greater. 1 mg/kg slow IV (max dose 100 mg) or 5 mg/kg IM (maximum dose is two doses of no more than 250 mg or 500 mg total). Call MCP for repeat doses</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Ketamine is a Schedule III Phencyclidine (PCP) derivative that is rapid acting and produces a ""dissociative"" anesthesia in which the patient's consciousness is detached from their nervous system.</li>
            <li>Due to its ""dissociative"" properties, Ketamine is a potent analgesic.</li>
            <li>May be given as an adjunct to narcotic pain medication, particularly in patients at risk for hypotension or respiratory depression.</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Suspected cardiac chest pain</li>
            <li>Hypertensive crisis</li>
            <li>When significant elevations in BP might prove harmful: Acute Myocardial Infarction, Angina Pectoris, Aortic dissection</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Emergence reaction may occur, when patient is awakening (hallucinations, delirium, confusion, etc.)</li>
            <li>Provide continuous cardiac monitoring, EtCO2 and pulse oximetry with sedated patients.</li>
            <li>Management should include use of a nasopharyngeal airway, proper positioning and persistent suctioning to maintain a clear airway.</li>
            <li>Geriatric & debilitated patients require lower doses & are more prone to side effects.</li>
            <li>Catecholamine release (hypertension, tachycardia)</li>
            <li>Hypersalivation (the ketamine drool)</li>
            <li>Nausea, vomiting, particularly prevalent in pediatrics.</li>
            <li>Minimal cardiac depression occasionally reported with high doses administered rapidly IV.</li>
            <li>May transiently increase heart rate and blood pressure by central sympathetic stimulation.</li>
            <li>May require administration of midazolam prior to wearing off.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1008-Advanced Airway Management</li>
            <li>General Protocol 1010- Sedate to Intubate and Rapid Sequence Intubation</li>
            <li>General Protocol 1014-Pain Management</li>
            <li>Cardiac Protocol 2010- Bradycardia</li>
            <li>Cardiac Protocol 2011-Tachycardia</li>
            <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
            <li>Medical Protocol 4005 - Behavioral Emergencies - Combative Patients/Emergency Sedation</li>
        </ul>"
medication,8025,Lactated Ringers ,,"<h3>Packaging</h3>
    <ul>
      <li>Usually a 1000 ml flexible, non-latex plastic bag</li>
      <li>Generally with a pH of 6.5.</li>
      <li>Not in drug bags or caches</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Solution for fluid and electrolyte replenishment</li>
      <li>Hypovolemia</li>
      <li>Shock</li>
      <li>Flushing of wounds</li>
      <li>Pulmonary edema with systolic BP over 100 mmHg</li>
      <li>Sepsis</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Non traumatic shock without pulmonary edema: 500 ml IV, may repeat up to two times if needed</li>
      <li>Non traumatic shock with pulmonary edema: 250 ml IV</li>
      <li>Sepsis: 1 L IV. Additional IV fluid if indicated</li>
      <li>Penetrating trauma to chest or abdomen: enough fluid to obtain a radial pulse</li>
      <li>If BGL reads over 400 mg/dL or ""High"" on glucometer, administer 500 ml fluid IV - wide open.</li>
      <li>Crush syndrome: Initial treatment: 1 L IV then 500 ml/hour IV. If hypotensive and the patient has been trapped more than 1 hour, then additional 1 L IV</li>
      <li>Heat exposure: 500 ml IV, may repeat one time. Additional IV fluid, if indicated</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>20 ml/kg IV bolus</li>
      <li>In heat exposures, may repeat 20/ml/kg IV bolus</li>
      <li>In shock, call for orders to administer additional fluid</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Used for hydration and management of hypotension</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1005-General Patient Management</li>
      <li>Cardiac Protocol 2005 - Cardiac Arrest; V-Fib or Pulseless V-Tach</li>
      <li>Cardiac Protocol 2008 - Suspected Cardiac Chest pain</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
      <li>Trauma Protocol 3001 - General Trauma Management</li>
      <li>Trauma Protocol 3004 - Trauma Arrest</li>
      <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
      <li>Trauma Protocol 3014-Heat Exposure</li>
      <li>Medical Protocol 4002-Allergic Reaction/Anaphylaxis</li>
      <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia/Hyperglycemia</li>
      <li>Medical Protocol 4015-Sepsis</li>
      <li>Medical Protocol 4016-Shock</li>
    </ul>"
medication,8026,Lidocaine 2% ,,"<h3>Packaging</h3>
        <ul>
            <li>100 mg in 5 ml syringe (20 mg/ml)</li>
            <li>Three in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For AEMT and Paramedic: For pain caused by pressure of intraosseous fluid administration</li>
            <li>For Paramedic: Intubation on conscious patient; JITSO - Cardiac arrest: V-Fib/Pulseless V-Tach and Tachycardia, in the absence of Amiodarone</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Pain associated with IO infusion (AEMT, Paramedic): 1.5 mg/kg IO (maximum dose 100 mg)</li>
            <li>Intubation on conscious patient (Paramedic): 100 mg (5 ml) nebulized with 8-10 LPM 02 or 100 mg (5 ml) IN with 50 mg (2.5 ml) in each nostril</li>
            <li>JITSO for Cardiac Arrest: V-Fib or Pulseless V-Tach (Paramedic): 150 mg (7.5 ml) IV or IO. Repeat dose of 75 mg (3.75 ml) IV or IO</li>
            <li>JITSO for Tachycardia (Paramedic): 150 mg (7.5 ml) IV or IO</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Pain associated with IO infusion (AEMT, Paramedic): 0.5 mg/kg IO (maximum dose 100 mg)</li>
            <li>Intubation on conscious patient (Paramedic): 1.5 mg/kg nebulized with 8-10 LPM O2 or IN (maximum dose 100 mg)</li>
            <li>JITSO for Cardiac Arrest: V-Fib or Pulseless V-Tach (Paramedic): 1 mg/kg IV or IO (maximum dose 100 mg). Repeat dose of 1 mg/kg IV or IO (maximum dose 75 mg)</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Decreases automaticity</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Second degree or third degree heart block, in absence of an artificial pacemaker</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use extreme caution in patients with hepatic disease, heart failure, marked hypoxia, severe respiratory depression, hypovolemia or shock, incomplete heart block or bradycardia and atrial fib.</li>
            <li>Side Effects: Altered level of consciousness, confusion or lightheadedness, Cardiovascular collapse and/or hypotension, Bradycardia, Blurred vision, irritability, Muscle twitching and seizures with high doses</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1008-Advanced Airway Management</li>
            <li>General Protocol 1012-Intraosseous Infusion</li>
            <li>Cardiac Protocol 2003-Cardiac Arrest: Asystole or PEA</li>
            <li>Cardiac Protocol 2005-Cardiac Arrest: V-Fib or Pulseless V-Tach</li>
            <li>Cardiac Protocol 2011-Tachycardia</li>
            <li>Medical Protocol 4002 - Allergic Reactions/Anaphylaxis</li>
            <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
        </ul>"
medication,8027,Lidocaine 2% Gel ,,"<h3>Packaging</h3>
    <ul>
      <li>2% gel in a tube</li>
      <li>Not carried in drug bag</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Lubrication of airway adjunct on conscious patient</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Apply to airway adjunct.</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Apply to airway adjunct.</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Suppresses stimulation of the upper airway activity such as, swallowing, gagging or coughing that can cause cardiovascular stimulation and elevation in intracranial pressure</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1008 - Advanced Airway Management</li>
    </ul>"
medication,8028,Magnesium Containing Antacid ,,"<h3>Packaging</h3>
    <ul>
      <li>Varies by manufacturer or vendor</li>
      <li>Not carried in drug bag</li>
      <li>Examples include Maalox and Mylanta</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Ingestion of Hydrofluoric Acid</li>
      <li>Hydrofluoric Acid on skin</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>For Ingestion: Following dilution with water or milk, have patient drink 3-4 oz. Maalox or Mylanta.</li>
      <li>For exposure: Following irrigation, apply topically to burned area unless topical agents is already applied</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Same application as for adult patients</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Neutralize acid and increases the pH</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting.</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Use with caution in: Neonates, Geriatric patients, Patients with renal impairment</li>
      <li>Side Effects: Hypercalcemia, Hypermagnesemia, Hypotension, Nausea & vomiting</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Special Operations Protocol 6004-Hydrofluoric Acid Exposure</li>
    </ul>"
medication,8029,Magnesium Sulfate ,,"<h3>Packaging</h3>
        <ul>
            <li>4 grams pre-mixed in 100 ml IV bag (40 mg/ml)</li>
            <li>May be a 4 gm vial and a 100 ml NaCl IV bag depending on availability</li>
            <li>One in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Polymorphic ventricular tachycardia (torsades de pointes) in adult patient (with or without a pulse)</li>
            <li>Seizing pregnant patient with gestation greater than 20 weeks</li>
            <li>Seizing patient with less than 6 weeks postpartum</li>
            <li>Asthmatic bronchoconstriction, refractory to Duo-Neb, and Epinephrine and Solu-Medrol</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Polymorphic ventricular tachycardia: 2 gm (1/2 IV bag) infused with macro-drip tubing over 10 min.*</li>
            <li>Seizing pregnant/postpartum: 4 gm (whole bag) with macro-drip tubing over 20 min.*</li>
            <li>Asthma: 2 gm (1/2 IV bag) infused with macro-drip tubing over 10 min.*</li>
            <li>*when using either 10 gtt/ml or 15 gtt/ml tubing, a drip rate of 1 gtt/second will deliver 2 gm in 10 min. or 4 gm in 20 min. (approximately)</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Seizing pregnant/postpartum: 4 gm (whole bag) with macro-drip tubing over 20 min.*</li>
            <li>*when using either 10 gtt/ml or 15 gtt/ml tubing, a drip rate of 1 gtt/second will deliver 2 gm in 10 min. or 4 gm in 20 min. (approximately)</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>CNS depressant</li>
            <li>Blocks peripheral neuromuscular transmission</li>
            <li>Slows rate of sino-atrial node impulse formation in myocardium and prolongs conduction time</li>
            <li>Bronchial smooth muscle relaxation</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Any heart block, except for 1st degree block</li>
            <li>Administer with caution if SBP less than 90 mmHg</li>
            <li>Acute myocardial infarction (AMI)</li>
            <li>Abdominal pain</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Any patient receiving intravenous Magnesium Sulfate should have continuous cardiac monitoring and frequent monitoring of vital signs.</li>
            <li>Can cause respiratory depression</li>
            <li>Hypotension, bradycardia and conduction disturbances may occur if given rapidly</li>
            <li>Toxicity is associated with CNS and neuromuscular depression</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2005-Cardiac Arrest: V-Fib or Pulseless V-Tach</li>
            <li>Cardiac Protocol 2011 - Tachycardia</li>
            <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
            <li>Medical Protocol 4014-Seizures</li>
        </ul>"
medication,8030,Methylprednisolone ,,"<h3>Packaging</h3>
    <ul>
      <li>125 mg in 2 ml</li>
      <li>One in drug bag</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Severe allergic reactions</li>
      <li>Anaphylaxis</li>
      <li>Asthma</li>
      <li>COPD</li>
      <li>Emphysema</li>
      <li>Intended to augment standard therapy for anaphylaxis, allergic reaction, and to address airway edema and inflammation in asthma.</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Solu-Medrol 125 mg IV</li>
      <li>Given to patients in the Allergic reaction or Anaphylaxis protocol only after all other applicable first-line medications have been delivered.</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Solu-Medrol 2 mg/kg IV, max dose 125 mg</li>
      <li>Given to patients in the Allergic reaction or Anaphylaxis protocol only after all other applicable first-line medications have been delivered.</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Potent anti-inflammatory steroid</li>
      <li>Accelerates detoxification of cyanide</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Intended for cases that are of a more urgent nature.</li>
      <li>No significant change in patient condition in the field should be expected after administration.</li>
      <li>Do not to initiate an IV only to administer this medication.</li>
      <li>Side Effects: Cardiac arrhythmias, Syncope</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Medical Protocol 4002 - Allergic Reactions/Anaphylaxis</li>
      <li>Medical Protocol 4003 - Asthma/Emphysema/COPD</li>
    </ul>"
medication,8031,Midazolam ,,"<h3>Packaging</h3>
        <ul>
            <li>10 mg in 2 ml vial, (5 mg/ml)</li>
            <li>Two in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For the AEMT and Paramedic: Seizures, As chemical restraint for combative patient, Chest pain associated with stimulant overdose (adults only)</li>
            <li>For the Paramedic: Conscious patient requiring cardioversion, Conscious patient requiring pacing, (Sedate-to-Intubate) or (RSI) in normotensive patients, After intubation, if patient is resisting and SBP is normal for age.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>If seizures, chemical restraint, or chest pain in stimulant overdose (AEMT, Paramedic): 10 mg IN (5 mg in each nostril) or 2.5 mg slow IV or 5 mg IM. Repeat 5 mg IN (after 10 min.) or 2.5 mg slow IV (after 5 min.) or 5 mg IM (after 10 min.)</li>
            <li>If conscious patients requiring cardioversion/pacing or patient resisting ETT (Paramedic): 2.5 mg slow IV</li>
            <li>In (Sedate-to-intubate) or (RSI), 5 mg slow IV (in patients who are normotensive), may repeat up to 10 mg IV (Paramedic)</li>
            <li>For patients greater than 69 y/o reduce dosing for sedatives and analgesics to one half (12) of the adult doses (Exceptions: RSI or sedate-to-intubate), combative patients, pacing or cardioversion)</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>If seizures, or chemical restraint for combative patients (AEMT, Paramedic): 0.2 mg/kg IN (maximum dose 10 mg) or 0.1 mg/kg slow IV (maximum dose 2.5 mg) or 0.2 mg/kg IM (maximum dose 5 mg). In seizures, repeat same doses (maximum IN 5mg, maximum IV 2.5 mg, maximum IM 5 mg). In chemical restraint, call MCP for repeat doses</li>
            <li>If conscious patients requiring cardioversion/pacing or patient resisting ETT (Paramedic): 0.1 mg/lcg slow IV (maximum dose 2.5 mg)</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Provides sedation</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Respiratory distress</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use with caution with lactating mothers.</li>
            <li>Geriatric & debilitated patients require lower doses & are more prone to side effects.</li>
            <li>Can cause respiratory depression</li>
            <li>Monitor respirations and ventilate if necessary.</li>
            <li>The Paramedic should intubate as indicated, the AEMT should intubate if apneic.</li>
            <li>Provide continuous cardiac monitoring, EtCO2 and pulse oximetry with sedated patients.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1008 - Advanced Airway Management</li>
            <li>General Protocol 1010- Sedate to Intubate and Rapid Sequence Intubation</li>
            <li>Cardiac Protocol 2006 - AICD Activations</li>
            <li>Cardiac Protocol 2010- Bradycardia</li>
            <li>Cardiac Protocol 2011-Tachycardia</li>
            <li>Medical Protocol 4005 - Behavioral Emergencies - Combative Patients/Emergency Sedation</li>
            <li>Medical Protocol 4012 - Overdose/Poisoning</li>
            <li>Medical Protocol 4014-Seizures</li>
            <li>Special Operations Protocol - 6002 - Antidote Resources</li>
            <li>Special Operations Protocol 6005 - Organophosphate or Nerve Agent Exposure</li>
        </ul>"
medication,8032,Morphine ,,"<h3>Packaging</h3>
    <ul>
      <li>5 mg in 1ml vial</li>
      <li>Two in drug bag in the absence of fentanyl</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Pain relief in suspected cardiac chest pain, trauma emergencies, extremity fractures, dislocations, sprains, frostbite, abdominal pain, Hydrofluoric Acid (HF) exposure</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Up to 5 mg slow IV based on patient's weight, provided SBP greater than 100.</li>
      <li>May repeat up to 5 mg slow IV after 5 minutes</li>
      <li>If unable to establish IV, Morphine 5 mg IM, may repeat after 10 minutes.</li>
      <li>For patients greater than 69 y/o, reduce dosing for sedatives and analgesics to one half (1/2) of the adult doses</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Pain relief in pediatric patients greater than 2 years old:</li>
      <li>0.1 mg/kg slow IV (maximum dose 5 mg) provided appropriate SBP.</li>
      <li>May repeat 0.1 mg/kg, (maximum dose 5 mg) after 5 minutes</li>
      <li>If unable to establish IV, 0.1 mg/kg IM (maximum dose 5 mg)</li>
      <li>May repeat IM dose after 10 minutes</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Provides analgesia, reduces cardiac preload by increasing venous capacitance and decreasing afterload</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>Hypersensitivity to narcotics</li>
      <li>Hypotension</li>
      <li>Head injury, increased intracranial pressure</li>
      <li>Severe respiratory depression</li>
      <li>Patients who have taken MAO inhibitors within 14 days</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Use with caution in the elderly, those with asthma, and in those susceptible to CNS depression.</li>
      <li>Provide continuous cardiac monitoring, EtCO2 and pulse oximetry with sedated patients.</li>
      <li>Geriatric & debilitated patients require lower doses & are more prone to side effects.</li>
      <li>Side Effects: Hypotension, Tachycardia, or bradycardia, May worsen bradycardia or heart block in inferior MI (vagotonic effect), Palpitations, Syncope, Euphoria, Facial flushing, Respiratory depression, Bronchospasm, Dry mouth, Allergic reaction</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1014-Pain Management</li>
      <li>Cardiac Protocol 2006 - AICD Activations</li>
      <li>Cardiac Protocol 2008 - Suspected Cardiac Chest Pain</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
    </ul>"
medication,8033,Naloxone ,,"<h3>Packaging</h3>
        <ul>
            <li>2 mg in 2 ml vial (1 mg/ml)</li>
            <li>Four in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>High index of suspicion of narcotic overdose</li>
            <li>Respiratory depression</li>
            <li>Suspicion of drug abuse in cardiac arrest</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>(EMR or EMT): Up to 4 mg IN (half dose per nostril)</li>
            <li>(AEMT or Paramedic): Up to 4 mg IN (half dose per nostril) or 2 mg IV. If no IV, up to 4 mg IM</li>
            <li>Titrate dosing to adequate respirations, repeat as needed</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>(EMR, EMT): If 20 kg or less, then 0.1 mg/kg IN (maximum dose 2 mg) (half dose per nostril). If greater than 20 kg, then 2 mg IN, may repeat as needed</li>
            <li>(AEMT or Paramedic): If 20 kg or less, then 0.1 mg/kg IN (half dose per nostril), IV or IM (maximum dose 2 mg). If greater than 20 kg, then 2 mg IN (half dose per nostril). If using IN route and respirations don't improve after 2 mins., establish and administer via IV. Titrate dosing to adequate respirations, repeat as needed.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>A competitive narcotic antagonist</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Newborn patients</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Any intranasal administration should be given at a half dose in each nostril</li>
            <li>Onset of action is two minutes, if no response two minutes after dosing, then give additional doses</li>
            <li>For the AEMT or Paramedic: if the patient has a pulse, Naloxone should be given before intubation.</li>
            <li>After administration, patient transport by EMS is encouraged, even if patient becomes responsive.</li>
            <li>Use with caution in narcotic-dependent patients who may experience withdrawal syndrome (including neonates of narcotic-dependent mothers).</li>
            <li>Caution should be exercised when administering to narcotic addicts (may precipitate withdrawal symptoms)</li>
            <li>Side Effects: Tachycardia, Hypertension, Dysrhythmias, Diaphoresis, Blurred vision, Nausea and vomiting, May not reverse hypotension</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>General Protocol 1005- General Patient Management</li>
            <li>General Protocol 1012-Intraosseous Infusion</li>
            <li>Medical Protocol 4012-Overdose/Poisoning</li>
        </ul>"
medication,8034,Nitroglycerine ,,"<h3>Packaging</h3>
        <ul>
            <li>Dark brown glass bottle, 0.4 mg SL tablets</li>
            <li>One bottle in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For the EMT, AEMT and Paramedic: Cardiac related chest pain</li>
            <li>For the AEMT and Paramedic: Pulmonary edema with systolic BP over 100 mmHg, Stimulant overdose with chest pain</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>0.4 mg SL every 5 min for continued chest pain up to a total of 3 tablets</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Not indicated in pediatric patients</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Vasodilator which decreased preload and to a lesser extent, afterload</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Hypotension</li>
            <li>Use of sexual enhancement drugs (Viagra, Cialis, Levitra) in last 24 hours</li>
            <li>Taking Revatio (a pulmonary hypertension medication)</li>
            <li>Head injury</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use only on patients who are greater than 25 years old or have been prescribed Nitroglycerin</li>
            <li>Side Effects: Transient headache, Reflex tachycardia, Hypotension, Diaphoresis, Postural syncope, Nausea & vomiting</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2008 - Suspected Cardiac Chest Pain</li>
            <li>Medical Protocol 4012-Overdose/Poisoning</li>
            <li>Medical Protocol 4013-Respiratory Distress/Pulmonary Edema</li>
        </ul>"
medication,8035,Norepinephrine ,,"<h3>Packaging</h3>
        <ul>
            <li>4 mg in 4ml (1mg/ml) vial for dilution in 250 ml of IV fluids</li>
            <li>One in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For blood pressure control in acute hypotensive states in the non-trauma patient.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Add 4 mg to 250 ml of IV fluids.</li>
            <li>Infuse starting at 30 drops per minute (max 45 drops) with 60 drop tubing and titrate to effect.</li>
            <li>Increase by 5 drops every 5 minutes.</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Contact MCP for dosing and administration guidance.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Peripheral vasoconstrictor.</li>
            <li>Positive inotrope (increases cardiac contractility) and chronotrope (increases heart rate).</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Should not be given to patients who are hypotensive from acute hemorrhage.</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Do not use the solution if its color is pinkish or darker than slightly yellow or if it contains particles.</li>
            <li>Protect the vial from light</li>
            <li>This drug must be diluted before administration.</li>
            <li>Administer in free-flowing IV and watch for infiltration.</li>
            <li>Avoid hypertension.</li>
            <li>If extravasation occurs, stop the infusion immediately as necrosis may occur.</li>
            <li>Leave the catheter in place so that a reversal agent can be given through the infiltrated catheter.</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
            <li>Medical Protocol 4015-Sepsis</li>
            <li>Medical Protocol 4016-Shock</li>
        </ul>"
medication,8036,Normal Saline ,,"<h3>Packaging</h3>
    <ul>
      <li>Usually a 1000 ml flexible, non-latex plastic bag</li>
      <li>Not in drug bags or caches</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Solution for fluid and electrolyte replenishment</li>
      <li>Hypovolemia</li>
      <li>Shock</li>
      <li>Flushing of wounds</li>
      <li>Pulmonary edema with systolic BP over 100 mmHg</li>
      <li>Sepsis</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Non traumatic shock without pulmonary edema: 500 ml IV, may repeat up to two times if needed</li>
      <li>Non traumatic shock with pulmonary edema: 250 ml IV</li>
      <li>Sepsis: 1 L IV, Additional IV fluid if indicated</li>
      <li>Penetrating trauma to chest or abdomen: enough fluid to obtain a radial pulse</li>
      <li>If BGL reads over 400 mg/dL or ""High"" on glucometer, administer 500 ml fluid IV - wide open.</li>
      <li>Crush syndrome: Initial treatment: 1 L IV then 500 ml/hour IV. If hypotensive and the patient has been trapped more than 1 hour, then additional 1 L IV</li>
      <li>Heat exposure: 500 ml IV, may repeat one time. Additional IV fluid, if indicated</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>20 ml/kg IV bolus</li>
      <li>In heat exposures, may repeat 20/ml/kg IV bolus</li>
      <li>In shock, call for orders to administer additional fluid</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Used for hydration and management of hypotension</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1005-General Patient Management</li>
      <li>Cardiac Protocol 2005 - Cardiac Arrest; V-Fib or Pulseless V-Tach</li>
      <li>Cardiac Protocol 2008 - Suspected Cardiac Chest pain</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
      <li>Trauma Protocol 3001 - General Trauma Management</li>
      <li>Trauma Protocol 3004 - Trauma Arrest</li>
      <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
      <li>Trauma Protocol 3014-Heat Exposure</li>
      <li>Medical Protocol 4002-Allergic Reaction/Anaphylaxis</li>
      <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia/Hyperglycemia</li>
      <li>Medical Protocol 4015-Sepsis</li>
      <li>Medical Protocol 4016-Shock</li>
    </ul>"
medication,8037,Normasol-R ,,"<h3>Packaging</h3>
    <ul>
      <li>Usually a 1000 ml flexible, non-latex plastic bag</li>
      <li>Not in drug bags or caches</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Solution for fluid and electrolyte replenishment</li>
      <li>Hypovolemia</li>
      <li>Shock</li>
      <li>Flushing of wounds</li>
      <li>Pulmonary edema with systolic BP over 100 mmHg</li>
      <li>Sepsis</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Non traumatic shock without pulmonary edema: 500 ml IV, may repeat up to two times if needed</li>
      <li>Non traumatic shock with pulmonary edema: 250 ml IV</li>
      <li>Sepsis: 1 L IV, Additional IV fluid if indicated</li>
      <li>Penetrating trauma to chest or abdomen: enough fluid to obtain a radial pulse</li>
      <li>If BGL reads over 400 mg/dL or ""High"" on glucometer, administer 500 ml fluid IV - wide open.</li>
      <li>Crush syndrome: Initial treatment: 1 L IV then 500 ml/hour IV. If hypotensive and the patient has been trapped more than 1 hour, then additional 1 L IV</li>
      <li>Heat exposure: 500 ml IV, may repeat one time. Additional IV fluid, if indicated</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>20 ml/kg IV bolus</li>
      <li>In heat exposures, may repeat 20/ml/kg IV bolus</li>
      <li>In shock, call for orders to administer additional fluid</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Used for hydration and management of hypotension</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1005-General Patient Management</li>
      <li>Cardiac Protocol 2005 - Cardiac Arrest; V-Fib or Pulseless V-Tach</li>
      <li>Cardiac Protocol 2008 - Suspected Cardiac Chest pain</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
      <li>Trauma Protocol 3001 - General Trauma Management</li>
      <li>Trauma Protocol 3004 - Trauma Arrest</li>
      <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
      <li>Trauma Protocol 3014-Heat Exposure</li>
      <li>Medical Protocol 4002-Allergic Reaction/Anaphylaxis</li>
      <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia/Hyperglycemia</li>
      <li>Medical Protocol 4015-Sepsis</li>
      <li>Medical Protocol 4016-Shock</li>
    </ul>"
medication,8038,Ondansetron ,,"<h3>Packaging</h3>
        <ul>
            <li>4 mg in 2 ml vial, (2 mg/ml) - 1 vial in drug bag</li>
            <li>4 mg tablet - 1 tablet in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>For nausea or active vomiting</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>For the AEMT and Paramedic: 4 mg tablet PO</li>
            <li>For the Paramedic: 4 mg slow IV, preferred route for active vomiting as patient may need hydration. If no IV, may use 4 mg tablet PO. Consider administering 4 mg (2 ml) of the IV form by discharging into the patient's mouth.</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>For the AEMT and the Paramedic: 4 mg tablet PO if patient 12 y/o or older and weight is 40 kg or more. Transport time should be considered prior to administration.</li>
            <li>For the Paramedic: 0.1 mg/kg IV (max 4 mg) if patient 12 y/o or older and weight is 40 kg or more.</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Stimulation of 5-HT 3 receptors causes transmission of sensory signals to the vomiting center via vagal afferent fibers to induce vomiting.</li>
            <li>By binding to 5-HT 3 receptors, Ondansetron blocks vomiting mediated by serotonin release.</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Known hypersensitivity to Ondansetron</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>During pregnancy it should only be used where clearly needed.</li>
            <li>Ondansetron (Zofran) is NOT to be given prophylactically with Naloxone.</li>
            <li>Side effects: Constipation or diarrhea, Fever, Headache, Sudden blindness of 2-3 minutes duration. (the speed of delivery may contribute to the blindness)</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 4001-Abdominal Pain</li>
        </ul>"
medication,8039,Oral Glucose ,,"<h3>Packaging</h3>
        <ul>
            <li>Tube; concentration varies, check label</li>
            <li>Not carried in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Hypoglycemia</li>
            <li>Generalized hypothermia without arrest</li>
            <li>Altered level of consciousness of unknown cause</li>
            <li>Seizures with BGL of less than 60 mg/dl, no BGL monitor; or suspicion of hypoglycemia despite BGL reading</li>
            <li>For the AEMT and Paramedic, no IV access</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>1 tube</li>
            <li>May be repeated in 10 minutes if BGL remains less than 50 mg/dl</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>1 tube</li>
            <li>May be repeated in 10 minutes if BGL remains less than 60 mg/dl</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Raise blood glucose concentration</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Inability to control the airway</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Use caution when giving to unresponsive patients.</li>
            <li>Hyperglycemia</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Medical Protocol 4008- Diabetic Emergencies - Hypoglycemia</li>
        </ul>"
medication,8040,Plasmalyte-A ,,"<h3>Packaging</h3>
    <ul>
      <li>Usually a 1000 ml flexible, non-latex plastic bag</li>
      <li>Generally with a pH of 7.4.</li>
      <li>Not in drug bags or caches</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Solution for fluid and electrolyte replenishment</li>
      <li>Hypovolemia</li>
      <li>Shock</li>
      <li>Flushing of wounds</li>
      <li>Pulmonary edema with systolic BP over 100 mmHg</li>
      <li>Sepsis</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>Non traumatic shock without pulmonary edema: 500 ml IV, may repeat up to two times if needed</li>
      <li>Non traumatic shock with pulmonary edema: 250 ml IV</li>
      <li>Sepsis: 1 L IV, Additional IV fluid if indicated</li>
      <li>Penetrating trauma to chest or abdomen: enough fluid to obtain a radial pulse</li>
      <li>If BGL reads over 400 mg/dL or ""High"" on glucometer, administer 500 ml fluid IV - wide open.</li>
      <li>Crush syndrome: Initial treatment: 1 L IV then 500 ml/hour IV. If hypotensive and the patient has been trapped more than 1 hour, then additional 1 L IV</li>
      <li>Heat exposure: 500 ml IV, may repeat one time. Additional IV fluid, if indicated</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>20 ml/kg IV bolus</li>
      <li>In heat exposures, may repeat 20/ml/kg IV bolus</li>
      <li>In shock, call for orders to administer additional fluid</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Used for hydration and management of hypotension</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the emergency setting</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>General Protocol 1005-General Patient Management</li>
      <li>Cardiac Protocol 2005 - Cardiac Arrest; V-Fib or Pulseless V-Tach</li>
      <li>Cardiac Protocol 2008 - Suspected Cardiac Chest pain</li>
      <li>Cardiac Protocol 2009 - Cardiac Alert Program</li>
      <li>Trauma Protocol 3001 - General Trauma Management</li>
      <li>Trauma Protocol 3004 - Trauma Arrest</li>
      <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
      <li>Trauma Protocol 3014-Heat Exposure</li>
      <li>Medical Protocol 4002-Allergic Reaction/Anaphylaxis</li>
      <li>Medical Protocol 4008 - Diabetic Emergencies - Hypoglycemia/Hyperglycemia</li>
      <li>Medical Protocol 4015-Sepsis</li>
      <li>Medical Protocol 4016-Shock</li>
    </ul>"
medication,8041,Pralidoxime ,,"<h3>Packaging</h3>
    <ul>
      <li>600 mg auto-injector</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>To be used following Atropine in organophosphate, or nerve agent poisoning.</li>
      <li>Both for treatment of civilian patients at the scene, as well as for protection of public safety personnel who walk into scene & become unexpectedly contaminated.</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>600 mg IM auto-injector</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Patients greater than 20 kg: 600 mg IM auto-injector</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Reactivates cholinesterase after poisoning with anticholinesterase agents, (Organophosphate or Nerve Gas)</li>
      <li>Reverses muscle paralysis after organophosphate poisoning</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>Hypersensitivity</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Use with caution in myasthenia gravis, renal impairment, pregnancy, children</li>
      <li>Can spread to child through breast feeding</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Special Operations Protocol 6002-Antidote Resources</li>
      <li>Special Operations Protocol 6005- Organophosphate or Nerve Agent Exposure</li>
    </ul>"
medication,8042,Sodium Bicarbonate ,,"<h3>Packaging</h3>
        <ul>
            <li>50 mEq in 50 ml syringe (1 mEq/ml)</li>
            <li>Two in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Not for routine arrests. Studies indicate no proven efficacy.</li>
            <li>Renal dialysis patient in asystole or PEA cardiac arrest</li>
            <li>Excited delirium patients that go into cardiac arrest</li>
            <li>Known tricyclic overdose</li>
            <li>Crush Syndrome</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>Cardiac Arrest: In renal dialysis patient: 100 mEq IV. Consider for the excited delirium patient who goes into arrest: 100 mEq IV</li>
            <li>Tricyclic Antidepressant OD: 100 mEq IV. May repeat dose of 50 mEq IV for persistent or prolonged QRS</li>
            <li>Crush Syndrome: 100 mEq IV</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>Cardiac Arrest: In renal dialysis patient: 1 mEq/kg IV</li>
            <li>Tricyclic Antidepressant OD: 1 mEq/kg IV. May repeat dose of 0.5 mEq/kg IV for persistent or prolonged QRS</li>
            <li>Crush Syndrome: 1 mEq/kg IV</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Buffers metabolic acidosis</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>None in the emergency setting</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Metabolic alkalosis</li>
            <li>Hypoxia</li>
            <li>Rise in intracellular PCO2 and increased tissue acidosis</li>
            <li>Electrolyte imbalance (hypernatremia)</li>
            <li>Seizures</li>
            <li>Tissue sloughing at injection site</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Cardiac Protocol 2004 - Cardiac Arrest - Renal Failure/Dialysis</li>
            <li>Cardiac Protocol 2010 - Bradycardia</li>
            <li>Trauma Protocol 3007 - Crush Syndrome Trauma</li>
            <li>Medical Protocol 4005 - Behavioral Emergencies - Combative Patients/Emergency Sedation</li>
            <li>Medical Protocol 4012 - Overdose/Poisoning</li>
        </ul>"
medication,8043,Sodium Nitrite ,,"<h3>Packaging</h3>
    <ul>
      <li>300 mg in 10 ml vial (30 mg/ml)</li>
      <li>Available in caches located in each county in Homeland Security Region 3.</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Patients with known or suspected cyanide poisoning</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>300 mg (10 ml) 3% solution slow IV</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Not indicated in pediatric patients</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Oxidizes hemoglobin which then combines with cyanide to form an inactive compound</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>Nitrite/nitrate allergy</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Methemoglobinemia if given in excessive amounts</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Trauma Protocol 3008 - Cyanide Poisoning & Antidotes</li>
    </ul>"
medication,8044,Sodium Thiosulfate ,,"<h3>Packaging</h3>
    <ul>
      <li>12.5 gm in 50 ml vial (250 mg/ml)</li>
      <li>Available in caches located in each county in Homeland Security Region 3.</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Conscious patient with known or suspected cyanide poisoning</li>
      <li>Smoke inhalation with suspected cyanide component</li>
      <li>Cardiac arrest from known or suspected cyanide poisoning or smoke inhalation</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>12.5 gm (50 ml) 25% solution slow IV</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Greater than 25 kg: 12.5 gm (50 ml) 25% solution slow IV</li>
      <li>Less than 25 kg: 412.5 mg/kg (1.65 ml/kg) of 25% solution (max dose 12.5 g (50 ml))</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Accelerates detoxification of cyanide</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>Possible hypotension</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Trauma Protocol 3008 - Cyanide Poisoning & Antidotes</li>
    </ul>"
medication,8045,Tetracaine ,,"<h3>Packaging</h3>
        <ul>
            <li>0.5%/ml eye drop bottle (10 ml)</li>
            <li>One in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Prior to eye irrigation in cases of chemical injury to the eye and in other situations with significant eye pain without possibility of penetrating trauma to eye.</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>2 drops in each affected eye</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>2 drops in each affected eye</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>Provides rapid, brief, superficial anesthesia by inhibiting conduction of nerve impulses from sensory nerves</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity to Tetracaine</li>
            <li>Open injury to eye</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>May cause burning or stinging sensation or irritation</li>
            <li>Can cause epithelial damage and systemic toxicity</li>
            <li>Incompatible with mercury or silver salts often found in ophthalmic products</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Trauma Protocol 3011 - Eye Injuries</li>
        </ul>"
medication,8046,Tranexamic Acid (TXA) ,,"<h3>Packaging</h3>
        <ul>
            <li>1 gram in 10 ml vial (100 mg/ml)</li>
            <li>Two in drug bag</li>
        </ul>
        <h3>Indications</h3>
        <ul>
            <li>Known or suspected hemorrhage secondary to trauma</li>
            <li>Time since injury is known to be less than 3 hours</li>
            <li>Uncontrolled post-partum hemorrhage</li>
        </ul>
        <h3>Adult Dosing</h3>
        <ul>
            <li>2 gm IV/IO over 1-2 minutes</li>
        </ul>
        <h3>Pediatric Dosing</h3>
        <ul>
            <li>In pediatric patients with uncontrolled bleeding from a recent tonsillectomy, TXA nebulized: Less than 25 kg: 250 mg, nebulized with 3 ml normal saline, O2 flowing at 8-10 LPM. 25 kg or greater: 500 mg, nebulized with 3 ml normal saline, O2 flowing at 8-10 LPM</li>
        </ul>
        <h3>Therapeutic Action</h3>
        <ul>
            <li>An anti-fibrinolytic and the synthetic equivalent of the amino acid lysine</li>
            <li>Inhibits both plasminogen activation and plasmin activity</li>
            <li>Prevents clot breakdown and reduces hemorrhage</li>
        </ul>
        <h3>Contraindications</h3>
        <ul>
            <li>Hypersensitivity</li>
            <li>Pediatric patients, unless treating uncontrolled bleeding from a recent tonsillectomy</li>
            <li>Time elapsed from initial injury is greater than 3 hours or otherwise unknown</li>
            <li>Known or suspected pregnancy of greater than 20 weeks</li>
            <li>Gastrointestinal bleeding</li>
        </ul>
        <h3>Precautions And Side Effects</h3>
        <ul>
            <li>Do not delay transport for administration of Tranexamic Acid (TXA)</li>
            <li>It is important to accurately note the time of administration</li>
            <li>Gastrointestinal disturbances may occur</li>
            <li>Monitor patient for hypotension usually found in rapid infusions</li>
            <li>Side effects: Nausea, Vomiting, Visual disturbances, Seizure</li>
        </ul>
        <h3>Protocols</h3>
        <ul>
            <li>Trauma Protocol 3015 Hemorrhage Control</li>
            <li>Medical Protocol 4006 - Childbirth with Complications</li>
        </ul>"
medication,8047,Vasopressin ,,"<h3>Packaging</h3>
    <ul>
      <li>20 units in 1 ml vial, 20 units/ml</li>
      <li>Usually 2 vials (20 ml) present</li>
      <li>Not routinely present in the drug bag</li>
    </ul>
    <h3>Indications</h3>
    <ul>
      <li>Adult patients in cardiac arrest</li>
    </ul>
    <h3>Adult Dosing</h3>
    <ul>
      <li>40 units IV</li>
      <li>Once IV is established, Vasopressin is permitted after either first or second dose of Epinephrine.</li>
    </ul>
    <h3>Pediatric Dosing</h3>
    <ul>
      <li>Not indicated in pediatric patients</li>
    </ul>
    <h3>Therapeutic Action</h3>
    <ul>
      <li>Potent peripheral vasoconstrictor.</li>
      <li>May be used as an alternative pressor to Epinephrine in the treatment of adult shock-refractory VF and PEA</li>
    </ul>
    <h3>Contraindications</h3>
    <ul>
      <li>None in the adult cardiac arrest</li>
    </ul>
    <h3>Precautions And Side Effects</h3>
    <ul>
      <li>May produce cardiac ischemia and angina</li>
    </ul>
    <h3>Protocols</h3>
    <ul>
      <li>Cardiac Protocol 2005 - Cardiac Arrest: V-Fib or Pulseless V-Tach</li>
    </ul>"